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The Committee for Economic Development
is an independent research and policy organization
of some 250 business leaders and educators.
CED is nonprofit, nonpartisan, and nonpolitical.
Its purpose is to propose policies that bring
about steady economic growth at high employ-
ment and reasonably stable prices, increased
productivity and living standards, greater and
more equal opportunity for every citizen, and an
improved quality of life for all.
All CED policy recommendations must have
the approval of trustees on the Research and
Policy Committee. This committee is directed
under the bylaws, which emphasize that “all
research is to be thoroughly objective in character,
and the approach in each instance is to be from
the standpoint of the general welfare and not from
that of any special political or economic group.”
The committee is aided by a Research Advisory
Board of leading social scientists and by a small
permanent professional staff.
The Research and Policy Committee does not
attempt to pass judgment on any pending 
specific legislative proposals; its purpose is to urge
careful consideration of the objectives set forth
in this statement and of the best means of accom-
plishing those objectives.
Each statement is preceded by extensive dis-
cussions, meetings, and exchange of memoran-
da. The research is undertaken by a subcommittee,
assisted by advisors chosen for their compe-
tence in the field under study.
The full Research and Policy Committee par-
ticipates in the drafting of recommendations.
Likewise, the Trustees on the drafting subcom-
mittee vote to approve or disapprove a policy state-
ment, and they share with the Research and
Policy Committee the privilege of submitting
individual comments for publication.
Except for the members of the Research and Policy
Committee and the responsible subcommittee, the
recommendations presented herein are not necessar-
ily endorsed by other trustees or by the advisors,
contributors, staff members, or others associated 
with CED.
RESPONSIBILITY FOR CED STATEMENTS ON NATIONAL POLICY
vii
Chairman
JOSH S. WESTON
Honorary Chairman
Automatic Data Processing, Inc.
Vice Chairmen
IAN ARNOF
President and Chief Executive Officer
First Commerce Corporation
ROY J. BOSTOCK
Chairman and Chief Executive Officer
The MacManus Group
BRUCE K. MACLAURY
President Emeritus
The Brookings Institution
CLIFTON R. WHARTON, JR.
Former Chairman and Chief Executive Officer
TIAA-CREF
____________________________________
REX D. ADAMS
Dean
The Fuqua School of Business
Duke University
ALAN BELZER
Retired President and Chief Operating
Officer
AlliedSignal Inc.
PETER A. BENOLIEL
Chairman, Executive Committee
Quaker Chemical Corporation
GORDON F. BRUNNER
Senior Vice President and Director
The Procter & Gamble Company
FLETCHER L. BYROM
President and Chief Executive Officer
MICASU Corporation
DONALD R. CALDWELL
President and Chief Operating Officer
Safeguard Scientifics, Inc.
PHILIP J. CARROLL
President and Chief Executive Officer
Shell Oil Company
JOHN B. CAVE
Principal 
Avenir Group, Inc.
CAROLYN CHIN 
Executive Vice President
Reuters America
A. W. CLAUSEN
Retired Chairman and Chief
Executive Officer
BankAmerica Corporation
JOHN L. CLENDENIN
Retired Chairman
BellSouth Corporation
GEORGE H. CONRADES
Executive Vice President
GTE Corporation and President
GTE Internetworking
RONALD R. DAVENPORT
Chairman of the Board
Sheridan Broadcasting Corporation
FRANK P. DOYLE
Retired Executive Vice President
GE
T. J. DERMOT DUNPHY
Chairman and Chief Executive Officer
Sealed Air Corporation
W. D. EBERLE
Chairman
Manchester Associates, Ltd.
WILLIAM S. EDGERLY
Chairman
Foundation for Partnerships
WALTER Y. ELISHA
Retired Chairman and Chief Executive
Officer
Springs Industries, Inc.
EDMUND B. FITZGERALD
Managing Director
Woodmont Associates
HARRY L. FREEMAN
President
The Freeman Company
RAYMOND V. GILMARTIN
Chairman, President and Chief Executive
Officer
Merck & Co., Inc.
BOYD E. GIVAN
Senior Vice President and Chief
Financial Officer
The Boeing Company
BARBARA B. GROGAN
President 
Western Industrial Contractors
RICHARD W. HANSELMAN
Retired Chairman
Genesco Inc.
RODERICK M. HILLS
President
Hills Enterprises, Ltd.
MATINA S. HORNER
Executive Vice President
TIAA-CREF
GEORGE B. JAMES
Senior Vice President and Chief
Financial Officer
Levi Strauss & Co.
JOSEPH E. KASPUTYS
Chairman, President and Chief
Executive Officer
Primark Corporation
CHARLES E.M. KOLB
President
Committee for Economic Development
ALLEN J. KROWE
Retired Vice Chairman
Texaco Inc.
RICHARD KRUIZENGA
President
ISEM, Southern Methodist University
CHARLES R. LEE
Chairman and Chief Executive Officer
GTE Corporation
A. V. LIVENTALS
Vice President, Strategic Planning
Mobil Corporation
ALONZO L. MCDONALD
Chairman and Chief Executive Officer
Avenir Group, Inc.
HENRY A. MCKINNELL
Executive Vice President
Pfizer Inc.
JOSEPH NEUBAUER
Chairman and Chief Executive Officer
ARAMARK Corporation
JOHN D. ONG
Chairman Emeritus
The BFGoodrich Company
JAMES F. ORR III
Chairman and Chief Executive Officer
UNUM Corporation
VICTOR A. PELSON
Senior Advisor
SBC Warburg Dillon Read Inc.
PETER G. PETERSON
Chairman 
The Blackstone Group
NED V. REGAN
The Jerome Levy Economics Institute
JAMES Q. RIORDAN
Stuart, Florida
MICHAEL I. ROTH
Chairman and Chief Executive Officer
The Mutual Life Insurance Company of
New York
HENRY B. SCHACHT
Director & Senior Advisor
Lucent Technologies Inc.
ROCCO C. SICILIANO
Beverly Hills, California
MATTHEW J. STOVER
Group President, Information
Services Group
Bell Atlantic Corporation
ARNOLD R. WEBER
Chancellor
Northwestern University
LAWRENCE A. WEINBACH
Chairman and Chief Executive Officer
Unisys Corporation
MARTIN B. ZIMMERMAN
Executive Director, Governmental
Relations and Corporate Economics
Ford Motor Company
RESEARCH AND POLICY COMMITTEE
*
*Voted to approve this statement but submitted memorandum of comment, reservation, or dissent, see page 80.
viii
Chairman
GEORGE H. CONRADES
Executive Vice President
GTE Corporation and President
GTE Internetworking
MELVYN E. BERGSTEIN
Chairman and Chief Executive Officer
Diamond Technology Partners
GORDON F. BRUNNER
Senior Vice President and Director
The Procter & Gamble Company
FLETCHER L. BYROM
President and Chief Executive Officer
MICASU Corporation
DONALD R. CALDWELL
President and Chief Operating Officer
Safeguard Scientifics, Inc.
CAROLYN CHIN
Executive Vice President
Reuters America
JOHN DIEBOLD
Chairman
John Diebold Incorporated
CHRISTOPHER D. EARL
Senior Vice President
Perseus Capital, LLC
PATRICIA O’DONNELL EWERS
President
Pace University
KATHLEEN FELDSTEIN
President
Economics Studies, Inc.
RAYMOND V. GILMARTIN
Chairman, President and Chief Executive 
Officer
Merck & Co., Inc.
CAROL R. GOLDBERG
President
The Avcar Group, Ltd.
JUDITH H. HAMILTON
President and Chief Executive Officer
First Floor Software
NOAH T. HERNDON
General Partner
Brown Brothers Harriman & Co.
ROBERT C. HOLLAND
Senior Fellow
The Wharton School
University of Pennsylvania
JAMES P. KELLY
Chairman and Chief Executive Officer
United Parcel Service of America, Inc.
FRANKLIN A. LINDSAY
Retired Chairman
Itek Corporation
COLETTE MAHONEY
President Emeritus
Marymount Manhattan College
HENRY A. MCKINNELL
Executive Vice President
Pfizer Inc.
WESLEY D. RATCLIFF
President and Chief Executive Officer
Advanced Technological Solutions, Inc.
HOWARD M. ROSENKRANTZ
President and Chief Operating Officer
United States Surgical Corporation
NEIL L. RUDENSTINE
President
Harvard University
GEORGE E. RUPP
President
Columbia University
JONATHAN M. SCHOFIELD
Chairman and Chief Executive Officer
Airbus Industrie of North America, Inc.
ALISON TAUNTON-RIGBY
President and Chief Executive Officer
Aquila Biopharmaceuticals, Inc.
JAMES A. THOMSON
President and Chief Executive Officer
RAND
CHANG-LIN TIEN
NEC Distinguished Professor
of Engineering
University of California, Berkeley
LINDA SMITH WILSON
President
Radcliffe College
MARGARET S. WILSON
Chairman of the Board
Scarbroughs
Ex-Officio Members
FRANK P. DOYLE
Retired Executive Vice President
GE
CHARLES E.M. KOLB
President
Committee for Economic Development
JOSH S. WESTON
Honorary Chairman
Automatic Data Processing, Inc.
Non-Trustee Members
CHARLES P. HOLT
Vice President
Joseph C. Wilson Center for Research and 
Technology
Xerox Corporation
PAUL SCHIMMEL
Professor and Member
The Scripps Research Institute
Skaggs Institute for Chemical Biology
LARRY K. SMITH
Former Counselor for Secretary of
Defense, William J. Perry
FRED W. TELLING
Vice President
Corporate Strategic Planning & Policy
Pfizer Inc.
CHARLES VEST
President
Massachusetts Institute of Technology
Guests
LEWIS BRANSCOMB
Professor Emeritus
Harvard University
THOMAS CLARK, JR.
President and Chief Executive Officer
Carver Federal Savings Bank
GREG FARMER
Vice President, Government Relations & 
International Trade
Nortel
JOHN MONTJOY
Senior Vice President and
General Counsel
GTE Internetworking
HERMINE WARREN
President
Hermine Warren Associates Inc.
PROJECT
DIRECTORS
WILLIAM J. BEEMAN
Vice President and Director of Economic 
Studies
Committee for Economic Development
SCOTT MORRIS
Senior Economist
Committee for Economic Development
ADVISORS
CLAUDE BARFIELD
Resident Scholar
The American Enterprise Institute
for Public Policy Research
M. ISHAQ NADIRI
Jay Gould Professor of Economics
New York University
RICHARD NELSON
Professor, Department of Economics
Columbia University
PHILIP M. SMITH
Partner
McGeary and Smith
EDITORIAL
ADVISOR
HOWARD GROSS
HG Communications
SUBCOMMITTEE ON SUSTAINING AMERICAN BASIC RESEARCH
ix
Basic research is a critically important—yet 
often undervalued—source of American eco-
nomic growth and prosperity. Advances in fun-
damental science and engineering knowledge
resulting from basic research have made possi-
ble most of our recent technological progress
and the resulting improvements in incomes and
quality of life. Our nation now invests a mere 
0.4 percent of Gross National Product on basic
research.
As this policy statement is being released,
American science and scientists are acknowl-
edged as preeminent in the world. Many of our
scientific endeavors do receive significant polit-
ical, public, and financial support. But compet-
ing demands for scarcer federal dollars, shifting
economic and social priorities, political pres-
sures, and short-term corporate earnings pres-
sures pose long-term threats to the continued
strength of America’s basic research and its con-
tributions to our prosperity.
This policy statement takes a broad look at
America’s basic research enterprise and lays out
the processes and systematic reforms needed
to meet emerging risks to the valuable outcomes
from our investments in basic research. CED’s
Trustees undertook this important project in the
firm belief that significant progress with many
of society’s problems and new discoveries will
primarily depend upon fundamental scientific
insights derived from basic research.
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PURPOSE OF THIS STATEMENT
1Asked why American scientists have won so
many Nobel prizes, a former secretary-general
of the Royal Swedish Academy of Sciences once
remarked, “No other country has invested as much
money in research over the years as the U.S. It’s
as simple as that.” Indeed, America’s long-stand-
ing endowment of basic research has been over-
whelmingly successful, providing American
society not only with the fruits of new knowledge,
but also with the practical benefits of economic
growth and improvements in the welfare of its
citizens. 
CED believes, however, that the success of
American basic research is not simply a matter
of money. Rather, as we argue in this report,
that success has grown from a uniquely American
organization of the basic research enterprise.
That organization has relied on an abiding faith
in the superiority of a free market in ideas and
entrepreneurial competition over top-down deci-
sion-making in ensuring the quality and effi-
ciency of research efforts.
We believe it is essential to uphold the inte-
gral role of government in supporting basic
research, as industry continues to focus on R&D
with specific product-directed goals. The large
economic returns from investments in basic
research show it to be an extremely productive
use of the taxpayer’s money. We are encour-
aged by recent bi-partisan proposals to increase
the nation’s investment in basic research. But we
cannot take today’s political support for grant-
ed, especially as we look towards a future of
greater resource constraints. American excel-
lence in basic research is truly a national treasure,
but its supporters must be vigorous and articu-
late in its defense. 
Basic research—conducted in academic insti-
tutions, federal laboratories, private companies,
and nonprofit research institutions—has pro-
vided the intellectual and technological founda-
tion for innumerable practical inventions that are
integral to American technological and eco-
nomic leadership. Industries as diverse as phar-
maceuticals, defense, electronics, and aerospace
have relied on basic discoveries fueled by gov-
ernment grants.
A critical factor in the translation of basic
research into functional applications has been
America’s unique entrepreneurial spirit. From 
small start-ups to large multinational corpora-
tions, American ingenuity has excelled in con-
verting new knowledge into practical and
profitable products. A common misconception
is that fundamental research is conducted in an
ivory tower, with no regard for practical bene-
fits. On the contrary, a consistent virtue of U.S.
basic research has been the pursuit of funda-
mental knowledge with a sharp eye out for
downstream applications. American entrepreneurs
have been distinguished by their ability to cap-
italize effectively on new knowledge wherever
it arises. 
Like any far-reaching enterprise that com-
prises hundreds of institutions and thousands of
workers, America’s basic research establishment
must constantly renew itself in response to
changing conditions in global economic, politi-
Chapter 1
INTRODUCTION AND SUMMARY OF 
FINDINGS AND RECOMMENDATIONS
2cal, and scientific markets. This enterprise must
also recognize the legitimate expectations of the
society that supports its efforts. 
The basic research enterprise faces impor-
tant questions about the priorities and balance
of its basic research missions, the consistency of
government support, the global dissemination
of new knowledge, and the collapse of Cold
War rationales for massive investment in defense
research. At the same time, the institutions that
perform basic research must maintain the excep-
tional quality of their faculties, grapple with
ever-increasing costs, and confront the complex
challenges of the expanding ties between cor-
porations and universities. 
The goals of this report are first, to set forth
the compelling case for basic research and its ben-
efits to society, and second, to make recom-
mendations to policymakers and practitioners.
We endorse the strength of American universi-
ty-based research and its tradition of excellence.
But we also advocate a ceaseless quest to mea-
sure output against investment, and results
against expectations. This means extending the
use of peer review and competition for research
grants. We argue for an end to political ear-
marks for research, and we are concerned about
“mission creep” in those sectors of the basic
research establishment—particularly certain of
the Department of Energy’s national laboratories
—that have completed or lost their mandates. In
this regard, we are concerned about the growing
tendency of government to directly fund the
development and commercialization of tech-
nologies which, with few exceptions, is proper-
ly the function of the private sector.
This report also reaffirms positions taken in
previous CED policy statements that have spe-
cial relevance to basic research. We place great
emphasis on improving K-12 education to ensure
our future supply of outstanding scientists. We
also insist on the importance of curbing federal
entitlement spending, so that future investments
in basic research will not be undermined by the
budgetary effects of inexorable demographic
pressures.
We take the long view: Although a few scien-
tific breakthroughs find immediate applications,
yields on basic research are typically realized far
in the future. Frequently the greatest benefits are
the least anticipated. The virus research initiat-
ed by the War on Cancer in the 1970s delivered
its most significant benefits—both unintended
and unexpected—in the treatment of AIDS in the
1990s; only now is this research yielding new drugs
that will transform clinical oncology in the 2000’s.
The medical, environmental, social and mil-
itary challenges of the 21st century will demand
solutions that can only emerge from a healthy and
productive basic research system. CED firmly
believes that maintaining excellence in basic
research is essential to America’s continued
prosperity and global leadership. 
FINDINGS
1. Basic research in science and engineering has
made a major contribution to the growth of
the U.S. economy. Economic returns on
investments in basic research are very high.
In addition, the returns to the nation from
basic research investments are substantial-
ly higher than the returns to private firms,
since advances in fundamental knowledge
tend to be widely dispersed and exploited
in innovations that deliver substantial eco-
nomic benefits over a lengthy period.
2. Basic research performed in major research
universities is typically correlated with
strong economic activities in their neighbor-
ing locales. For example, there are more
than 1,000 MIT-related companies in
Massachusetts, with world wide sales of more
than $53 billion. Similar developments have
taken place in California’s Silicon Valley
and the Research Triangle of North Carolina.
3. The federal government has long been the
most important source of support for basic
research. Government funding of basic
research exceeds that of private industry in
both absolute amount and as a share of its
total R&D activities. Of the nearly $63 bil-
lion that government spends on R&D annu-
ally, $18 billion goes to basic research, while
just $8 billion of industry’s total R&D spend-
ing of $133 billion does so. However, the long-
3term future of federal funding is clouded by
the likely budgetary effects of impending
demographic pressures.
4. Publicly-funded basic research is critical
to private sector innovation. Although pri-
vate industry conducts basic research, these
efforts are primarily to “fill-in-the-gaps”
within broader programs of applied research
aimed at new product development. Industry
depends on the intellectual foundations
provided by basic researchers in the nonprofit
and public sectors for innovative products
and services. A recent study found that 73
percent of research publications cited by
industrial patents were derived from gov-
ernment-funded research. 
5. American science is not conducted in an
“ivory tower.” Even basic researchers who
are exploring fundamental problems of the-
oretical physics, advanced materials, or
molecular biology are doing so with the
expectation that their work will be relevant
to the development of new chips, compos-
ite aircraft, or cancer drugs. 
6. Federal funding is directed principally not
to institutions, but to individual investiga-
tors who compete directly for government
grants. These investigators represent the
backbone of the American basic research
enterprise. An essential strength of the
American basic research system is the allo-
cation of grants through a rigorous and com-
petitive peer review process.
7. The most important American institutions
conducting basic research are the nation’s
200 major research universities. These insti-
tutions are characterized by highly com-
petitive allocation of funds, a tradition of
excellence, and a brain trust of highly trained
and motivated faculty, post-doctoral fel-
lows, and graduate students. The wide,
unrestricted dissemination of research
results has been important to the broad
benefits of university-based basic research
for our society.
8. Passage of the Bayh-Dole Act in 1980 explic-
itly allowed recipients of government grants
to retain title to inventions made using
government funds. This law has stimulat-
ed intense growth in university patenting
and subsequent technology transfer from
basic research institutions to industry. As a
result, industry is increasingly involved in
collaboration with, and sponsorship of,
university-based researchers. While cer-
tain fields are comparatively untouched
by Bayh-Dole, the biotechnology industry
in particular has been a major beneficiary.
9. When managed skillfully, university-indus-
try relationships can benefit both the research
institutions and companies, while society
reaps rewards from the efficient transfer
of technology into useful products. CED
believes, however, that these relationships
should be conducted according to guidelines
that protect the primary basic research mis-
sion of the universities. 
10. The priorities of the federal government
are changing. With the end of the Cold
War, Pentagon requirements for basic
research have shifted and contracted. As a
result, the missions of the massive federal
laboratory system have changed, and in
some cases, disappeared. The federal lab-
oratories continue to play important roles
in defense, health, and energy. But some, par-
ticularly among the national laboratories at
the Department of Energy, have not acted
forcefully to eliminate work in areas no
longer relevant to their missions, nor to
expose themselves to merit-based peer
review processes. 
11. Deficiencies in science teaching in primary
and secondary education threaten our future
supply of outstanding young researchers.
These deficiencies may also limit the capac-
ity of women and minorities to pursue
careers in basic research. Moreover, con-
tinued societal support for basic research
depends on an informed electorate who
recognize the benefits of a strong basic
research system.
12. As other nations build their economic
strength, they will inevitably also invest
4in basic research capabilities. While the
United States continues to be the world’s
leader in the generation of new knowl-
edge, other countries are contributing more
than in the past. We have nothing to fear from
these trends. So long as basic research is freely
disseminated around the globe and the
U.S. continues to capitalize on the practical
application of new knowledge, global expan-
sion of basic research on balance will ben-
efit the U.S. economy and society at large.
SUMMARY OF RECOMMENDATIONS
1. Policymakers in Congress and the Admin-
istration, informed by a national policy
debate, should set broad national priorities
for basic research that reflect the needs of
society at large. Scientists have an impor-
tant role to play in informing the debate, but
such priorities are appropriately set by our
accountable, elected political leaders.
2. Federal support for basic research should
continue to be diverse in its sources and objec-
tives. Efforts to impose central control or to
concentrate resources in a single research 
area should be resisted. 
3. Within the broad priorities established by
policymakers, the primary mechanisms for
allocating federal basic research funds in all
agencies and to all institutions should be
based on scientific merit determined through
peer review. In general, support should be
given to individuals and not to institutions.
Political earmarks for basic research are an
unproductive use of scarce resources.
4. Because federal support is essential for a
thriving basic research enterprise, the long-
term federal budget outlook is critical. Basic
research should be a high priority in the
federal budget in the decades to come. This
will require reforms of the federal entitlement
programs that otherwise will grow explosively
in response to demographic pressures a few
years hence.
5. The most productive recipients of federal basic
research funds are the nation’s research uni-
versities. Their leadership and productivi-
ty should continue to be a guide for other
institutions receiving federal support.
6. Individual investigators are increasingly
weighed down by the complex demands of
seeking grant support. Mechanisms should
be devised to allow researchers to compete
for longer-term funding, and administrative
burdens from granting agencies should be
reduced. 
7. Funding agencies are increasingly attempt-
ing to reduce payments for indirect costs and
to shift costs to research institutions. We rec-
ommend reform of the system for deter-
mining indirect costs to ensure simplicity,
fairness, and reductions in the costs of com-
pliance. 
8. CED calls on Congress and the Admin-
istration to clearly determine the missions
of the Department of Energy’s national lab-
oratories and decide what realignments of
missions and functions are necessary. The
activities of the national labs must be jus-
tified on the basis of strong missions, peer-
reviewed determinations of scientific merit,
and efficient structures for management
and oversight.
9. With few exceptions, government should not
be in the business of directly funding the
development and commercialization of
technologies, which is properly a function
of the private sector. Exceptions generally
occur in cases where the funding serves a
clear procurement function for government
missions, such as defense technology needs. 
10. The federal government should continue to
play a major role in funding large-scale
infrastructure projects that are used exten-
sively by many researchers, such as exper-
imental energy generation facilities and
the Hubble Space Telescope.
11. As CED has recommended in previous
reports, the United States must raise acad-
emic achievement in math and science in
grades K-12. To improve learning in math and
science, we urge the adoption of national stan-
5dards, policies to increase teacher knowledge
and skills, and upgrades in classroom cur-
ricula, facilities, and teaching materials. 
12. The training of graduate students is an
indispensable role of the research universi-
ties. The federal government should make
graduate student training a higher priority
and increase its funding of scholarships
and training grants. Research universities
should explore ways to reduce the time and
expense required to obtain a doctorate. Since
a majority of Ph.D. graduates will not return
to the research universities as faculty, grad-
uate schools should offer training programs
and mentorships to prepare their students
for employment outside of academe.
13. Industry-university relations and univer-
sity patenting and licensing should be
directed towards maximizing benefits for
the society at large. As a general principle,
new knowledge from university basic
research should be freely disseminated. In
cases where new knowledge has commer-
cial potential, however, patenting and licens-
ing may be appropriate and in the public
interest. However, these technology trans-
fer activities should not dilute or compro-
mise the basic educational and research
missions of the university.
14. The United States should expand its efforts
to benefit from international collaboration
and the globalization of basic research. To
this end, public and private policies should
ensure that the United States is an attractive
place for researchers to live and work. Our
immigration policies should be further 
liberalized to allow foreign scientists and engi-
neers more long-term and permanent 
visas as well as more short-term visits to act
as consultants, collaborators, and visiting
scholars.*
*See memorandum by James Q. Riordan, page 80.
6America’s basic research is one of the nation’s
greatest assets. Advances in fundamental sci-
ence and engineering derived from basic research,
combined with strong economic incentives for
technological change and innovation, have made
an enormous contribution to the economic pros-
perity and social progress enjoyed by U.S. citi-
zens. Achievements in basic science and
engineering have also contributed to our nation’s
role as economic, social, political, and military
leader, which has helped bring about an histor-
ically unique period of relative peace and stability
in the world. It is clearly in the national inter-
est to maintain and to strengthen America’s
commitment to basic research and to improve
the productivity of resources used in basic
research.
As in the past, the economic prosperity of
future generations will depend critically on pre-
sent day efforts to sustain this country’s his-
toric and fundamental commitment to basic
research. Indeed, this commitment is a tremen-
dous source of hope for the future; the solu-
tions to many of society’s greatest challenges
and the key to exploiting new opportunities—
such as the cure for cancer and AIDS, unlocking
new productive potential from natural and man-
made resources, and the antidote to looming
environmental concerns like global warming—
will depend upon fundamental scientific insights
derived from today’s basic research.
It is important that policymakers and the
public understand the benefits of basic research.
Without an appreciation of these benefits, it will
be difficult to maintain our national commit-
ment to the basic research enterprise, and thus
maintain our nation’s leadership in the future.
THE BENEFITS OF BASIC RESEARCH
Although basic research—experimental or
theoretical work undertaken to add to the knowl-
edge of fundamental science and engineering—
accounts for only 15 percent of total R&D in the
United States, it has been a major factor in the
improvement of technologies, living standards,
and life styles. For non-scientists, the contribu-
tion of basic research may not be obvious because
of the complicated “trail” between research, dis-
covery, and innovation. One reason the trail is com-
plicated is that fundamental knowledge derived
from basic research is generally widely shared
and often exploited by scientists and entrepre-
neurs who were not involved in the original
discovery. Moreover, the potential value of new
discoveries from basic research may not be
immediately evident even to the discoverers
and consequently the associated innovations
often occur several decades after the initial dis-
covery. By contrast, there may be only a few
months or years between applied and develop-
ment research and commercial innovations. (For
definitions of basic, applied, and development
research see Box 1, page 7.) Consequently, the
results of applied research can easily be observed
in new or improved products and processes
introduced by the business firms that sponsored
the research. Of course, basic, applied, and devel-
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7Traditional Definitions
Scientists and R&D sponsors have traditional-
ly divided R&D activities into three categories:
basic, applied, and development research. Al-
though it is often difficult to place a specific
research project exclusively in one of these cate-
gories, the data on R&D activity published by
the federal government continue to follow this
division. These three categories may be
described as follows:
• Basic research is experimental or theoretical
work undertaken to add to fundamental sci-
ence and engineering knowledge. This
knowledge is often drawn upon in subse-
quent basic or applied research. Although
basic research can be exploratory, without
any particular application in mind, the vast
majority of basic research is directed toward
achieving new science or engineering knowl-
edge in areas of interest to funders.
• Applied research includes investigations
that draw from basic research or other
applied research to create new knowledge
that in turn can be used to develop new or
improved products and processes.
• Development research draws on existing
knowledge gained from basic and applied
research and from practical experience for the
purpose of creating innovative new products
or processes, as well as incremental improve-
ments for existing products or processes.
The Discovery Process and 
Alternative Definitions
Despite the traditional distinctions and bound-
aries between basic, applied, and development
research, it would be a mistake to draw the con-
clusion that the best description of the discovery
and innovation process is a linear model which
begins with basic research, proceeds to applied
research and ends in development. Discovery
and innovation often do not proceed in such a
sequential and uni-directional fashion.
Analysis of individual cases demonstrates that
technological advances occur in an interactive,
interwoven process where breakthroughs take
place both before and after basic research. There
are numerous examples of technological break-
throughs occurring well before the basic science
was understood (see bullet on “Xerography”
page 9). This interactive discovery and innova-
tion process—often described as a “chain link”
or “continuous” model incorporating feedback
loops—appears to be more characteristic of the
R&D process than the linear model.
Given this deeper understanding of the dis-
covery process, and its rejection of a linear
model, characteristics other than the traditional
definitions have been proposed to delineate
basic research. For example, it has been suggest-
ed that the time period between research and its
effects on output is one useful point of distinc-
tion. There have been many instances where a
long period—often 10 to 20 years—has elapsed
before new knowledge derived from basic
research had any influence on output. However,
there are also cases where the time lapse
between basic research and innovation is very
short. Moreover, many business firms have
recently instituted reforms in the research
process designed to shorten this time lag. 
An additional distinction between basic and
applied research is based upon the extent to
which the results are shared with others.
Fundamental knowledge tends to be widely
shared, because, unlike most products, its use
by another individual does not reduce its avail-
ability to those who made the discovery (see
Box 2, page 12). By contrast, the dispersion of
the results of applied research is generally more
circumscribed by patents or secrecy so that the
fruits of discovery can accrue to the firms spon-
soring the research.
The Myth of Untargeted and
Unmanageable Research
Perhaps because individual discoveries are
often serendipitous and the discovery process
Continued on page 8
BOX 1
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8opment research are all vitally important for
economic progress. However, basic research is
the foundation of most technological change, as
explained below.
Although the critical role of basic research in
the development of new technology is some-
times easily observed, as in the case of biomed-
ical research undertaken explicitly for the purpose
of developing new drugs, more often the rela-
tionship between fundamental science and new
or improved goods and services is quite complex
and indirect. Only retrospective examination of
specific cases makes evident that basic research
has been the foundation of many revolutionary
technological innovations. The following are
some examples:
• Lasers owe their heritage to basic research by
a number of scientists including: Albert
Einstein, the first to recognize in 1917 the
theory of “stimulated emissions;” Charles
Townes of Columbia University who in 1958
discovered how to create a focused microwave
beam; Townes and Arthur Schawlow (of Bell
Labs) who published the theory of how stim-
ulated emissions would work with shorter
wavelengths, including those in the spec-
trum of visible light; and Theodore Maiman
who constructed the first laser at Bell Labs in
1960. Today, laser applications have a wide vari-
ety of applications, including surgery, telecom-
munications (lasers with fiber optics), printers,
precision drills, and other machine tools. 
• X-rays were initially and fortuitously discov-
ered in 1895 by William Roentgen, as he was
experimenting with cathode rays. Since then,
many scientists and engineers have devel-
oped diverse uses for x-rays. The best known
applications are in the medical field. In more
recent years, the value of x-rays has been
enhanced greatly by the mathematical con-
tributions of physicist A.M. Cormack (for
which he won a Nobel prize). Cormack’s work
contributed to the development of computerized
axial tomography (CAT), which has revolu-
tionized medical imaging and diagnosis. Today,
CAT scans produce three dimensional x-ray
itself is inherently complex, it is sometimes
assumed that basic research cannot be targeted
toward objectives or managed effectively. But in
fact, R&D investments, including basic research,
can be and generally are, carefully managed
and directed to achieve specific objectives. 
An institution or an individual invests in
basic research within a particular context, in a
setting in which the research investment is
aimed at the creation of valuable results. In a
university, research makes a contribution to the
education of students, and to fields of knowl-
edge, which may impact the economy, the envi-
ronment, the health of the populace, or the
security of the nation. Government laboratories
exist in the context of a particular government
mission, be it health care, energy, defense, agri-
culture, etc., which affects the value context of
that institution’s basic research efforts. The
same is also true in industry research, where the
objectives and applications are clear. 
Management of all research, including basic
research, is aimed at maximizing the value that
is likely to be created from the research invest-
ments, where the notion of value is particular to
the mission and setting of the institution.
Implementing this principle forces the institu-
tion and the individuals within the institution,
to develop a clear understanding of what value
is, and what can be done to increase it. Choices
of research areas, for both basic and applied
research, reflect this understanding of value.
Realistic measures of progress and of success
are developed in the value context, and
employed to influence the course of research. In
short, a set of processes, deeply involving the
researchers themselves, but including the other 
stakeholders is created, affecting basic research
at many stages—in the allocation of funding
across sectors, the decisions on resources for
particular efforts, and the measures of progress
and results.
Continued from page 7
9images. X-rays are also used for the detection
of internal stress defects in materials and in the
assembly of small electronic microcircuits. 
X-rays also have security applications, such as
in airport baggage inspection.
• Semiconductors were first discovered in 1886
by German chemist Clemens Winkler, but
remained little more than a laboratory oddi-
ty for many years. Before World War II some
uses were found for semiconductors (in radars,
for example), but wide-ranging use waited until
the advent of transistors in 1948. Semiconductors
have since created a revolution in electronics.
Tiny electric circuits are now used in every imag-
inable electric device—miniature radios, tele-
vision, telephones, airborne navigational aids,
diagnostic instruments, etc. Transistors were
developed at Bell Labs by American physicists
Walter Brattain, John Bardeen, and William
Shockley. Just as the transistor replaced the vac-
uum tube, integrated circuits and micro-
processors replaced transistors. 
• The Global Positioning System (GPS) owes
its origin to theoretical research on atomic
structure and to the construction of an atom-
ic clock. Work on an atomic clock, which
began before World War II, was initially under-
taken by researchers interested in the effects
of gravity on time. These researchers cer-
tainly did not anticipate the contribution of their
work to a GPS constellation of 24 satellites that
make it possible to provide extremely accu-
rate information on location. GPS has had a
major impact on transportation and its economic
impact is anticipated to grow very rapidly
(e.g., in the “smart” highway program).
• Treatment for HIV disease and AIDS—espe-
cially the impact on HIV protease inhibitors
on slowing disease progression and pro-
longing survival—resulted from more than 10
years of public and private sector funding of
biomedical research in several areas includ-
ing immunology, virology, and biochemistry
(see Merck discussion in Case Studies sec-
tion). Research at the NIH elucidated the
pathogenesis of HIV infection and the slow but
steady deterioration of the immune system by
HIV that eventually leads to AIDS, and helped
characterize the molecular composition of
HIV. Research conducted by academic and
other nonprofit laboratories demonstrated
the capacity of HIV to replicate and seed
numerous reservoirs of virus throughout the
immune, central nervous, and gastrointesti-
nal systems. Research conducted by several
pharmaceutical companies contributed fun-
damental knowledge about the role of HIV pro-
tease enzyme in the HIV life cycle—including
its molecular 3-D structure and the mechanism
of the emergence of viral resistance—and
eventually led to the design of several potent
HIV protease inhibitors that prevent replication
of the virus and reduce viral levels in the
body.
• Xerography, invented by Chester Carlson in
1938, had a profound impact on information
processing (see Xerox discussion in Case
Studies section), but that impact was delayed
by a quarter of a century. Many advances in
technology, basic science, and engineering
were necessary before Carlson’s discovery
was commercialized. Research in the private
labs of Battelle Memorial Institute provided
the foundation for Haloid-Xerox (now Xerox
Corporation) copier products, more than 20
years after the original discovery by Carlson.
Xerox acquired a license to the process in
1947 and assembled a large team of scientists
and engineers to further advance the xero-
graphic process, filling in the gaps in funda-
mental knowledge that stood in the way of
necessary product improvements. Xerox spon-
sored both basic and applied research and
involved scientists and engineers in many
disciplines, generating advances that led to
the modern high-speed copier.
• The Internet. When BBN and others built
the ARPANET—the forerunner to the Inter-
net—in 1969, its primary goal was to enable
scientists and engineers across the country
to share ideas and information. But its efforts
also brought together more than a century
of fundamental research and discovery. The
size, speed, reliability, and cost-efficiency of
network switching equipment were initially
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based on advances in miniaturization of elec-
tronics—particularly digital electronics—which
had its origins in the development of logic
circuits in the 1850’s. Early circuits were built
with various complex forms of electrically
controlled switches, such as the Strowger step-
by-step switch, which was the heart of the
first completely automated telephone exchange.
The invention of the transistor made possible
economical and reliable packet switching,
which depends on a robust mesh of large
numbers of relatively inexpensive, dedicat-
ed computers able to run unattended for long
periods. The links between these switching ele-
ments also rest on the results of basic research
in information theory. In the 1940’s, Claude
Shannon, a scientist at Bell Labs, presented a
means of symbolically analyzing the behavior
of switching circuitry. Shannon’s work was close-
ly related to the system of symbolic logic
developed by George Boole in 1848, and which
has come to be known as Boolean algebra.
Today’s scientists and engineers still rely on these
developments as they continue to enhance
the Internet with remarkable speed. 
Hundreds of additional cases could be cited
to illustrate that the economic and social effects
of basic research are pervasive in our society. 
The innovations described above and many
others demonstrate certain characteristics of
technological advances:
1. The benefits of basic research are large,
widely dispersed, and frequently unan-
ticipated;
2. New scientific discoveries and technolog-
ical advances generally have a rich history
of basic science behind them, often build-
ing on and extending the work of others;
3. Technological advances often combine dis-
coveries in several fields—see the above
example where x-rays, mathematics, and
computer technology were combined to
develop CAT scans;1
4. Knowledge resulting from basic research
tends to be widely dispersed and employed
by researchers in other fields;2
5. Even applied and development research
can help drive new basic discoveries: 
• by developing new tools and instru-
mentation for use in basic research;
• applied researchers frequently must step
back and perform basic research to fill gaps
in fundamental knowledge that are
required to achieve their practical goals; 
• development researchers often make new
discoveries in the course of their applied
work that adds to our basic understanding
of nature.
For further observations on the discovery and
innovation process see Box 1, page 7.
THE ECONOMIC IMPACT OF BASIC
RESEARCH
There is strong evidence indicating that basic
research in science and engineering has made a
major contribution to the growth of the U.S. econ-
omy. The study of individual cases shows that dis-
coveries and innovations derived from basic
research have led to new products and industries
that employ thousands of workers nationwide. Of
course, technological change resulting from basic
research often results in temporary displacement
of workers in older industries, as well. And basic
research is only one of several factors—such as the
education of the labor force and the stock of cap-
ital—that accounts for economic growth. Thus, iden-
tifying the net impact of research expenditures on
national economic growth generally involves the
employment of sophisticated models of economic
growth, an area of economic research that has
been ongoing over the last four decades.3 A con-
servative interpretation of the results of this work
indicates that total R&D accounted for 12 to 25 per-
cent of the annual growth in productivity during
post-World War II decades.4 This suggests that the
cumulative impact on living standards has been
very large. Moreover, a new view of economic
growth suggests that R&D has dramatically larg-
er economic effects.5
Basic research is a critical part of this contri-
bution to growth. One reason that basic research
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is so important is that advances in fundamental
knowledge tend to be widely dispersed, with
discoveries extended by other scientists, and
built on in ways that often result in enormous 
economic benefits for society over a prolonged 
period. Also, as noted earlier, advances in applied
and development research activities are often
critically dependent on earlier advances in fun-
damental science and engineering derived from
basic research.
The Rate of Return on Basic Research
Investments
Another approach for gauging the impact on
productivity of basic research, and of R&D gen-
erally, is to estimate the internal rate of return on
R&D investments made by individual firms or
industries.6 Many such studies provide strong evi-
dence of the economic benefits of R&D.7 Rate of
return studies measure both the increase in pro-
ductivity experienced by the industries funding
R&D and the “spillover” benefits that improve
productivity in other industries. Although the range
of estimated rates of return is quite wide, the con-
sensus is that on average private returns are
very high relative to other investment opportu-
nities—on the order of 20 to 30 percent annual-
ly, or roughly double the average historical
return to stock market investments. Moreover,
“social” returns on R&D investments—that is, the
returns to society as a whole—are substantially
higher than private returns.8 The social returns
to basic research are often particularly high due,
in part, to the wide dispersion of fundamental
knowledge, which frequently leads to additional
discoveries and applications in diverse fields.
The difference between private and social
returns on investments in basic research, often
described as a “market failure,” is an important
justification for public funding of research and
for tax policies to encourage increased research
(see Box 2, page 12). Business investments in
research are driven by expected private benefits.
In order to maximize the benefits to society as a
whole, the optimal government investment strat-
egy is to provide additional funding for those
research activities that offer social returns in
excess of private returns. 
Although basic research investments are com-
monly viewed as “high risk,” this best describes
the private sector’s, rather than the public sector’s,
investments in basic research. Aprivate firm must
capture some minimum level of benefit over a rea-
sonable period of time to justify its investment.
Because the results of basic research are often
unpredictable (in outcome and in timing) and
widely dispersed, capturing adequate returns at
the firm level is difficult, and consequently risky.
But for government, the returns to public invest-
ments in basic research need not be captured by
an individual entity—be it a researcher, univer-
sity, or agency—in order to justify the invest-
ment. Rather, so long as the results are widely
dispersed and used by many different individu-
als and institutions, the public benefits from the
government’s investments. The risk, then, is much
smaller for these public investments than it would
be for a comparable investment by a private firm.
Further, the “portfolio” of basic research
investments which the government holds is far
larger and more diversified than that of any
individual firm. As a result, risk associated with
the whole universe of government-funded pro-
jects, which will include many winners and
losers, is much lower than would ever be pos-
sible within a single firm.
Regional Economic Benefits
Basic research performed in major research uni-
versities (and in other public and private labs)
often has a large indirect impact on the econo-
my of the regions where the universities are
located. For example, a study by BankBoston
shows that research conducted at MIT has had
a large impact on the economy of Greater Boston,
where numerous knowledge-based companies
are located.9 There are now estimated to be more
than one thousand MIT-related companies locat-
ed in Massachusetts with world-wide sales of 
$53 billion. About 125,000 workers are employed
by these companies in Massachusetts. World-wide
employment of these MIT-related companies is
about 353,000 workers. Of course, many other
regions of the nation, such as the Silicon Valley
of California and the Research Triangle of North
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Carolina, have benefited similarly from the pres-
ence of major research universities.
PUBLICLY-FUNDED BASIC
RESEARCH IS CRITICAL TO 
PRIVATE SECTOR INNOVATION
As described in Chapter 3, universities are the
largest venue for basic research, but it is also
performed in government laboratories, industry
laboratories, and in other private nonprofit insti-
tutions. In several of the historical cases mentioned
earlier in this chapter, the basic research under-
lying technical advances was undertaken in pri-
vate labs operated by business firms. Nevertheless,
empirical evidence on industrial innovation in
earlier decades found that many important new
products and processes in the marketplace could
The federal government is by far the most
important funder of basic research (see
Appendix 1 for an overview of government and
industry resources for basic research). What
accounts for this role? There are two general
explanations, one defined by the needs of the
government itself, and the other by the inability
of private markets to adequately respond to the
needs of the economy and society at large. First,
government funds basic research, and R&D in
general, simply as a matter of procurement. Just
as government purchases pens and pencils to
carry out administrative tasks, it also “purchas-
es” research to support agency missions. In this
sense, the Department of Defense funds research
in physics and computer science in order to gen-
erate knowledge that will lead to better defense
systems. In general, this explanation applies
more strongly to development activities than it
does to basic research, which explains the pre-
dominance of federal development spending
over basic research spending. That is, short-
term, well-defined needs take precedence over
longer-term, less-defined needs.
But there is a second, broader category of
explanations for why government is the primary
funder of basic research. These explanations
transcend the narrowly-defined needs of the
various federal agencies. As we discuss through-
out this chapter, basic research has resulted in
countless social and economic benefits in the
United States. The very fact that the benefits of
basic research are so broadly realized explains
the central government role in its support. 
In economic terms, the knowledge that results
from basic research is, by and large, a public
good. Unlike private goods, a public good can be
used simultaneously by any number of individ-
uals without anyone’s use diminishing its sup-
ply. For example, one person’s use of a scientific
formula does not exclude another person’s use,
nor does it diminish the formula in any way.
This general characteristic has many implica-
tions, one of the most important of which is that
it makes private ownership of a public good dif-
ficult and economically inefficient. 
Because an individual or firm cannot easily
reap all of the benefits of the scientific formula
(or other potential outcomes from basic
research), these private market actors tend to
underinvest in basic research activities from soci-
ety’s perspective. As a result, a gap emerges
between the prevailing level of private invest-
ment in basic research and the level that would
maximize the benefits to society at large.
Economists identify this gap as a market failure
and point to government intervention as neces-
sary to fill this funding gap and exploit the posi-
tive externalities of basic research.
The Pfizer case study (see Case Study section)
puts the distinctions of public and private sup-
port for R&D in very practical terms as they
apply to drug innovation: “Industry and acade-
mia each play vital yet different roles in [the
innovation] process, with industry focusing on
integrating basic science findings in a directed,
applied process of managed drug develop-
ment...This development enterprise is consider-
ably different from the inquisitive, open-ended
nature of basic academic research.”
BOX 2
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not have occurred without academic research.10
Today industry continues to perform basic research
in many areas (see Appendix 1 for an overview
of industry support for basic research), but height-
ened competitive and financial pressures have
encouraged many firms to place more emphasis
on short-term applied and development work (see
Chapter 3). Consequently, government-funded 
(primarily university-based) basic research is
now more critical to industrial technology.
The growing importance of publicly funded
research in industrial innovation was recently con-
firmed in a 1997 study based upon an analysis
of citations in patents issued to U.S. industry.11
U.S. patent law requires that the front pages of
patents report “other references,” i.e., impor-
tant prior art upon which the patent improves.
The study examined 430,226 citations on the
front pages of 397,660 patents issued from 1987
to 1988 and 1993 to 1994. This analysis revealed that
73 percent of the research papers cited by industry patents
referred to “public science”—government funded
research reported in papers authored by scientists
working in academic, governmental, or other insti-
tutions. Only 27 percent of cited materials was
authored by industrial scientists. Moreover, a
comparison of citations in the two time periods
showed rapid growth in the dependence of pri-
vate technology on public science.
Although much of the research undertaken in
universities is intended to advance fundamen-
tal knowledge in science and engineering, it fre-
quently has very practical applications. Indeed,
in recent years many talented scientists employed
by research universities have participated in
cooperative research efforts with businesses and
consequently, a growing proportion of their
research has become directed at commercially valu-
able objectives. Moreover, the major research
universities have very active technology trans-
fer offices working to assist businesses to acquire
new technology. As noted in Chapter 3, while
research universities perform large portions of
the basic research underlying commercial tech-
nology, they also benefit society by training
future scientists and engineers. In fact, the train-
ing of future researchers is the most important
thing that universities can do to ensure a strong
future for basic research.
Because of the characteristics of basic research,
government is its primary funder (see Box 2, page
12). CED strongly disagrees with the “new
thinking” currently in vogue among some com-
mentators12 which holds that government fund-
ing of basic research is unnecessary in a free
market economy and that a reduction in fund-
ing for basic research would have little eco-
nomic effect because business innovation relies
primarily on existing technology. The evidence
on patent references described above indicates
that this “new thinking” is seriously flawed.
Technological development in industry is high-
ly dependent on publicly funded basic research
undertaken in universities and elsewhere.
THE FUTURE IMPACT OF BASIC
RESEARCH
Basic research has been tremendously impor-
tant to our economy and society throughout
this century. But what of the next century? Does
basic research promise to bring just as big a
payoff to as many areas of our lives in the
future? The answer, we believe, is a resounding
yes. The challenges and opportunities facing
our economy and society in the years to come
are varied and plentiful. And in case after case,
advances in fundamental scientific knowledge
are necessary before we can hope to see reme-
dies or benefits.
For example, as computers and information
technologies become increasingly sophisticated,
our expectations for future progress will be
unrealized absent advances in fundamental
knowledge. The hopes for a “computer that
learns” require significant scientific break-
throughs—possibly in DNA research as well as
in computing13—and not simply steady tech-
nological improvements and tinkering.
DNA research itself holds great promise for
benefits in all aspects of human health and well-
being. But moving from the current process of
mapping genes to that of understanding the
maps themselves and the significance of gene
sequences is an enormous challenge that will occu-
py scientists for decades.
Basic research will also be important in iden-
tifying and defining social problems that vex us
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today. For example, the current debate swirling
around global warming is a measure of our
ignorance in this area. With scientific progress we
can move beyond political contention to prop-
erly defining problems and determining reme-
dies, which themselves will likely be derived from
basic research.
Of course, the prospects for future scientific break-
throughs in specific areas are largely unknowable
to us today, and in many cases, appear almost
unfathomable. Ideas that currently exist in theo-
ry would, if brought to fruition, redefine the way
we exist as human beings and as a society.
“Nanotechnology” is but one remarkable exam-
ple. The ability to manipulate molecules sys-
tematically, today a theoretical proposition, may
offer the potential to live in a world of science fic-
tion, where nature can be replicated in a million
different ways to any number of ends. Basic
research itself might ultimately prove molecular
engineering to be fantasy rather than reality; but
speculating about its potential underscores the dra-
matic nature of scientific progress and the tremen-
dous unknowns that are associated with it. 
The list of potential outcomes in basic research
is endless, but in considering the opportunities
and challenges of the future, one way to think of
basic research is as low-cost insurance—cur-
rently, basic research uses less than one-half of
one percent of GDP to create very significant long-
term economic and social gains.14 We have only
the slightest understanding of what lies ahead.
But our greatest hope for capitalizing on unknown
opportunities and avoiding unknown calamities
is investing in the scientific knowledge that will
meet these unknowns in the decades ahead.
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The success of basic research in this country
is due in large part to the unique characteristics
of the American research system. The American
way of doing research is characterized by the
flexibility and heterogeneity of its institutions
and disciplines, the intense competition for
research funds, and the independence and creativity
of individual scientists and engineers. More than
anything else, the high caliber of our individual
scientists and engineers accounts for the excep-
tional quality of our basic research. In the words
of one observer, American scientists are a “nation-
al treasure chest.” Moreover, the economic impact
of our basic research also reflects the respon-
siveness of the U.S. economy to technological
change, innovation, and commercial needs. 
The dynamic character of the U.S. basic
research system is particularly evident now as
the entire R&D system is undergoing substan-
tial change. The characteristics of this most recent
wave of changes include the following:
• Because of increased competitive pressures, many
businesses are taking steps to improve the man-
agement of their research activities and the return
on R&D investments. This is reflected in (1)
greater emphasis on applied and develop-
ment activities, which have more timely and
certain payoffs, (2) efforts to become more
competitive by reducing time-to-market; and
(3) actions to reduce R&D costs, including
the downsizing of large industrial labs.
• The priorities of the federal government are chang-
ing. (1) The end of the Cold War, which re-
sulted in sharp cuts in defense appropriations,
has placed basic research in areas traditional-
ly funded by the Pentagon at a disadvantage,
while funding for certain civilian priorities,
particularly health research, continues to grow
rapidly. (2) Unless entitlement programs for
the elderly are reformed, entitlement spending
will crowd out other discretionary expendi-
tures, creating the potential for declines in fed-
eral investment in basic research. (3) With
heightened concern for our international com-
petitiveness, the federal government has
increased funding of collaborative efforts by 
government and business to accelerate com-
mercial technology, a change that threatens to
squeeze resources for future basic research.
• Modern technology is bringing forth radical changes
in the research enterprise itself. The revolution in
information technology has resulted in more
rapid transfer of knowledge and increased
opportunities for one researcher to build upon
the discoveries of others. This trend is partic-
ularly important in those fields of research
where modern technology permits rapid repli-
cation of work that the original researcher
took years to complete.
• In many cases university research has taken on a
greater entrepreneurial character. Federal leg-
islation enacted in the 1980s to facilitate eco-
nomic development now permits universities
to hold patents to, and license, work funded
by the federal government, and business has
increased funding of research in universities.
Chapter 3
THE EVOLVING AMERICAN BASIC
RESEARCH SYSTEM
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This trend is also explained by the ability of
industry, particularly the biotechnology indus-
try, to translate basic research into commer-
cial products very quickly. 
• Collaborative efforts between basic research insti-
tutions—universities and business, business and
government etc.—and between disciplines are
growing in importance. Rapidly rising research
costs, particularly for capital equipment,
have been an important motivation for insti-
tutional collaboration. Inter-disciplinary col-
laboration has been driven by the nature and
complexity of the questions explored.
International collaboration in research has
also expanded, encouraged by the need to share
costs, especially in projects with large capi-
tal infrastructure requirements such as high
energy physics and space exploration.
• Increased foreign presence in R&D has intensi-
fied in recent years, even in basic research. Other
countries are increasing their investments in
R&D and basic research, including develop-
ing countries which spent virtually nothing on
R&D just a few decades ago. This trend is
reinforced by the rapid dispersion of knowl-
edge and the tendency of international cor-
porations to locate research in countries where
skilled workers are abundant and specialized
skills are available. The increased availability
of opportunities for employment abroad has
also reduced the number of foreign scien-
tists—including those educated in the United
States—choosing to locate in the United States.
This chapter briefly describes the qualities of
the American basic research system that have
led to its success, as well as the evolving nature
of these qualities: its institutional structure, the
human infrastructure, and the system of funding.
Finally, the chapter points to international trends
that promise an increasingly global context for
American basic research in the years to come.
TODAY’S BASIC RESEARCH 
INSTITUTIONS
The current institutional structure for basic
research is largely a legacy of important decisions
made by government and industry after World
War II and throughout the Cold War about how
and where to allocate resources for basic research
(see Box 3, page 17). One key characteristic of the
American basic research enterprise since the
late 1930’s has been the predominance of feder-
al government funding relative to other funding
sources (see Box 2, page 12). Industrial and other
sources of funding, though smaller, have also
played important roles in supporting basic
research (see Appendix 1 for an overview of
funding patterns for basic research).15
Yet, financial resources alone do not account
for the high quality of basic research in the
United States. How, or to whom, those resources
are allocated matters a great deal. Perhaps more
than any other country, the United States relies
on competitive mechanisms in allocating funds
for basic research. Competitive, peer-reviewed
grants to individual investigators are a hallmark
of the American system. The basic research insti-
tutions that have succeeded in this allocation
mechanism, primarily large research universities,
have set the standard for quality in the post-
Cold War era. On the other hand, research insti-
tutions that have grown up under a different
regime, one defined by centralization and 
top-down management, have struggled to jus-
tify their cost-effectiveness in an era of tight
budgets.
Industry
Basic Research Conducted by Industry
Industry is, by far, the largest funder of total
R&D in the United States, but its relative pres-
ence in basic research is less significant (see
Appendix Figure 2 in Appendix 1). Basic research
conducted by industry is largely targeted at its
own proprietary product development—often fill-
ing in the gaps remaining from publicly-supported
research and in areas of inquiry that are neces-
sary to proceed with product development16—
though a small amount of industrial basic research
is conducted for the government, particularly in
the area of defense.
Industry spending on basic research varies great-
ly from sector to sector. A relative few, such as
pharmaceuticals, are highly dependent on their
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The basic research system that exists in the
United States today—with world-class research
funded and conducted by federal agencies, large
corporations, state governments, public and pri-
vate universities, small businesses, and private
nonprofit research institutions—has come a long
way from its infancy a century ago. At the turn
of the century, scientific inquiry was still largely
a European affair. At the time, the United States
was known for its individual inventors, the
clever non-scientists tinkering in their homes to
discover a new product or process, but rarely a
fundamental scientific insight. 
With the emergence of large, multi-product
corporations and the scientific and technologi-
cal demands of World War I, the modern
American basic research enterprise began to
take shape. In a drive to innovate, large firms
turned to scientists and engineers for expertise
(most significantly in chemicals, petroleum, and
electrical machinery), establishing in-house
research laboratories or contracting out to inde-
pendent labs. During these years, federally-
sponsored research was largely agricultural,
though the land grant universities did sponsor
other important areas of research, often related
to local and regional economic needs. 
World War II was a watershed for American
research, creating a public enthusiasm for science
and technology that would carry over into the
post-war years. The aftermath of World War II
created an infusion of resources into basic
research directed to military objectives, codifying
a system of public funding that flourished dur-
ing the post-war period as it was enlarged to
address civilian objectives as well. Under this
system, basic research projects were funded by
the government and conducted in universities,
government laboratories, and private companies.
Vannevar Bush’s post-war blueprint17 for
public research led to the creation of the
National Science Foundation (NSF) and with it,
a system of allocating federal dollars for all of
the sciences based on scientific merit. Most of
the federal resources devoted to research were
(and are) allocated through federal agency mis-
sions. The federal government invested heavily
in research as a means to achieve supremacy in
weapons systems and space technology.
Government investment in health research also
grew rapidly during this period, as public poli-
cies sought to focus the nation’s scientific exper-
tise on major diseases. Clearly, during these
years, government funding for basic research
was largely targeted, even if broadly so. 
Whether funded by the NSF or by other fed-
eral agencies, publicly-supported basic research
came to be characterized as “individual investi-
gator” research. For it was the individual inves-
tigator who would “define problems and design
the best approaches to solving them.”18 In the
case of NSF grants, this process was predomi-
nantly investigator-initiated. But even within
the narrower confines of agency missions, basic
research was largely driven by the expertise of
scientists, rather than through “task oriented
management by sponsors or ultimate users.”19
As the system for publicly-supported basic
research took shape, many large U.S. firms
expanded their own basic research activities.
The Cold War era also marked an extraordinary
economic period during which many firms
were able to command significant market
power. Companies like AT&T, Xerox, General
Electric, and Eastman Kodak used the resources
from this market power to fund activities in
some of the nation’s premier basic research lab-
oratories. Indeed, work at industrial labs would
lead to numerous Nobel prizes for scientific
breakthroughs.
The end of the Cold War marked a turning
point for basic research in the United States. By
the 1990’s, the federal labs, which sustained a
great deal of basic research after W.W.II, faced
an uncertain future. Universities also prepared
for belt-tightening in response to an expected
decline in federal support. As businesses faced
an increasingly competitive and global market-
place, they began to shift their R&D activities
toward projects with short-term horizons.
BOX 3
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long-term basic research investments for new prod-
ucts and processes, while others spend very lit-
tle, if anything, on basic research. In the aggregate,
industry places a much greater emphasis on
shorter-term development activities in the allo-
cation of its R&D dollars, leaving the majority of
the nation’s basic research investments to the pub-
lic sector.
But there is much more to the differences
between industrial basic research and basic
research supported by the government (per-
formed primarily in universities) than the rela-
tive size of the investments. Basic research in
companies and basic research in universities
may both achieve new, fundamental scientific
understanding, but they are characterized by
different motivations and different goals. The uni-
versity researcher is attempting to ask and answer
questions of deep scientific importance, to gen-
erate knowledge and theories with the most
power to explain natural processes. The indus-
try researcher has a very targeted goal: to gain
understanding that is essential for further devel-
opment of technology, which in turn, is expect-
ed to drive development of new products. When
university researchers make an important basic
discovery, they and their colleagues immedi-
ately increase their efforts along similar lines to
confirm and amplify the discovery. Further, the
academic researchers will direct new efforts
toward questions that are inherently most inter-
esting. Once the company researcher has made
a discovery, he or she attacks the next set of
problems that must be solved for product devel-
opment to continue, and may leave elaboration
of the discovery to others (including university
researchers).
Industry as Partner and Collaborator in Basic
Research
While industry performs a significant share
of the nation’s basic research, increasingly com-
panies have also found it useful to support basic
research projects at universities, and to collabo-
rate with the individual investigators. Direct
industry funding of “sponsored research” at
universities, though small relative to govern-
ment funding, has expanded significantly, from
4 percent of total support for academic research
in 1980 to 7 percent in 1996 (see Appendix Figures
8 and 9 in Appendix 1). Much of this expansion
occurred in the biomedical field where compa-
nies have rapidly translated basic research dis-
coveries into new product development programs
in therapeutics, diagnostics and medical devices. 
The willingness of industry to fund spon-
sored research has been spurred, in part, by the
Bayh-Dole Act of 1980, a federal law which
allows recipients of federal grants to retain title
to inventions made in the course of research
funded by the grant.20 In practice, this means that
an industrial sponsor may have the right to
license proprietary rights not only to the work
which is being sponsored, but also additional rights
to earlier inventions funded by government
grants. Thus, the industry sponsor may be able
to license a coherent “package” of intellectual prop-
erty. In certain cases these rights may provide a
sufficient platform for the company to initiate its
own internal R&D toward the development of
new products.21
At the major research universities in the
United States, a sponsored research contract
negotiated between a company and the univer-
sity’s technology transfer office has the follow-
ing attributes: the company provides a specific
amount of funds in return for the investigator’s
agreement to perform an agreed-upon research
plan; the company receives an option to license
any new inventions, which takes the form of a
first right of negotiation; the company agrees dur-
ing the option period to fund any related patent
applications filed by the university; and the
company is given a brief period in which to
review for patentability any written or oral pre-
sentations (such as conference presentations or
journal articles) prior to their public disclosure.
The latter understanding maintains the univer-
sity’s right and need to freely disseminate its
research findings, while preserving both the
sponsor’s and the university’s interest in the
value of any proprietary inventions.
With appropriate safeguards for the role of the
university,22 industry sponsorship of basic research
can bring benefits to both parties. The industry
sponsor gains access to some of the most creative
minds in its field of interest, which can stimulate
important breakthroughs. The company is also
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able to license technological innovations and
associated patent rights that can be the basis for
important new product lines. Indeed, the biotech-
nology industry originated with the formation of
new companies around technologies that had
been licensed from universities.
The university benefits by allowing its facul-
ty members to supplement publicly-funded grants
with additional support. For many researchers this
additional support contributes to maintaining
the productivity of their laboratories. In addi-
tion, if a company converts technology licensed
from the university into a successful product or
service, the university receives milestone pay-
ments and royalties, which in the case of a block-
buster product (such as a major pharmaceutical)
can amount to millions of dollars per year. An addi-
tional intangible benefit of a well-managed col-
laboration can be the value of the intellectual
collaboration between the individual researchers
in the industry and university laboratories.
Industry Benefits from Open Dissemination of
University Research
The increasing significance of industry-uni-
versity research partnerships does not diminish
what continues to be the primary channel of
benefit of university basic research to industry
and the economy at large: the open dissemina-
tion of new knowledge, without restriction on use
or on the number of users. The primary benefit
of university research to society stems from the
free and open dissemination of new knowledge,
whether the research is funded by the govern-
ment, foundations, or corporations, and whether
or not the research leads to patentable inventions.
Indeed, most technology transfer agreements
at major universities are designed to permit only
a brief delay in public dissemination of indus-
try-sponsored research for this reason.
As discussed in the previous chapter, recent
analyses of patent data suggest that the dis-
seminated results of university research has
accounted for a great deal of the new knowledge
embodied in commercial patent applications.
There is also evidence that open dissemination
of university research—through publications,
public meetings and conferences, and through
informal channels—has been much more impor-
tant to industrial innovation than more restric-
tive relationships.23
Open dissemination of basic research does
not occur solely in universities. The case of AIDS
research at Merck (see Case Studies section)
illustrates how and why many private compa-
nies also subscribe to a standard of open dis-
semination of knowledge derived from many of
their basic research activities. As the Merck case
demonstrates, even when there are no legal bar-
riers to establishing proprietary rights over
research findings, companies like Merck have
found that a more open approach to dissemination
not only yields greater benefits to society at
large, but in many cases to themselves. Also,
industry researchers are, like university col-
leagues, motivated by prestige to disseminate their
work openly through peer-reviewed journals
whenever possible. The prestige generated by pub-
lication benefits the company by enhancing its
recruitment of top-notch scientists and increas-
ing the perceived value of the company’s research,
and ultimately its products.
Universities
Without question, the most important insti-
tution in American basic research is the research
university. The research university system has
become the nation’s largest basic research enter-
prise as a result of large and sustained federal fund-
ing throughout the post-World War II period
(see Appendix 1 for an overview of resources for
university research). But the real success of the
system is based upon: 
1. the unique structure that supports the individual
university researcher, rather than the institu-
tion itself; 
2. the dual role that universities play in con-
ducting research and training graduate students;
3. the competitive funding mechanisms for uni-
versity research;
4. and the flexibility and diversity of research uni-
versities. 
As we describe later in this chapter and in the
previous section, the success of the university
research system has contributed to a great deal of
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business interest in recent years, leading to new
roles and challenges for universities and their
researchers in the marketplace.
University Support for the Individual Investigator
The heart of the university research enter-
prise is the highly-skilled independent investi-
gator (see “The Critical Value of the Individual
Researcher,” page 27, for further discussion).
Typically tenured or tenure-track faculty mem-
bers,24 university scientists rely on a combination
of university support (in the form of salary, facil-
ities, and research assistants) and external grants
to conduct their research. The university research
environment allows faculty scientists consider-
able autonomy to define the nature of their
research projects, to pursue external support for
the projects, and to carry out the research in a way
that is suitable to the researcher and the funding
agency (or other entity). The quality of univer-
sity research in general is guided by a compet-
itive process through which thousands of
individual university scientists nationwide seek
external (mostly federal) grants. Of course,
department chairs, deans, and university admin-
istrative officials also play important roles in
shaping and ensuring quality in university
research portfolios. Particularly important in
this regard is the extensive review undertaken
in hiring faculty members.
As the trends in federal support for univer-
sity research (outlined in Appendix 1) illustrate,
university scientists often seek support from a num-
ber of agencies, because the fundamental nature
of their work can support a number of federal mis-
sions.25 (For example, the same grant application
may be eligible for consideration by the National
Science Foundation, the Department of Defense,
and the National Institutes of Health). The plu-
rality of routes to funding has increased grant
opportunities for applicants and sustained the
flow of new knowledge despite shifting agency
priorities and budget fluctuations (see Appendix
1 for a description of these funding patterns). The
availability of multiple funding sources has per-
mitted a greater diversity of scientific investigations
and approaches than would be possible under
a single-source funding structure.
The educational function of universities gives
them a particular advantage in basic research. As
an integral part of their training in science and engi-
neering, graduate students are employed in uni-
versity labs as assistants to the faculty researchers.
Graduate students at research universities are
technically proficient, intimately familiar with cut-
ting-edge research, and highly motivated. Their
PhD theses and their future careers as researchers
depend on making a significant intellectual con-
tribution by performing research that is worthy
of publication in first-tier, peer-reviewed journals.
Indeed, the laboratory experiments that lead to
fundamental discoveries are typically performed
by graduate students and post-doctoral fellows,
whose tuition and stipends are funded by gov-
ernment and foundation grants.
The Diversity of Research Universities
Nearly all university research (96 percent)
conducted in the United States is concentrated
in about 200 public and private institutions.26
Twenty-five universities (see Figure 1) account
for about 35 percent of total research expenditures
by the 3,600 higher education institutions in the
United States. These top 25 recipients account for
39 percent of federally-funded research. The top
100 account for 78 percent of total federal fund-
ing—representing only modest diffusion of
resources over four decades of expansion of the
university system in the United States.
Even though the diffusion of total resources
has not changed dramatically, many more aca-
demic research institutions receive federal research
funds today than did so 25 years ago—from 567
institutions in 1971 to 875 in 1993.27 Almost all
of this increase has gone to non-doctorate grant-
ing universities—i.e., liberal arts, two-year com-
munity colleges, and other technical and
professional schools.
Given the emphasis in the United States on inves-
tigator-initiated grants, it follows that the repu-
tation of a research university and its collective
impact as a research institution are the aggre-
gate of the productivity, reputation, and grants-
manship of its individual faculty members and the
students they recruit to their laboratories. As
individual scientists and engineers move from one
university to another, the financial and educational
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benefits of their research activities move with
them. Consequently, while there are differences
in quality and in economies of scale among insti-
tutions which tend to sustain institutional patterns
of research funding over time, the hierarchy of
research universities that receive the most federal
research support is not static. Competition for
research grants by individual investigators has a
similar competitive effect on the academic insti-
tutions that employ them. It is in universities’ inter-
est as producers and disseminators of knowledge
to employ the highest quality scientists.28
Figure 1
Top 25 Research Universities, by Total Research Expenditures and Federally Financed
Research in 1995
Total Research Expenditures Federally Financed Research
(dollars in thousands)
Total, all institutions $21,654,220 Total, all institutions $12,884,158
1 University of Michigan $443,070 1 University of Washington $291,284
2 U WI Madison $403,541 2 U CA San Diego $284,445
3 University of Washington $289,160 3 University of Michigan $275,956
4 MA Institute of Tech 1/ $370,800 4 MA Institute of Tech 1/ $273,543
5 Texas A&M University $362,539 5 Stanford University $273,157
6 U CA San Diego $357,333 6 Johns Hopkins Univ 2/ $259,049
7 Cornell University 1/ $343,786 7 U WI Madison $299,381
8 University of Minnesota $336,524 8 U CA San Francisco $224,271
9 Johns Hopkins Univ 2/ $331,387 9 Cornell University 1/ $207,391
10 Pennsylvania State U $330,881 10 Columbia University $206,495
Total, top 10 institutions $3,669,321 Total, top 10 institutions $2,524,972
11 U CA San Francisco $329,742 11 Harvard University $203,965
12 Stanford University $318,871 12 U CA Los Angeles $201,773
13 U CA Los Angeles $303,668 13 U of Pennsylvania $200,895
14 University of Arizona $292,351 14 University of Minnesota $194,819
15 U CA Berkeley 1/ $291,200 15 Pennsylvania State U $187,481
16 Harvard University $276,422 16 Yale University $174,868
17 U of Pennsylvania $272,393 17 University of Colorado $168,674
18 University of Colorado $249,695 18 University of Arizona $168,791
19 Ohio State University $246,287 19 U of Southern California $163,606
20 U of Illinois Urbana $246,174 20 U CA Berkeley 1/ $157,826
21 Columbia University $244,991 21 U of NC Chapel Hill $156,626
22 U CA Davis $244,116 22 Duke University $148,526
23 Yale University $231,819 23 Washington University $146,921
24 U TX Austin $228,676 24 University of Pittsburgh $144,457
25 U of Southern California &222,159 25 U TX Austin $143,939
Total, top 25 institutions $7,667,885 Total, top 25 institutions $5,089,169
1/ These data do not include research expenditures at university-associated federally-funded R&D centers.
2/ Johns Hopkins University data do not include Applied Physics Lab, with $447 million in total R&D expenditures.
NOTE: Because of rounding, data may not add to totals.
SOURCE: National Science Foundation, Science Resource Studies Division, Survey of Scientific and Engineering Expenditures at
Universities and Colleges, FY 1995 (data available at www.nsf.gov).
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Research Universities and 
the Marketplace
Two important trends are helping to shape the
face of tomorrow’s research university. Both
promise to push university research closer to the
marketplace. The first is the ability of universi-
ties and academic researchers to reap financial
rewards for inventions that are to be commer-
cialized by industry. The other related trend is
the growing number of industry-university col-
laborations and the increasing emphasis of
research institutions on developing such col-
laborations into a major long-term source of
funding.
For nearly 20 years it has been the policy of
the federal government to encourage universi-
ties (and other performers of government-sup-
ported research) to file patents and to transfer
useful inventions to industry for commercial
development. As described earlier, the key leg-
islation related to this policy was the Bayh-Dole
Act of 1980, which ushered in a new era for
university research. Figures 2 and 3 illustrate the
magnitude of these changes. A gauge of the
impact of Bayh-Dole is the number of patents
issued to academic institutions, which increased
from 249 in 1974 to 1,761 in 1994.29
It is important to recognize, however, that
involvement of universities in commercialization
of technology is still a small portion of total
university research, and, indeed of total indus-
try R&D. For example, the patents awarded by
the U.S. Patent Office to universities in 1994
amounted to less than one percent of all patents
issued that year. Despite the growing presence
of industry in funding sponsored research on cam-
puses, companies provide only seven percent of
total university research support.
The open nature of university research has
always allowed for external funding from many
sources, not just the federal government.
Nonetheless, the nature of industry funding
and the effects of university licensing raises
issues and concerns not encountered with pub-
lic funding. These concerns include the poten-
tial for:
• restrictions on open dissemination of research;
• a reorientation of university research to accom-
modate the interests and needs of industrial
sponsors;
• conflicts of interest between the individual finan-
cial interests of researchers and the broader
interests of the academic department, univ-
ersity, and society as a whole;
• application of criteria other than basic research
productivity and teaching performance, such
as ability to obtain industry support and
generate royalties, in consideration of hir-
ing and promotion decisions for faculty.
Most research universities have developed poli-
cies and guidelines that confront these issues, and
have promulgated them among faculty, staff
and graduate students (see Appendix 2 for two
examples of university patent policies).
Nonetheless, universities deeply involved in
sponsored research must now serve a new con-
stituency, their industrial partners. The acade-
Figure 2
Number of U.S. Patents Awarded to
Academic Institutions
SOURCE: National Science Board, Science & Engineering
Indicators—1996 (Washington, DC: U.S. Government Printing
Office, 1996), Appendix Table 5-42.
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mics must cope with a new bureaucracy—the uni-
versity’s Office of Technology Transfer. And the
university’s administrators must wrestle with a
range of potential conflicts of interest on the
part of faculty and staff.
Patenting and Licensing of University Research
Because university inventions are frequent-
ly made with the use of public funds, universi-
ties have a special responsibility to maximize the
societal benefit from the use of such inventions.
This responsibility goes beyond the need to
freely disseminate the descriptions of the inven-
tions, and extends to the manner in which such
inventions are commercialized, since patents, by
their nature, imply a restriction on use.
Clearly, there is no simple formula by which
such decisions can be made. Many leading
research universities have technology transfer
policies that specifically identify the public inter-
est as the primary criterion for making tech-
nology licensing decisions (see Appendix 2). In
general, once a university has filed for patent pro-
tection on a discovery, it then must decide
whether to commercialize the technology on
an exclusive or non-exclusive basis.
Research advances that can be translated
into distinct products or services, such as a new
therapeutic compound, a new polymer, a new
electronic instrument, or a new medical device,
are typically considered appropriate candidates
for exclusive licensing. In these cases, the pro-
tections of both patent protection and an exclu-
sive license are essential incentives for a company
to invest time, money, and resources in creating
a new product. Society benefits from the will-
ingness of industry to make those commitments
and bring a useful new product to market.
On the other hand, new knowledge that
serves as a research tool potentially benefiting
Figure 3
Growth in U.S. University Licensing Activities Relative to U.S. Totals,
1991-95 Cumulative % Change
*Adjusted gross royalties are gross royalties minus royalties paid to other institutions.
SOURCE: Association of University Technology Managers, Licensing Survey FY 1991-95, (ATUM, 1997).
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the development of a range of new products in
multiple companies, is typically commercial-
ized through a non-exclusive license made wide-
ly available on commercially reasonable terms.
The most prominent example is the Cohen-
Boyer patents, assigned to Stanford University
and the University of California, which cover the
fundamental techniques of gene splicing. Since
these patents were issued, Stanford and the
University of California at San Francisco (UCSF)
have made a non-exclusive license available to
all companies involved in genetic engineering for
a minimal annual fee starting at $10,000 and a small
royalty on sales. These modest requirements
have imposed no undue burdens on industry, and
in 1997 generated $38.5 million for the two uni-
versities.30 Moreover, basic research institutions
have been able to practice the methods without
charge.
The distinction between products and tools is
needed, since a particularly important tool based
on a major breakthrough such as gene splicing
may be essential for the unfettered pursuit of addi-
tional basic and applied discoveries. If excessive
barriers are placed in front of others’ entry into
a field, important new avenues of research will
be impeded. The policies of Stanford and UCSF
toward the commercialization of the invention
by Professors Cohen and Boyer have become a
model for other universities that own a broad-
ly useful tool or process: license non-exclusive-
ly; make the terms reasonable; and allow basic
researchers to use the technology at no cost.
This approach optimizes the benefit both to soci-
ety and to the university.
The Impact of Industry Funding on 
University Research
Initial evidence on the growing university-
industry research relationship suggests there
may be some cause for concern. According to a
number of recent studies on the impact of indus-
try support for academic research, industry
funding is associated with greater restrictive-
ness in disclosure of research results and with
research that is less basic in nature.31 This is not
to say that industry sways the direction of uni-
versity research toward applied and development
work. Rather, companies seek types of univer-
sity research projects that suit their needs, and
these types of research typically may not be as
clearly basic in nature as those supported through
federal grants. In the aggregate, there is no strong
evidence that university research has shifted
away from basic science and engineering, even
as industry support has increased substantially. 
Yet, given the characteristics of industry fund-
ing just described (greater restrictiveness and pro-
jects that are less basic in nature), it clearly is
misguided to view industry and government fund-
ing for university research as interchangeable. A
significant change in the balance between gov-
ernment and industry funding for university
research as a whole would likely impact the
character of university research and its dissem-
ination. 
Among the conflicts of interest receiving the
most intense scrutiny are those that may be gen-
erated by the university researchers who bene-
fit personally from affiliation with companies.
Faculty find themselves able to improve their finan-
cial status through:
• participation in royalties on their inventions,
(an explicit directive of Bayh/Dole);
• paid consulting to companies, particularly to
companies that are sponsoring research in
the faculty member’s laboratory; and
• equity ownership in start-up companies.
In many cases, these potential areas of conflict
have been resolved to the benefit of the univer-
sities, faculty members, and the companies with
which they interact. Nevertheless, these rela-
tionships are evolving rapidly; new precedents
are set each year; and universities must be vig-
ilant in defending their fundamental educa-
tional and basic research missions. 
As the Columbia University case illustrates (see
Case Studies section), the leading research uni-
versities are well aware of the complex nature of
university-industry research relationships. In
this case, the real and potential benefits are clear
for all parties: Columbia receives funding from
the private firm (VIMRx Pharmaceuticals),
VIMRx has access to potential knowledge that
may translate into new products, and society
may ultimately benefit from a faster innovation
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process due to the direct relationship between uni-
versity and firm. The potential downside is also
recognized by Columbia officials: the possibili-
ty that the traditional openness in dissemination
of basic research findings will be threatened;
the narrowness of single company relationships;
and the influence on the overall balance of
Columbia’s research portfolio, potentially away
from basic research. As a case study in progress,
Columbia’s relationship with VIMRx illustrates
the benefits, costs, and unknowns of the research
university’s new role in the marketplace. 
The Federal Laboratories
Although a vast majority of federal R&D is
either not basic research or is performed outside
of the government on a contract or grant-award
basis, the government itself does perform basic
research through the federal laboratory system.
In 1995, for example, federal laboratories account-
ed for $2.7 billion or about 20 percent of feder-
al basic research dollars (see Appendix Figure 6
in Appendix 1).32 Historically, the federal labs have
been a very important venue for basic research,
generating many important discoveries and sci-
entific insights in fields as diverse as the health
sciences and nuclear physics. 
The management structure of federal labs
varies. Some are operated directly by the gov-
ernment (e.g., the National Institutes of Health,
the National Institute for Standards and
Technology, and the U.S. Geological Survey),
while others are operated for government by
private or nonprofit entities, including univer-
sities and other nonprofit organizations (e.g.,
Los Alamos, Oak Ridge, and the Jet Propulsion
Laboratory). Among the largest of the 700 labs
funded by the federal government are the so-called
“national labs,” administered by the Department
of Energy and historically charged with energy
and defense missions. These labs perform a mix
of basic, applied, and development research 
and command substantial R&D budgets (see
Figure 4). 
Since the end of the Cold War, the missions
of the Department of Energy national labs have
been in flux. These labs have moved to deal
with the problem of disappearing missions by
seeking new “missions,” often related to civil-
ian technology needs and the international com-
petitiveness of U.S. industries. For example,
Intel, Motorola and Advanced Micro Devices
recently announced a commercial research part-
nership with three national labs to develop
computer chips using extreme ultraviolet 
technologies.33
Critics have charged that such efforts are
wasteful of federal tax dollars, and that the num-
ber and size of labs administered by the
Department of Energy are no longer justified
by the mission of the agency that supports them.
In the case of the computer chip partnership, there
has been further criticism due to the potential for
foreign firm participation in the project, which
would amount to a federal subsidy of foreign com-
panies.34 This criticism highlights the political 
problems that can arise as agencies attempt to 
justify initiatives under the “national competi-
tiveness” rubric. 
The problems of many federal labs are not lim-
ited to their missions. Of all the institutions that
perform basic research, the DOE labs are said to
be the most lacking in flexibility and cost-efficiency,
Figure 4
Federal Obligations for Research and
Development at the “National
Laboratories”
Fiscal Year 1995
(Dollars in Thousands)
Total National Labs $3,012,548
Idaho National Engineering Lab $77,745
Oak Ridge National Laboratory $288,332
Sandia National Laboratories $654,472
Argonne National Laboratory $252,879
Brookhaven National Laboratory $216,094
Ernest Orlando Lawrence Berkeley 
National Laboratory $170,870
Lawrence Livermore National Lab $500,622
Los Alamos National Laboratory $102,278
Pacific Northwest National Laboratory $208,529
SOURCE: National Science Foundation, Survey of Federal Funds for R&D:
FY 1995, 1996, 1997, (data available at www.nsf.gov).
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resulting from an overly-centralized, micro-
managed resource allocation system.35 Indeed,
governance reform was a key area of concern in
the 1995 Galvin Task Force, charged with advis-
ing the Secretary of Energy on alternative futures
for the national laboratories. 
Unlike the decentralized, competitive inves-
tigator-driven model that characterizes univer-
sity research, administration of research at the
national labs has been centralized, top-down
(from within the Department of Energy and from
Congress) and largely lacking in outside peer
review. The Galvin Task Force reported that,
while the DOE labs support a small amount of com-
petitively-determined individual investigator
research projects, “the research culture at many
of the laboratories has been influenced by their
relative physical and intellectual isolation and by
a sense of entitlement to research funds.”36
Despite all of these problems, the labs have con-
siderable resources in the form of physical and
human capital. Unlike the individual investi-
gator work that typically characterizes univer-
sity research, basic research performed at the
national labs has often been performed on a
much larger scale, with considerable physical cap-
ital investments made over many years. Critics
and supporters of the labs alike now struggle with
the question of how to put these large-scale
resources to work, short of abandoning them
altogether. This question has been the impetus
for a number of blue-ribbon commissions in
recent years.37 Unfortunately none of these ini-
tiatives has produced a politically-viable consensus
on meaningful restructuring. 
Nonprofit Institutions
Basic Research at Nonprofit Research Institutions
Although they account for only seven percent
of basic research in the United States, nonprof-
it institutions (that are not universities) perform
a significant amount of basic research. In some
cases, they provide a unique alternative to the dom-
inant model of university-based basic research. 
Many nonprofit research institutions are affil-
iates of universities, maintaining formal ties
with the university but remaining independent
of its non-research functions. The Whitehead
Institute for Biomedical Research, an affiliate of
the Massachusetts Institute of Technology, is
one notable example.
Nonprofit institutions sometimes offer the
individual researcher attractive alternatives to
the predominant university basic research venue.
Two noteworthy examples are The Howard
Hughes Medical Institute (HHMI) and the Scripps
Research Institute. HHMI offers much sought-after
appointments for scientists, who are attracted by
generous and stable financial support and a
research environment that does not require time
outside the lab devoted to fundraising. HHMI lab-
oratories are located at research universities across
the country; these universities serve as collaborators
with the Institute. HHMI maintains the laboratory
facilities at these universities and employs the
scientist and all necessary support staff (includ-
ing research associates and technicians). Scientists
employed by HHMI are appointed to five or
seven-year terms, with the possibility of renew-
al under rigorous standards of review. These
terms represent a longer and more stable period
of support than many university scientists are
able to achieve through research grants from the
federal government or other funding sources.
Scripps maintains its own research campus in
La Jolla, California, also attracting eminent
researchers through generous and stable finan-
cial support, affording researchers maximum
time spent in the labs and away from fund-rais-
ing duties. Like the nation’s research universi-
ties, Scripps relies on federal grants for a majority
of its research funding, though it has aggres-
sively pursued funding from industry and phil-
anthropic sources. Unlike the academic research
model though, Scripps does not isolate its faculty
and labs into separate disciplines. Rather, it
emphasizes cooperation and collaboration across
disciplines.
Institutions like Scripps also present an inter-
esting alternative to one aspect of the universi-
ty-based training model for graduate students.
Scripps offers graduate-level training in various
research disciplines, but does not educate under-
graduates. As the “teaching versus research”
debate continues on university campuses, this alter-
native model—which couples basic research with
graduate training, but excludes undergraduate
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teaching—may become more attractive for fac-
ulty scientists and graduate students.
Basic Research Funding from the Nonprofit Sector
Certainly, HHMI is tremendously important
to basic medical research, not simply due to its
unique administrative and performance structure,
but also for the considerable financial resources
it brings to the research enterprise. In fact, the non-
profit philanthropic sector has always been an
important source of funding for research. HHMI
is a relative newcomer: the Rockefeller Foundation
and the Carnegie Institution have been impor-
tant sources of such philanthropic support
throughout this century. 
As a funding source, foundations are very
small relative to the federal government; yet,
they can offer distinct advantages, which allow
them to leverage their funds to greater effect. For
example, foundations can move more quickly than
the government to fund projects. In this way, they
can act as a funding bridge, stepping in to main-
tain funding for important projects whose grants
are about to expire. Foundations may also be more
progressive than the government in valuing and
funding cross-disciplinary research. 
THE CRITICAL VALUE OF THE 
INDIVIDUAL RESEARCHER
As discussed in Appendix 1 (see Appendix 
Box 1, “Research Dollars Versus Other Inputs”),
basic research in the United States is not adequately
described by dollars spent. Nor can it be char-
acterized only by the institutions that house it.
In fact, the core strength of the research enterprise
lies in the people who do the research. Indeed,
the history of science and engineering and of the
great discoveries is a history of individual scientists,
whose names—James Watson, Jonas Salk, Linus
Pauling—are often more readily recognized than
their discoveries. The success of the American basic
research system has rested in its ability to foster
such creative minds and ensure a robust flow of
new scientists through the education, training,
and employment pipeline.
As we described earlier, a great strength of our
basic research system is the symbiotic relation-
ship between research and graduate education
in the research university. The university scien-
tist has in the institution’s graduate students a
pool of highly skilled and motivated labor. At the
same time, the experience and training that the
graduate student receives in a university lab
ensures a stream of talented future scientists.
The education function of the university—that
is, the training of future scientists—is as impor-
tant to the future of basic research as the research
function itself. 
Young scientists trained in the research uni-
versity go on to careers in the university, gov-
ernment, and industry sectors. As Figure 5, page
28, indicates, a growing proportion of scientists
and engineers are employed by industry, although
in absolute terms employment in all sectors is
growing (see Appendix Figure 3 in Appendix 1).
Industry-employed scientists are an important
link in the transfer of basic research to industry.
In-house basic research expertise is often necessary
even when little basic research is conducted
within the company. Industry scientists play an
important role in identifying and interpreting basic
research performed outside of the company for
use internally.38
It remains, though, that much of the success
of our basic research system lies in the ability of
academic researchers, and particularly young
academic researchers, to exploit the individual
autonomy and freedom that their institutions pro-
vide them. The university environment fosters
a spirit of independence and creativity among sci-
entists that is hard to find in other organiza-
tions. This environment is particularly important
for young scientists, who are given opportuni-
ties for advancement early in their academic
careers that are rare in more hierarchical orga-
nizations. In short, the university research envi-
ronment is able to recognize and exploit talent
regardless of seniority. Consequently, the flow of
new scientists into the university workforce has
been an important dynamic in the basic research
enterprise.
Yet, there are signs along the length of the
“pipeline” of new scientists and engineers to
suggest that the future quality of the human
infrastructure for basic research is not assured.
In order to assess our human capacity to do
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basic research in the future, we must consider the
condition and quality of today’s educational
pipeline at all of its stages: 
1. The poor performance of our K-12 students in
the sciences is well-documented.39 A recent 
survey reported that 43 percent of high school
seniors have a below-grade level knowledge
of science.40 Further, evidence from interna-
tional studies suggest that even our best stu-
dents perform poorly relative to students in
other countries in the sciences and math.41 Poor
performance in the sciences and mathematics
(and all disciplines) during these early years
not only effectively precludes many American
students from later scientific training and
employment, it also places an increased bur-
den on universities and colleges to provide
remedial education, at the expense of more
sophisticated study in the sciences. 
2. At the undergraduate level, the share of sci-
ence and engineering degrees has declined over
the past three decades.42 Increasingly, many
of our “best and brightest” are opting out of
future careers in the sciences during their
undergraduate years. 
3. An important source of high quality scientists
and engineers—foreign students—may be
leveling off (see Figure 8, page 31) and is far
from assured in the future. As other coun-
tries develop their own basic research capa-
bilities, the supply of foreign students who train
in the United States and remain here for
careers in basic research should not be expect-
ed to match earlier decades, when there was
a paucity of basic research performed in other
countries (particularly in Asia).
4. The current system of graduate training has
contributed to problems in the employment
Figure 5
Where Doctoral Scientists and Engineers Are Working
Distribution of Employment of PhD Scientists and Engineers by Employment Sector
NOTE: Percentages do not total 100 percent due to non-response and omission of the non-university education sector.
SOURCE: Reshaping Graduate Education of Scientists and Engineers, Committee on Science, Engineering and Public Policy, (Washington,
DC: National Academy Press, 1995).
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of new PhD’s and may have a discouraging
effect on the number and quality of students
entering graduate programs in the future:
• The time to degree for PhD recipients in the
sciences has been rising, from 5.4 years in
1962 to 7.1 years in 1993.43
• The number of new PhD’s entering post-doc-
toral fellowships and other temporary or part-
time employment is also on the rise,44
creating an increasingly unstable work
environment during the critical early years
of employment in basic research. In some
fields, recent graduates have gone from a
first to a second, and in some instances a third
post-doctoral research grant while contin-
uing their search for an academic position.
• Without adequate flexibility in training
and in career counseling, new PhD’s emerge
from graduate programs into a very nar-
row, academic job market. While training
for a career in academic research is critical
to the quality of science and engineering
PhD’s, additional training to provide stu-
dents with additional options upon grad-
uation is also important.
5. Finally, the employment environment in uni-
versities for scientists and engineers is strained
by the amount of time devoted to fundrais-
ing-related activities and away from the
research lab.
All of these issues point to potential trouble
spots in coming years. It is worth reaffirming,
however, that these problems arise within a
system of education and training for basic
research that continues to perform very well, per-
haps better than any other in the world.
Nonetheless, as we discuss in the next chapter,
all of the concerns we identify here should and
can be addressed today, long before small prob-
lems become big ones. 
THE INTERNATIONAL CONTEXT
FOR AMERICAN BASIC RESEARCH
The 20th century has seen the United States
rise to a position of global preeminence in gen-
erating new knowledge. World leadership in
innovation has been viewed as both a cause
and a consequence of the nation’s economic
success on the world stage. But it appears
inevitable that as other nations develop their inno-
vative capacities, the United States will become
less dominant in various scientific disciplines and
economic sectors.
Recent trends suggest that while the United
States continues to be the world’s leader in the
generation of new knowledge, other countries
are contributing more than in the past. The U.S.
share of all scientific and technical literature
worldwide continues to be much larger than any
other country’s, but it has declined slightly in recent
years from 36 percent in 1981 to just under 34 per-
cent in 1993.45 Most of that decline can be attrib-
uted to Japan’s increasing share. 
It would be a mistake to view these trends as a threat
to the United States. As basic research activities grow
worldwide and the global stock of new knowl-
edge increases, all countries benefit. Further,
other countries are increasingly our collaborators
in basic research. Cross-national collaboration in
research, facilitated by rapid advances in infor-
mation technology, is a growing phenomenon and
an increasingly important mechanism for pool-
ing resources for large basic research projects.
Figures 6 through 8, pages 30  and 31 illustrate
three measures of this trend. 
• As Figure 6 indicates, foreign R&D expendi-
tures in the United States have grown dra-
matically since 1980; R&D performed abroad
by U.S. firms has also increased, though at a
slower rate. 
• As a share of total national science articles, inter-
nationally co-authored articles have increased
for all of the leading industrial countries (see
Figure 7, page 30). 
• Finally, the number of foreign graduate stu-
dents in academic research programs in the
United States has increased 75 percent since
1980, although as a share of all graduate stu-
dents, their numbers have increased only
slightly over this period and their share is now
declining (see Figure 8, page 31). 
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Figure 6
Increasing Cross-National R&D Investments
SOURCE: National Science Board, Science & Engineering Indicators, 1996. Washington, DC: U.S. Government Printing Office, 1996).
SOURCE: National Science Board, Science & Engineering Indicators—1996, (Washington, DC: U.S. Government Printing Office, 1996),
Appendix Table 5-34.
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Internationally Coauthored Articles, Selected Countries
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Some observers have questioned the ability
of the United States to capture the return on its
research investments in an increasingly global
economy and scientific community. For exam-
ple, the growing number of foreign graduate 
students who leave the United States upon
graduating has provoked concern in some quar-
ters. But it is not at all clear that the U.S.-trained
foreigner who returns to his or her country 
represents a net loss to the U.S. economy. After
all, much of the value of the U.S. research 
university is derived from the work performed
by graduate students during their enrollment in
the university. Further, U.S. industry benefits from
research undertaken abroad, often performed by
American-educated scientists and engineers.
CONCLUSION
Basic research in the United States is unques-
tionably one of the great success stories of the
past 50 years. Indeed, the basic enterprise
described in this chapter is strong and effec-
tive. But to maintain, and even build on, this enter-
prise for the next 50 years, there are problems to
address. From how federal policymakers allo-
cate funds for basic research, to how individual
researchers balance their research and teaching
responsibilities with the demands of fundrais-
ing and entrepreneurship—these issues set the
agenda for policymakers and business leaders
concerned about basic research and will guide
the discussion of policy recommendations in
the next chapter.
Figure 8
Full-time Foreign and U.S. Graduate Students in Science and Engineering Fields in
U.S. Universities
SOURCE: National Science Foundation/SRS, Survey of Graduate Students and Postdoctorates in Science and Engineering (data available at
www.nsf.gov), Table B-5.
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The remarkable scientific progress that has
helped to define 20th century America is due in
no small part to the unique characteristics of our
basic research enterprise. Chapters 2 and 3 have
described these elements of success in American
basic research— public funding, merit-based allo-
cation of resources, the central role of the research
university, the primacy of the individual investi-
gator, and a robust education pipeline for future
scientists and engineers— and how they have
contributed to the social and economic benefits that
we enjoy today. But in each of these elements
there are currently signs of stress that need to be
addressed if the promise of tomorrow’s basic
research is to meet the expectations created by the
successes of the past. In this chapter we will
describe the challenges to our system of basic
research, offering policy recommendations that
address:
• problems in the way resources are allocated
for basic research
• the threats to ensuring adequate resources
for future basic research
• the challenges of maintaining a pipeline of high-
quality scientists and engineers into the basic
research system
• the potential conflicts and problems arising from
the increased interaction between universities
and the marketplace
• the challenges that American basic research faces
in an increasingly global economy and research
enterprise.
IMPROVING THE ALLOCATION OF
RESOURCES FOR BASIC RESEARCH
In addition to ensuring an adequate level of
resources for basic research, policymakers have
a responsibility to maximize the potential of
those resources through efficient allocation
mechanisms. There is waste and inefficiency in
the current allocation systems for basic research.
Shortcomings in allocation arise on two levels:
1) in the allocation of the research grant from the
funding agency to the researcher, whether it is
done competitively, based on peer review, and
whether it is directed toward individual inves-
tigators rather than institutions; 2) in the allo-
cation of funds to agencies and missions from
Congress.
Mechanisms to Ensure Quality in Funding
If basic research were like any other produc-
tion process, efficient allocation of resources
would be a relatively straight-forward matter.
Resources would go toward efforts that demon-
strated the highest productivity, as calculated
through a measure of output. But as described
in Chapter 2, measuring research outputs and the
productivity of basic research in general, let
alone for individual basic research projects, is high-
ly problematic. 
Over the years, government agencies under
various mandates have attempted to develop out-
put measures and related productivity and qual-
ity indicators for federally-sponsored research.
The most recent initiative has been mandated by
Chapter 4
MAINTAINING U.S. LEADERSHIP IN BASIC
RESEARCH: THE CED PRESCRIPTION
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Congress under the auspices of the Government
Performance and Results Act (GPRA). GPRA
requires all government agencies to submit per-
formance plans for measuring and assessing
program impacts as a means of increasing pub-
lic accountability, an exercise that has proved
understandably problematic for science and
research-related programs. Efforts to increase
accountability in government are laudable and
government-funded basic research should not
be exempt. Nonetheless, GPRA should not
impose one-size-fits-all criteria for measuring
results. Such an approach would, at best, prove
unworkable for basic research programs; at
worst, a rigid imposition of quantified perfor-
mance standards would undermine basic research
by shortening the timeframe of projects and
limiting their scope to areas where the payoff is
predictable at the outset.
Measuring basic research output is no less a
troublesome issue for business, which compa-
nies have addressed with mixed success. The IBM
case (see Case Studies) highlights that compa-
ny’s efforts to quantify its own research out-
put, measuring for example, number of patents
filed, number of external awards received by IBM
researchers, and self-assessments of key results
for the year.
Absent meaningful and practical output
measures, we must rely on other means of
efficiently allocating resources. The best alter-
native, we believe, is the system of peer-
reviewed competition for research grants.
Peer-reviewed awards to individual research-
ers— and increasingly to teams of researchers—
for individual research projects helps to ensure
quality on a project-by-project basis. Some crit-
ics have charged that peer review encourages an
“old boy” network because it favors the status
quo in grant awards. Yet, we know of no better
mechanism for emphasizing substance over
reputation or political interests. 
The worst abuse in the allocation of basic
research dollars, leading to the least productive use
of research funds, is Congressional earmarking.
The most recent survey of these activities demon-
strates dramatic growth in the number of ear-
marks for academic research in recent years.46
Figure 9, page 34 shows the increase in number
of earmarks during the 1981-1992 period; over the
course of a decade, academic earmarks increased
in value from the tens to the hundreds of millions
of dollars. Such earmarks frequently place narrow
constituent interests or even otherwise laudable
goals like regional economic development, over
scientific merit.47 In bypassing the competitive,
peer-review process for determining merit, ear-
marking for basic research is a form of pork-bar-
rel, like any other; it should be recognized as such
and acknowledged to have no place in our pub-
licly-supported basic research enterprise.
Of course, allocation of funds through peer-
reviewed grants to individual investigators does
not meet all the needs of our basic research
enterprise. For example, there has long been, and
continues to be, a need for public investments
in large-scale projects, often referred to as “big
science.”48 Historically, projects like the fusion
reactor at Princeton University, the historic
Voyager satellite missions, and NSF’s deep sea
drilling project have proved very important to
basic research and could not have proceeded in
the context of relatively small individual inves-
tigator grants. In cases such as these, when
the nature and size of the research project
makes individual investigator grants imprac-
tical, direct funding of institutions rather than
individuals is appropriate. 
Unfortunately, because of the large institutional
and regional economic stakes, funding for big
science often falls prey to political interests.
Also, it is often threatened by budget cuts or other
outside attempts to influence the character of the
project. It is the responsibility of policymak-
ers to ensure that necessary investments in
big science and institutional grants proceed on
the basis of scientific merit (determined by
expert advisory committees) and in the larger
context of national needs and priorities.
Further, it is important to emphasize that allo-
cation for big science through institutional grants
simply means investing in the infrastructure nec-
essary to make certain fields of inquiry possible
by giving researchers the tools to do their work.
The scientific work that proceeds from invest-
ments in these tools should conform to the
same process of competitive peer review that indi-
vidual investigator projects do.
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In sum, the primary mechanisms for allocating
federal basic research funds in all agencies
and to all institutions—whether universities,
federal labs, or elsewhere—should be based on
scientific merit determined through peer review
and the support of individuals and projects.
Political earmarks for basic research are an
unproductive use of scarce funds and should
be halted. The needs of big science can be met
without sacrificing scientific quality, but this
depends critically on the motivations of poli-
cymakers and the input of scientists.
Ensuring Adequate Funds for All Basic
Research Disciplines
Peer review goes a long way toward ensuring
quality in the allocation of funds from federal agen-
cies to individual research projects. But at the start
of the funding stream—the allocation of basic
research dollars from Congress to federal agen-
cies—there is no such mechanism to ensure
overall quality. Setting broad priorities in basic
research is the domain of policymakers in
Congress and the Administration, and should
be the result of informed policy debate. Scientists
have an important role to play in ensuring that
the debate is an informed one; but ultimately, these
decisions are appropriately made by our elect-
ed leadership. 
Certainly, as the growth in earmarking illus-
trates, there is room for improvement in how pri-
orities are established in public funding for
basic research. CED does not believe an overhaul
of the congressional appropriations process in
order to serve the needs of basic research is
practical or remotely likely. Just the same,
Congress can act in a number of ways to ensure
quality basic research in its appropriations. We
believe it critical that Congress work to achieve
a balance among basic research missions, a
diversity of missions, and that increasingly
important cross-disciplinary research receives
better treatment by congressional appropria-
tors and agency administrators alike.
Balance in Basic Research Missions
Currently, the health mission dwarfs all other
categories of federal support for basic research
(see “Life Sciences,” Appendix Figures 7 and 10).49
Although we recognize that missions must be
prioritized to ultimately reflect the needs of
society at large, we also believe that neglect of
less popular areas of research is foolhardy.
Health research has benefited immeasurably
from advances in the computer sciences, the
behavioral and social sciences, mathematics,
and physics—yet these disciplines receive most
of their federal support from non-health missions.
The defense mission, in particular, has been an
important, and in some cases a primary, source
of funding for diverse scientific disciplines (see
Appendix Figure 12). But, the decline in fund-
ing for this mission alone from its Cold War
levels has had negative consequences for some
areas of basic research. 
While the health sciences have clearly benefited
from applications of advances in other disci-
plines, various non-health fields of science have,
in turn, been furthered by biomedical research.
In addition, the needs of biomedical science have
created demand for further research in other
fields such as chemistry, physics, materials and
engineering, and information technology. 
Figure 9
Growth in Number of Congressionally-
Earmarked Academic Projects
SOURCE: National Science Board, Science & Engineering
Indicators—1993, (Washington, DC: U.S. Government Printing
Office, 1993), p.139.
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These observations underlie the concept that
basic research and subsequent development is a
mutually reinforcing process occurring between
a variety of science and engineering fields. All
of these fields will require adequate support in
an increasingly multi-disciplinary environment. 
The agency missions themselves are depen-
dent on many scientific disciplines. Ultimately,
progress in any single field will not be sustained
if other fields whither on the vine. In order to
achieve an appropriate balance in funding for
scientific disciplines, appropriators need to
pay close attention to the impact of agency
and mission funding decisions on specific sci-
entific disciplines. As some missions become
lower priorities in the federal budget (the post-
Cold War defense mission), or as Congress pur-
sues structural reforms in major programs tied
to basic research,50 the impact (direct or indirect)
on scientific disciplines should be assessed and
those disciplines should be accommodated in a
way that is consistent with mission/agency
goals and the needs of basic research generally.
Often, this may mean making basic research
funding a higher priority in other missions and
agencies (such as the NSF), as it becomes less of
a priority in declining missions (as in defense). 
A Diversity of Missions
The National Science Foundation has long
been a model of support for peer-reviewed basic
research independent of agency missions at the
federal level, providing funds on the basis of merit
to the entire spectrum of science and engineer-
ing disciplines. Nevertheless, much of the scientific
progress of the past half-century resulted from
much larger allocations to basic research fund-
ed by the Department of Defense and the National
Institutes of Health. Consequently, any effort to
abandon agency and mission-based support for
basic research in favor of the “secular” efforts of
the NSF would ultimately reduce the amount of
public support for basic research in general and
undermine the value of a diverse approach to fund-
ing. Federal support for basic research should
be diverse in its funding sources, resisting
efforts for central control or concentration in one
mission area. The diverse model is most viable
politically and is best-suited for the unpre-
dictable nature of basic research outcomes.
Therefore, we do not support calls for a
“Department of Science” or for an NSF that
would envelop all other federal sources of
basic research support.
Cross-Disciplinary Research within Missions
All sources of federal basic research fund-
ing should recognize the cross-disciplinary
imperative of much of today’s basic research and
encourage such approaches in their funding deci-
sions. The case studies (and particularly the
Pfizer, Merck, and Harvard cases) provide com-
pelling evidence that a cross-disciplinary approach
to scientific investigation is a necessity in many
areas of research today and is an approach
employed successfully by businesses and uni-
versities alike. 
It is not enough to ensure balance among mis-
sions; it is increasingly important to recog-
nize research that must take place across
funding missions and across scientific disci-
plines. Grant proposals that fall outside of the
traditional categories or scientific disciplines
should not be punished by a traditionally dis-
cipline-oriented funding structure and peer
review bias. This is an imperative that applies
to universities and peer review panels as much
as it does to agency administrators and con-
gressional appropriators. Evaluating merit in these
cases may require more effort (requiring, for
example, a peer review panel that consists of sci-
entists from more than one discipline). But the
effort should be made. Universities can pro-
mote collaboration by recognizing its value in
tenure decisions and through university-level ini-
tiatives that are independent of federal agency
directives. Harvard’s Mind/Brain/Behavior
program (see Case Studies) illustrates such an
initiative.
Keeping Research Universities at the Core of
American Basic Research
The Central Role of the Research University
CED believes the most productive use of
federal basic research funds institutionally is
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through the nation’s research universities. The
universities’ exceptional track record in per-
forming high-quality basic research is not sur-
prising given the central role of the individual
investigator and the widespread use of com-
petition in grant awards. 
The research university deserves to be the pre-
dominant basic research institution in America
for yet another reason: federal support of uni-
versity research ensures the future health of 
science and engineering by supporting the 
training of graduate students (see “Sustaining
the Education and Employment Pipeline,” 
page 40). Tomorrow’s scientists and engineers
receive the best possible training in today’s uni-
versity research laboratories through direct par-
ticipation in the leading research of the day.
There simply is no substitute for this type of train-
ing. A decline in support for research universi-
ties would terribly weaken the foundation for
the basic research enterprise of the future. 
Problems and Solutions in the Administration of
Federal Grants for University Research
Although federal funding of basic research in
universities has been very successful, there are
several aspects of the grants process that are
problematic—for the individual researcher and
the university—and should be reformed. 
There are concerns among many university
researchers that the competitive grant structure
has become overly-burdensome for the indi-
vidual researcher and has deterred young scien-
tists from pursuing careers in academic research.
The administrative burden for the individual
researcher lies in: 1) short-duration grants, which
require repeated preparation and re-submis-
sion of grant applications to sustain research
projects; 2) the low rate of success in applications;
3) the long time period between the submis-
sion of applications and the notification of
awards; 4) the very high dependency of the
individual investigator on external support and
the lack of seed money. To alleviate these prob-
lems we urge grant-making agencies (and uni-
versities) to review their requirements and
systems of support with an eye toward reduc-
ing administrative burden. 
Grant-making agencies should explore ways
to offer outstanding scientists longer-term
grant support, to provide young researchers
with sufficient resources to launch their careers,
and to ensure that established researchers who
temporarily lose grant support are not forced
to abandon long-term, productive research
endeavors. Institutions like the Howard Hughes
Medical Institute and the Scripps Research
Institute (see Chapter 3) provide cues for grant-
making institutions and universities in this effort.
In particular, we urge agencies to consider extend-
ing the funding period of their basic research
grants. The continual process of applying and re-
applying for grants has a very discouraging
effect on young scientists and engineers con-
sidering careers in university research. Longer
and more stable periods of grant support would
alleviate this problem 
Many funding agencies have already begun
the process of limiting administrative burden in
grant awards and have made some progress.
For example, some agencies now permit electronic
submissions of grants. However, a large and
persistent cause of administrative burden results
from a cumbersome system of overhead, or indi-
rect cost, reimbursement in the federal grants
process. Federal research grant awards to university
researchers include funding to cover the direct
costs of the research and overhead research costs
incurred by the university, reimbursements for
which vary considerably from grant to grant. From
the university’s perspective, there are large costs
associated with the investments in plant, equip-
ment, and human resources necessary to pursue
individual research grants and sustain a research
enterprise at the university. The universities’
tuition income and other funds received for
education are designated strictly for that func-
tion. Without overhead reimbursement, uni-
versities would not have the necessary level of
resources or incentives to sustain a vibrant basic
research enterprise. 
But the current retrospective, cost-based pro-
cedures for establishing federal reimbursement
for overhead have resulted in a fractious rela-
tionship between universities and government.
Present procedures are very costly and time
consuming and, according to some experts, dis-
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tort incentives for efficient expenditures.51 To
remove these distortions, and much of the unnec-
essary regulatory burden, they recommend a
system in which overhead rates associated with
all research grants are set by benchmarks, or
average overhead rates for similar universities.
The benchmarks would be determined on a
periodic basis by examining costs at a small
sample of universities within each class of insti-
tution. Such a procedure would greatly reduce
accounting and auditing costs for universities.
It would also minimize government leverage,
which universities consider excessive because of
the government’s power to demand lower reim-
bursement levels. Indeed, universities have
argued forcefully that cost-shifting has escalat-
ed in recent years, with federal agencies increas-
ingly unwilling to adequately cover overhead costs.
Finally, benchmarking would provide universi-
ties with a strong incentive to trim overhead,
because they would benefit from holding costs
below the benchmark. 
CED believes that the benchmarking of
overhead reimbursement rates has merit in
principle and encourages funding agencies
and universities to explore it on an experi-
mental basis. The determination of “similar
universities” is a difficult task, which should
take into account geographic variations among
other factors. In general, reform of indirect
cost reimbursement should be guided by the
principles of fairness (to both parties) and sim-
plicity.
Too Many Research Universities?
Some observers are concerned about the num-
ber of research universities vying for federal
funds today (see Chapter 3). As this number
grows, basic research resources are spread more
thinly and may be put to less effective uses. We
recognize this possibility, though we do not
support attempts to set a fixed number of
research universities eligible for funding, or
worse yet, a fixed list of specific universities eli-
gible for funding. Historical experience indicates
that it is very difficult to predict who will make
discoveries and where discoveries will take
place. Further, such “fixes,” in our minds, vio-
late the principles of flexibility and competition
that have defined the success of America’s uni-
versity research system. 
CED believes the appropriate number of
research universities will best be determined
by reinforcing existing mechanisms of peer
review, as well as by distributing funds at the
project and investigator levels rather than at an
institutional level. Competition for grants based
on scientific merit will ultimately separate the
wheat from the chaff among universities. Those
that do not attract quality researchers will not be
able to support a research program through fed-
eral grants. And the openness of the competition
to researchers regardless of institutional home
ensures accessibility to high talent wherever it
is based. 
Unfortunately, university research that is
funded outside of the peer review system is not
subject to this important competitive process.
Again, political earmarks are not an appropriate
funding mechanism to support universities or any
other research institution. University research sup-
ported by earmarks would not likely meet the peer
review standard, and a proliferation of research
universities due to earmarks would undermine
the quality of our basic research enterprise. 
Finally, although we do not support a “top-
down” approach to limiting the number of
research universities, we also do not believe
that all universities and colleges in the United
States should feel an entitlement or an oblig-
ation to pursue federal research dollars.
Competition for research dollars is healthy for
the basic research enterprise; it is not always in
the best interest of individual universities and col-
leges to enter this competition. In particular,
schools should not neglect their education mis-
sion in the process. For many institutions, the
pursuit of a research function comes at the cost
of undergraduate education, which is critical not
only to the basic research enterprise but to our
economy and society as a whole.
Existing Alternatives to Research Universities 
Are Weak
Although CED supports basic research fund-
ing through a diversity of missions and agencies,
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we question the degree of success that some
agencies have had in supporting basic research.
We believe that the further removed agencies are
from a merit-based, competitive grant system of
allocation, the poorer the science will be which
they support. The quality of research supported
by the Department of Agriculture has suffered
for this reason.52 In fact, just 5.4 percent of the
Department of Agriculture research budget goes
to nationally competitive research grants. If pay-
offs to our public investments in agricultural
research are going to improve in the future, this
percentage must increase substantially.
The Department of Energy’s national labs
face an uncertain future due, in part, to inade-
quate mechanisms for determining merit, but also
due to shifting missions. It would be a mistake
to view the end of the Cold War as the end of the
mission justification for the national labs. There
remain very strong defense and energy research
objectives that are within the purview of many
of these labs. However, at the prodding of the
Administration and Congress, many labs are
increasingly chasing the technology du jour, with
over half of their research dollars now devoted
to commercial product development, often
through industry partnerships.53 Although indus-
try partnerships with the national labs may
serve the competitive interests of specific indus-
tries in the development and commercializa-
tion of technologies, they do not always serve the
interests of the nation and its taxpayers. As we
argue later in this chapter (see “Choosing Basic
Research Among Competing Claims,” page 39),
subsidizing civilian technology for national
competitiveness purposes is not a justifiable fed-
eral mission and it should not be allowed to dis-
place federal investments in basic research.
Further, the Intel case described in Chapter 3 illus-
trates the political morass that such partner-
ships can create when mission justification is
weak, raising questions of favoritism among
companies, as well as concerns about indirect fed-
eral subsidies of foreign companies.
At the same time, the national labs continue
to represent a tremendous potential resource
for the nation’s basic research enterprise, par-
ticularly oriented toward large-scale scientific
inquiry. We call on the Congress and the
Administration to make a clear determination
of the missions of the labs and assess where
realignments of missions and functions are
necessary. The recommendations of the Galvin
Commission (see page 26) should serve as a
starting point for this work. The labs themselves
should be free to take actions to ensure the best
researchers are attracted and retained to accom-
plish lab missions. In particular, more of the
research conducted in the national labs, includ-
ing the large-scale science that they have the
capacity to perform, should be brought into a sys-
tem of competitive, merit-based peer review
that characterizes the best of our basic research
enterprise. 
Beyond scientific merit and mission justi-
fication, cost-efficiency in these labs must be
improved; performing basic research in the
national labs should not cost more than simi-
lar projects in other basic research institutions.
To this end, research projects performed in the
national labs should be free of the multiple lay-
ers of micromanagement emanating from the
Department of Energy and Congress that have
created gross inefficiencies and rigidity in the
labs.
In sum, it is clear to us that if the national labs
are to continue to play a productive role in
basic research, that role must be justified on the
basis of strong missions, outside peer-reviewed
determinations of scientific merit, and effi-
cient management and oversight structures. 
PRESERVING OUR CAPACITY TO DO
BASIC RESEARCH IN THE FUTURE
Future capacity to do basic research requires
long-term thinking today. Unfortunately, two
threats to tomorrow’s basic research enterprise
currently command too little attention from
political leaders and policymakers. 
One is funding for basic research. Today’s
federal budgetary environment, with rosy scenarios
for “budget surpluses as far as the eye can see,”
has created a decidedly optimistic attitude with-
in the science and engineering community (and
among its advocates in Washington). Speaking of
a threat to basic research funding in this envi-
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ronment may strike many as odd if not down-
right foolish. Yet, the likelihood of stable and ade-
quate support, not just for the next few years but
for the next few decades, is far from ensured.
The second area that requires long-term think-
ing today is in sustaining the human capacity to
do basic research. Sustaining the education and
employment pipeline for basic research also
means raising the technical and scientific abil-
ity of all students and society at large. This
effort is important both so our citizenry can
better exploit the increasingly flow of new
knowledge in an increasingly sophisticated
workplace and also so the importance of basic
research is not lost by a society that is less con-
nected to progress of science.
Ensuring Adequate Resources 
for Basic Research 
Throughout this chapter we recommend
ways that basic research resources can be used
more productively. But none of these policy rec-
ommendations should be taken as support for
getting along with less public support. As we
described in Chapter 2, the economic and social
payoff to American investments in basic research
has been tremendous in this century alone.
Given this level of benefit, adequate and sus-
tained funding for basic research must be a high
and consistent national priority. 
With this in mind, we are deeply concerned by
trends that have the potential to squeeze the
level of resources for basic research in the future.
Both the Administration and Congress now claim
a desire to increase basic research funding sub-
stantially over the next few years. It remains to
be seen, however, how these increases will mate-
rialize and if they will be sustained. Windfalls
derived from a booming economy or a hypo-
thetical tobacco settlement would certainly be
welcome additions to basic research funding.
They do not, however, eliminate political and
budgetary imbalances that stand as threats to
future funding. 
Recognizing the Role of Private Sector
Support for Basic Research
Advocates of a smaller government role in basic
research point to increasing private sector R&D
budgets as evidence that the federal govern-
ment’s efforts are no longer as important in this
area. Industry is doing more, the argument goes,
therefore government can do less. However, pri-
vate spending on total R&D should not be con-
fused with spending on basic research, nor
should industrial basic research be confused
with government-supported basic research. As
indicated in Chapter 3 and as the Pfizer case
study suggests, although the “Web of R&D
Innovation” is a complex one, with complex
interactions between basic and applied research,
it remains clear that the private sector role in basic
research, and in R&D in general, is and will
continue to be largely distinct from the govern-
ment’s role (also see Box 2, page 12). 
In sum, industry will continue to support and
perform important areas of basic research; but
this work should not be viewed as a substitute
for the much larger role of the federal govern-
ment in support of basic research. Given these
trends and the misunderstanding of them that
is prevalent among some political leaders and
the public generally, we urge business to begin
a dialogue with political leaders and the
American public so that they might better
understand the critical importance of stead-
fast government support of basic research.
Choosing Basic Research Among 
Competing Claims
Meeting the Entitlement Threat
Despite robust political support for short-
term funding increases, support for basic research
is likely to become less sure in years to come, due
to the budgetary costs of an aging population.
Basic research is one of many competing claims
on a shrinking discretionary portion of the fed-
eral budget, necessitated by rapid expansion of
entitlement programs, particularly Social Security,
Medicare, and Medicaid. The considerable rev-
enue boost the federal budget has received from
the current expansionary economic cycle does not
erase the underlying structural deficiencies in the
budget. This is a problem that will become dra-
matically worse the longer we wait to deal with
it; indeed, we may ultimately face devastating
cuts in the basic research budget if entitlement
spending is not brought under control before the
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baby-boom generation retires. As CED has
argued frequently in recent years, our political
leadership simply must deal with the growing
burden of the federal entitlement programs.54
Otherwise, the federal budget will have no room
left for government’s most important activities,
including investment in basic research. 
Federal Funding for Civilian Technology
One of the competing claims that basic research
faces in the federal budget comes in the form of
spending on applied and development research,
much of which is necessary to achieve objec-
tives in various missions, such as the develop-
ment of weapons systems technology for national
defense. A significant initiative of recent years,
however, has been to seek to improve the inter-
national competitiveness of U.S. industry by
increasing federal expenditures in certain areas
of applied research and civilian technology
development. The Advanced Technology Program
in the Department of Commerce is a product of
this initiative. 
CED does not believe that national com-
petitiveness programs have the same strong
claim to federal support that basic research
does. In Chapter 2, we described the very com-
pelling case for government support of basic
research. Although proponents of competitive-
ness programs often use the same language to
make their case—that public subsidies are nec-
essary to correct for insufficient levels of fund-
ing by the private sector in key areas (i.e., “market
failures”)—we find the case far from convincing.
Indeed, too often government spending on pro-
grams of this type amounts to little more than tax-
payer subsidies for favored industries and firms,
supporting research that the private sector would
have supported on its own or research that is not
worthy of public or private funding.55
With few exceptions, we do not think gov-
ernment should be in the business of directly fund-
ing what we view to be a function of the private
sector—development and commercialization of
technologies. The exceptions apply in cases
where the funding can be viewed strictly as a pro-
curement function, as in the national defense
example, or to correct a clearly defined and well
substantiated market failure.
Finally, CED believes that the government
should be sensitive to the basic research activ-
ities occurring in industry and should avoid
duplicative initiatives. Federal funding is most
vulnerable to duplication when research initia-
tives are overly-prescribed—as in research that
is targeted at specific diseases—and removed 
from a general peer-review process. 
Sustaining the Education and 
Employment Pipeline
In addition to the funding of basic research,
a second threat to our long-term basic research
capacity lies in our ability to sustain a pipeline
of future scientists and engineers, a work force
adequately skilled in the sciences to exploit new
knowledge, and a citizenry with enough under-
standing of basic science to recognize its impor-
tance and support its progress.
The United States is not in danger of run-
ning out of scientists and engineers to perform
basic research any time soon. After all, they
comprise only a tiny fraction of the nation’s
work force: in an American labor force of 132 mil-
lion, just 542,000 are doctoral scientists and engi-
neers.56 But there is a growing disconnect between
the need for a highly-skilled basic research labor
force on the one hand, and the quality of our 
K-12 math and science education and the inter-
est in science at the undergraduate level on the
other hand. Further, the desirability of basic
research employment at universities is eroded by
the amount of time devoted to applying for and
complying with federal grants, as well as the
demands of university technology transfer offices.
Left unchecked, we are concerned that these
trends will gradually erode the base of American
students willing or able to enter basic research
careers. 
These trends also exacerbate the on-going
challenge of attracting women and minorities to
training and careers in basic research. The severe
underrepresentation of these groups in the sci-
ence and engineering disciplines has far-reach-
ing effects on our basic research enterprise; in part,
in contributes to concerns that the peer review
process is biased against some researchers and
research projects. A more diverse research enter-
prise has been identified as a priority by uni-
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versities, agencies, and science organizations;
we support this goal and urge these institutions
to hasten its realization.
Finally, we are also concerned about a society
that is increasingly isolated from the world of sci-
ence and discovery. To a large extent, this isola-
tion is driven by science itself. Long gone are the
days when a well-educated citizen could be
expected to have even a cursory grounding in all
areas of knowledge (scientific or otherwise). But
the isolation we are particularly concerned about
involves a lack of understanding and accep-
tance of scientific methods and principles. This
deficiency is a detriment to the skill needs of 
today’s workplace. It also threatens to undermine
the public support for basic research, an enter-
prise that relies primarily on the public sector for
support. If society becomes less enthusiastic
about science and more suspicious, or simply 
indifferent, the case for research support will
become much more difficult to make in the halls
of Congress. 
Based on all of these concerns, we offer the fol-
lowing recommendations to strengthen the sci-
ence education and employment pipeline and
science education in general, not only for future
scientists but also for a public that must ultimately
support them.
Better Math and Science Education at the 
K-12 Level
In a series of policy reports on educational
improvement, CED’s trustees have done exten-
sive research into strategies for raising academ-
ic achievement in general and science and math
performance in particular.57 The complexity of
this task requires comprehensive and coordi-
nated change in several interdependent areas:
• establishing national mathematics and sci-
ence performance standards and assessing
progress based on these standards;
• increasing teacher knowledge and skill through
better training and more incentives;
• upgrading classroom curriculum and teach-
ing methods, including but not limited to
expanded use of technology in the classroom
and adequate investments in infrastructure,
such as lab space.
We maintain our strong support for high
achievement standards at the national level in
all core academic subjects, with particular
emphasis on mathematics and science. However,
given the inherent difficulties in getting nation-
al standards in these subjects developed and
accepted, we urge teachers and administrators
to actively and continuously pursue information
and research on new knowledge and effective,
innovative classroom practices and to redirect the
mission and goals of their schools toward rais-
ing standards for student performance.
Improved learning cannot happen without
improved instruction. Therefore, our schools need
to both attract and continuously support bet-
ter-qualified math and science teachers, par-
ticularly at the middle and high school levels.
Strategies to accomplish these ends include:
• improving the way teachers are educated in col-
lege, which includes requiring prospective
teachers to learn how to integrate technology
use and project-based learning into the cur-
riculum and requiring a math and/or science
major for teachers who plan to teach at the mid-
dle or high school level;
• raising certification standards to require mid-
dle and secondary science and math teachers
to have majored in their subjects and ele-
mentary school teachers to have taken 
substantive coursework in these subjects;
• employing stronger incentives, such as dif-
ferential pay, to attract more qualified science
and math teachers;
• developing alternative certification practices
to allow experienced scientists and mathe-
maticians from industry to enter teaching
without having to spend unnecessary time in
formal pre-service training, as long as they can
demonstrate their teaching skills;
• encouraging businesses and other organiza-
tions that employ scientists and engineers to
offer summer internships to teachers, giving
them direct exposure to math, science, and tech-
nology in the workplace. These organizations
should also explore opportunities to make
their scientists and engineers available for
The Carnegie Institution of Washington and
the New York Academy of Sciences are both
active in addressing the shortcomings of K-12
math and science education in the United States.
Their strategies reflect the key areas of concern:
that math and science instruction be adequately
substantive and that the instruction be engaging
enough to spark students’ interest in the subject
matter.
Under the leadership of Dr. Maxine Singer,
the Carnegie Institution launched the five-year
Carnegie Academy for Science Education
(CASE). Now in its fourth year, CASE provides
teachers in the District of Columbia (350 to date)
with intensive training in fundamental scientific
and mathematical concepts. CASE attempts to
re-train teachers whose standard training typi-
cally does not include sufficient grounding in
science and math. 
CASE recognizes that increasing the substan-
tive knowledge of teachers is half the battle. How
teachers impart this knowledge to students is
also important. The Summer Institute of CASE
emphasizes a pedagogy based on experimenta-
tion and questions, rather than rote answers and
memorization. Teachers participating in the
Summer Institute are engaged in the same exper-
iments and exercises that they will later pass on
to their students—for example, constructing the
perfect recipe for chalk, testing the city’s drink-
ing water, or building wind-powered land racers. 
The New York Academy of Sciences coordi-
nates a summer internship program in the sci-
ences for New York City school students. The
program places students in research labs (uni-
versity, government, and industry) alongside
professional scientists. The defining element of
the internship is the mentor-student relation-
ship, which gives the students access to the
world of scientific research through the eyes of a
scientist. Students also participate in lectures,
workshops, and discussion groups, all intended
to help them assimilate the knowledge derived
from the lab experience. The internship culmi-
nates in a research paper containing all the ele-
ments of a professional document.
Both of these initiatives make welcome con-
tributions to science education. Both also
demonstrate the importance of an organizational
“broker” in developing ties between the research
community and the local school system. One-on-
one efforts by individual scientists to assist
teachers or mentor students are laudable, but
can only hope to have a large-scale impact in the
context of coordinated efforts by intermediary
organizations. We believe the best candidates for
these efforts are organizations—like Carnegie
and the New York Academy—with public mis-
sions and considerable flexibility and autonomy.
Of course, not every city has a science-focused
foundation or professional society, which is why
we encourage universities to step into this role.
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in-school and after-school sessions with teach-
ers and students to help them keep up with
changes in knowledge and practice in tech-
nology and science-related fields (see Box 4 for
two examples in practice).
Finally, it is critical that students be actively
engaged in learning in the sciences and math. We
believe that improved teaching methods, togeth-
er with currently available interactive learning
technologies, including computers and Internet
connections, can effectively motivate student
performance and accelerate improvements in
learning. Substantial investment in infra-
structure improvements are also critical in this
regard—many schools have little or no lab
facilities to support science instruction. 
In order to further engage students in learn-
ing and to excite students about a possible career
in the sciences, they should have the opportunity
to interact with members of the research com-
munity. Businesses, universities, and schools
should work together to place more profes-
sional scientists and engineers in the class-
room as volunteers to assist in class lectures, lab
work, and field trips. These volunteers raise
BOX 4
BUILDING TIES BETWEEN PROFESSIONAL SCIENCE AND THE SCHOOLS
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the quality of instruction, demonstrate to the stu-
dents the future job benefits of a science and math
education, and communicate the role of science
and math in the world today. Similar initiatives
give students and teachers the opportunity to ven-
ture out of the classroom and explore the nature
of basic research in a professional setting (see Box
4, page 42).58 High-quality and engaging videos
and films can support this objective, while also
overcoming geographic, time, and resource con-
straints that might not allow for in-person inter-
action.
Improving Graduate Training
Graduate-level scientific training is perhaps
the most important segment of the education-
al pipeline for basic research. A science educa-
tion that is 16 years in the making can continue
on to a career in basic research or can be divert-
ed to some other field, depending on whether
or not the college graduate decides to complete
graduate training in the sciences. For those
choosing a future in basic research, their impact
as scientists and engineers depends a great deal
on the quality of their graduate training. 
Good scientific training is grounded in hands-
on exposure to basic research and scientific
inquiry. It is essential that graduate students
have access to hands-on research projects. Thus,
training of graduate students should be a para-
mount criterion for universities and faculties
in considering their research portfolios, par-
ticularly concerning the nature of the research.
The federal government can help to make
graduate student training a higher priority in
the research university by increasing the
amount of scholarships and training grants
available to students. Grant support that goes
directly to the student, versus support that
comes indirectly from grants for research pro-
jects, clearly places the priority on the student’s
training rather than the needs of any particular
research project.
Prolonged time to degree in graduate train-
ing is another concern, though admittedly one
that is not well understood. To the extent that more
time spent attaining the graduate degree reflects
a greater complexity of the field of study, there
is little to be done and the increased time like-
ly produces a more knowledgeable and pro-
ductive graduate. But it is undesirable for
prolonged time to degree to be caused by high-
er student-to-faculty ratios, excess time spent on
assisting faculty research, or difficulty in secur-
ing stable funding.59 The direct burden and
opportunity costs of a longer time to degree
are born by today’s student, and will also like-
ly have a deterrent effect on those considering
graduate training in the future. We urge research
universities to undertake frank and self-criti-
cal examinations of their graduate training
programs in an effort to expedite the time to
degree and reduce the financial and time bur-
den on their graduate students. Again, greater
investments in graduate education by science
and engineering-related federal agencies can
also play an important role in reducing this 
burden.
Academic employment is at the core of basic
research and will remain so. But an increasing
number of PhD scientists and engineers are
finding roles, whether by choice or due to a
lack of academic alternatives, in the private and
other non-academic sectors. Private sector
employment of PhD scientists and engineers
plays an important role in the dissemination of
scientific knowledge. In order to facilitate the
transition from academic training to private sec-
tor employment, graduate schools should offer
more training programs and mentorships in their
curricula that prepare and orient students for
employment outside of academe. 
Team-oriented and cross-disciplinary work—
an important component of these efforts—need
not detract from core disciplinary training. In fact,
the Pfizer, Harvard University, and BBN case 
studies (see Case Studies) all suggest that 
multi-disciplinary, cross-functional project teams
are an increasingly important element of success
in many areas of basic research, regardless of
whether it is private sector or university research.
At the same time, some university research
administrators have questioned whether there
is adequate grant support for cross-disciplinary
and team-oriented research, given the disci-
pline-oriented nature of current grant systems.
CED urges grant-making agencies to support
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more team and cross-disciplinary efforts in
research projects. 
CED notes that several recent reports address
the graduate training issues discussed here, and
that reforms in graduate education in the sciences
and engineering are underway.60 Agencies such
as the National Science Foundation are respond-
ing to the recommendations made by the National
Academies and others. Universities also are par-
ticipating in the renewal of graduate education
in the sciences and engineering. 
Academic Employment of Young Researchers
Although there is an important role for private
sector employment in sustaining the basic research
“pipeline,” academic employment of scientists
and engineers remains central to the health of the
basic research enterprise. The trend away from
full-time faculty positions at research universi-
ties and the increased reliance on post-doctoral,
part-time, and temporary employment are not
positive signs. They send the wrong signals to
today’s college and graduate students as they
embark on the long and rigorous training nec-
essary for a career in basic research.61 Hearing
horror stories of post-doctoral training that
extends well into a young researcher’s career, 
some prospective scientists and engineers are 
likely to opt out of this career path. Getting
young researchers out of temporary positions
and into stable employment should be a priority
for all research universities.
As we discuss earlier in this chapter (see
“Problems in the Administration of Federal
Grants for University Research,” page 36), aca-
demic employment also carries with it a large
administrative and grant-raising burden. Research
universities and the federal agencies that spon-
sor universities should be exploring ways to
make the academic scientist’s work environment
more stable and more productive, with less
time spent on raising money.
PRINCIPLES FOR UNIVERSITY
RESEARCH IN THE MARKETPLACE
American research universities have always
been oriented toward practical concerns, while
maintaining excellence in the most theoretical 
and exploratory corners of science. The transfer
of knowledge and new technologies from the uni-
versity to industry—as embodied in graduates
entering the work force, through open dissem-
ination of research results, or through private part-
nerships, patents, and licensing—is of great
economic benefit to the United States. But uni-
versities must walk a fine line as they seek to
increase the economic value of their basic research,
while maintaining a public mission defined by
openness and wide dissemination of research 
findings. This balancing act is made more diffi-
cult by the problems researchers face in obtain-
ing public grant support, as indicated earlier in
this chapter. CED believes universities, industry,
and the federal government should adhere to the
following principles as they pursue relation-
ships in basic research.
1. The primary channel of benefit from uni-
versity research to industrial innovation, and
to society at large, is through wide and
open dissemination of knowledge in research
journals, at conferences, and by the educa-
tion of graduate students. New knowl-
edge generated from university research
should continue to be openly dissemi-
nated. The publication of research findings,
upon which future research frequently
depends, should be only minimally delayed
by patent preparation and other require-
ments of sponsored research agreements.
2. Pursuit of patent protection on university
inventions, initiation of university-industry
partnerships, and licensing of intellectual
property for commercial development can
stimulate important new research and facil-
itate and expedite the transfer of new tech-
nologies to industry, ultimately benefiting
society at large. Therefore, such partnerships
and licensing activities, when structured
appropriately (see items 3-5), should be
encouraged.
3. These relationships can create conflicts of
interest among the universities, their faculty,
and collaborating industrial concerns.
Universities should be strongly encouraged
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to develop, and continually improve, poli-
cies and procedures for technology trans-
fer and industry relations, such that the basic
educational and research mission of the uni-
versity is neither diluted nor compro-
mised (see Appendix 2 for two examples of
university patent policies).
4. In addition to the need for universities to make
research results broadly available, these
institutions also have an obligation to devise
licensing agreements for technology devel-
oped using public funds in a fashion that gen-
erates the greatest benefit for society. The
guiding principle should be to prevent the
university technology transfer system from
impeding further research advances, wher-
ever they may occur. As a general principle,
research advances that can be turned into
distinct proprietary products are appro-
priate candidates for exclusive licensing and
development. On the other hand, tech-
nology that can serve as a tool for many
researchers to create new knowledge should
be made widely and nonexclusively avail-
able under commercially reasonable terms.
Industry should recognize and respect
these distinctions.
5. The success of America’s basic research
enterprise will continue to depend on the
use of patented inventions in basic research.
In general, basic research will benefit if a
patent holder’s rights (whether the owner
is a company or university) are not enforced
in a way that restricts further basic research.
Access of all parties to tools for basic research
is particularly important in cases where
federal funding supported the initial dis-
coveries. When a research tool is also a
research product (as may be the case in areas
of biomedical research), the interested
parties should work out terms that, first and
foremost, do not prevent broad future use
of the research tool, and secondly, permit
use of the product in the marketplace.
Industry and universities should contin-
ue to seek avenues which allow the fewest
possible restrictions on use of patented
inventions for new basic research.
6. The major research universities have devel-
oped policies that honor the public respon-
sibilities of their research mission. These
policies are particularly important in main-
taining the central purpose, value and
morale of the faculty who are the lifeblood
of the university. In particular, it is impor-
tant that the interests of industry not influ-
ence critical decisions of the university
regarding hiring, compensation and pro-
motion. The continued strength of basic
research in America depends on the abil-
ity of faculty members to devote their
energies to, and be evaluated by, their
quality and contributions as basic
researchers and their success in educating
new scientists. Commercial successes are
secondary to these missions.
7. Finally, private sector funding of univer-
sity research or research supported through
licensing fees should not be viewed by uni-
versities or the federal government as
substitutes for federal funding. The objec-
tives and goals of private firms are differ-
ent from public missions and should not be
allowed to define the character of univer-
sity research in general. Ultimately, the
only way to maintain basic research in the
university as it has been characterized over
the past half-century is through predomi-
nately public funding.
INTERNATIONAL CHALLENGES AND
OPPORTUNITIES FOR 
AMERICAN BASIC RESEARCH
Maintaining a Commitment to Basic
Research in a Global Economy
Basic research activities around the world
are increasing as other countries step up the
pace of their research investments. At the same
time, the new knowledge derived from basic
research moves more easily across national bor-
ders than ever before, thanks to the dramatic
advances in information technology. Transfer
of information is also facilitated by the steady pace
of economic globalization. 
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These trends have led some to question the via-
bility of our national basic research enterprise in
an increasingly international economy. In fact, some
argue that because the products of our basic
research now move freely and quickly to other
countries, or to foreign subsidiaries of U.S. firms,
U.S. taxpayers should not pay for it. They argue
that the United States should take better advan-
tage of other nations’ basic research, or should
attempt to limit foreign access to new American
knowledge. CED strongly believes that arguments
for reducing or restricting access to the out-
comes of U.S. efforts in basic research, based
on fears of foreign appropriation of American
discoveries, are misguided and could undermine
the central role that the federal government
plays in funding American basic research.
We readily acknowledge that other countries
benefit from our basic research. In some cases,
U.S. firms have been slow to capitalize on tech-
nological breakthroughs. This reflects poorly on
U.S. technological development and is not a fail-
ing of the basic research enterprise. 
The foreign benefit from American basic
research need not be our loss. Performing initial
basic research should position us to exploit ben-
efits faster than can the followers and the “free-
loaders.” If we reduce our efforts in basic research,
we will lose this “first mover” advantage. Also,
by promoting an open two-way environment for
new knowledge, we are able to share in other coun-
tries’ basic research findings, even to the point
of exploiting those findings more quickly than
firms in those countries. 
Finally, a robust basic research enterprise in
American universities keeps our high-tech firms
on-shore, while also attracting foreign firms to
invest within our borders. The scientists and
engineers at our research universities are an
enormous international strategic advantage.
In sum, more basic research activity around
the globe will present tremendous opportunities
for scientific progress, with large payoffs for all
nations. Nationalistic attitudes and policies are
counterproductive to this progress and have no
place in a productive global basic research enter-
prise. It is critical, then, that the United States
take a leadership position in ensuring the free
flow of fundamental knowledge and basic
research findings globally.
Intellectual Property Worldwide
Although CED does not view the interna-
tional spillover of non-proprietary knowledge
derived from basic research as a negative, we are
concerned about the impact of weak intellectu-
al property laws in other countries on innovation
in the United States and globally. U.S. patent
laws play a very large role in stimulating inno-
vative activities in this country by protecting a
company’s rights to discoveries and innova-
tions that are proprietary in nature; in this way,
the company is able to capture the returns on its
investment. In an increasingly global environment
and one in which a growing number of countries
are investing in research, it is in the interest of all
countries to play by the same rules regarding intel-
lectual property. The pirating of intellectual
property that occurs in other countries ulti-
mately hurts all levels of innovative activity,
from basic research to commercial development. 
Pursuing International Collaboration
Some areas of science have become too expen-
sive and too risky to be supported solely by a
single country. Because of their ultimate potential
benefit, such projects deserve international coop-
eration— in funding, institutional collaboration,
and sharing of scientists and results. Mistrust
between countries in such projects ignores the
reality of global science today. A great deal of sci-
entific information already flows freely across
national borders through publications, research con-
ferences, and through the Internet and other forms
of information technology. By cooperating in large-
scale projects, the United States and other coun-
tries extend globalization to projects that are not
sustainable at a national level. CED believes the
United States must pursue international coop-
eration in “big science,” in order to optimize
advances in science and technology.
Supporting Foreign Scientists and Engineers
in the United States
In an increasingly global scientific community,
American training of foreign scientists is anoth-
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er welcome form of international research co-
operation. The participation of foreigners in
American universities and in American science
and engineering programs benefits the U.S.
research enterprise and the economy in gener-
al.62 Foreign students contribute to our basic
research through participation in university
research. Given the capacity of the American
research university system, it is unlikely that
these students are significantly “crowding out”
high-potential American students. Many for-
eign graduates will choose to remain in the
United States as professional scientists and engi-
neers (about 40 percent in recent years).63
The direct participation of foreign students and
professionals in American basic research will
likely decline in the future, as foreign economies
become more sophisticated. How the United
States reacts to these trends is critical to the
future of our own basic research enterprise. CED
believes the United States should continue to make
reasonable efforts to attract foreign scientists.
Our immigration policies should be further
liberalized to allow foreign scientists and engi-
neers to live and work in the United States
through permanent visas. Also, immigration poli-
cies should encourage foreign scientists and engi-
neers to visit the United States on a temporary
basis as consultants or participants in research
collaborations.
CONCLUSION
We are in the midst of a remarkable period of
discovery and innovation. Ask those engaged
in the discovery process what they think about
the future of their particular discipline and the
answer is likely to be strikingly positive, with pos-
tulations about breakthroughs that are unfath-
omable to us today. Add to this optimism the impact
of the current economic boom, which is making
the most of product innovations and bringing new
technologies to market at a dizzying pace. Together,
these trends create an atmosphere of almost
boundless enthusiasm about the future.
Raising a cautionary note about the future of
the basic research enterprise in this environ-
ment, then, is no easy task. Certainly, we do not
foresee calamity on the horizon. The United
States will continue to see pay-offs from its basic
research investments, as it has throughout this
century. 
Yet, today’s emerging problems, left unchecked,
become a potent threat to tomorrow’s research enter-
prise. In this sense, the reforms we have recom-
mended in this report—shoring up the system of
competitive peer review, maintaining adequate
resources, and correcting deficiencies in the edu-
cational and employment pipeline, to name a
few—are more than just fine-tuning. Problems in
each of these areas have the potential to erode the
quality and quantity of output we have come to
expect from American basic research.
Dealing with these challenges requires resolve.
Certainly, if reforming the national laboratories
is politically difficult, K-12 educational reform is
even more so. The key for policymakers, and for
the citizens they represent, is to keep their focus
on the potential for the future. The pay-offs from
a basic research enterprise that is working at its
full capacity are tremendous, and far too great
to forgo for lack of political will.
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An important constant in the success of
American basic research has been the substan-
tial financial support it has received throughout
most of the post-World War II era. In terms of
dollars spent and the number of scientists
employed in research activity (see Appendix
Box 1, “Research Dollars Versus Other Inputs”),
both total R&D and basic research have expand-
ed over the past fifty years. 
However, in recent years, as post-Cold War
priorities and missions are being sorted out,
growth in basic research spending relative to GDP
has been weaker. As Appendix Figure 1, page 49
indicates, federal basic research is about the
same today as a proportion of GDP as it was in
1970. While industrial support for basic research
has risen slightly in the last decade, it remains
well below federal support. Moreover, the rate
of increase in industrial support for basic research
has slowed considerably during the 1990’s. 
Basic research is not a large share of total
R&D for industry or government (see “Why
Does Government Support Basic Research?,”
page 12). Industry spends considerably more
on R&D overall but much less than the federal
government on basic research (see Appendix
Figure 2, page 50). Indeed, the large amount of
industry development spending overshadows all
other categories of research spending both in
industry and government. Of the nearly $63 bil-
APPENDIX 1
OVERVIEW OF RESOURCES 
FOR BASIC RESEARCH
Focusing solely on the financial resources
devoted to basic research overlooks other
important factors in measuring research
activity, namely the amount of labor and
capital inputs devoted to science. While
research dollars are frequently used as a
proxy for these inputs and for research activ-
ity in general, it is important to keep in mind
that these dollars purchase the services of
scientists and engineers, as well as the equip-
ment they employ. Does an increase or
decrease in dollars spent on research activi-
ties represent a one-for-one movement in the
number of researchers or amount of research
equipment employed? Or has the cost of
these inputs—that is, the real cost of doing
research—changed in a way that our stan-
dard cost measures fail to capture?
In fact, the amount of research inputs
employed appears to have kept pace with
dollars spent on R&D. Over the same period
(1981-1993) that total R&D spending
increased about 40 percent in inflation-
adjusted dollars, the number of scientists
and engineers engaged in research activities
also increased about 40 percent (see
Appendix Figure 3, page 51). 
At the same time, attempts to account for
the cost of research at a macroeconomic level
suggest that some types of research have
become more expensive relative to other
forms of economic activity.1 Specifically, the
cost of university research (reflecting person-
nel, equipment, and facilities) rose 10 percent
faster than prices in the economy in general in
1992. However, the cost of industrial research
grew at a slightly slower rate than economy-
wide prices, and non-manufacturing R&D
costs grew at an even slower rate.
APPENDIX BOX 1
RESEARCH DOLLARS VERSUS OTHER INPUTS
49
lion that government spends on R&D annually,
$17.7 billion goes to basic research. And of the 
$133 billion that industry spends on R&D, a
much smaller share, just $8 billion, goes to basic
research.
The Central Role of Federal Government in
Funding Basic Research
The most important source of funds for basic
research since World War II has been the feder-
al government. Through most of the post-World
War II period, growth in federal support for
basic research was substantial and quite stable.
However, relative to growth in the economy,
federal support for basic research has remained
virtually flat in recent years (see Appendix
Figure 1) and long-term federal budgetary and
demographic trends suggest an even less favor-
able outlook for the future.
As a relative priority in the federal budget, basic
research expenditures are well below the peak
achieved during the height of the space pro-
gram in the mid-1960’s (see Appendix Figure 4,
page 52). However, basic research spending has
maintained a level of just over one percent of fed-
eral outlays in the past decade, a period when
total federal R&D slipped as a budget priority.
The relative importance of basic research, and
of R&D in general, has been greatly overshad-
owed by rapid growth in outlays for entitle-
ment programs and interest on the debt, which
have crowded out discretionary spending in
general, including research spending (see
Appendix Figure 5, page 52). 
It is the long-term funding picture, however,
that is most striking. The retirement of the baby
boomers will place unprecedented demand on
the federal budget, primarily for Social Security
and Medicare.2 Under current policies, entitle-
ment and interest outlays are projected to account for
70 percent of the federal budget by 2002, compared
to just one-third of the budget during the peak years
Appendix Figure 1
Federal, Industry, and Other Funds for Basic Research as a Percentage of GDP
*Industry data prior to 1986 are not comparable to post-1989 data.
**Includes universities’ and colleges’ own funds, state/local government funds to universities and colleges, and funds from other non-
profits.
SOURCE: National Science Board, Science & Engineering Indicators—1996, (Washington, DC: U.S. Government Printing Office, 1996),
Appendix Tables 4-1 and 4-5.
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for research spending (the mid-1960’s). Under such
a scenario, basic research would almost cer-
tainly see a substantial decline in funding.
Again, a majority of federal R&D funds is
devoted to development work, which is pri-
marily carried out by private companies (see
Appendix Figure 6, page 53). In contrast, the 
smaller portion of federal R&D devoted to basic
research is directed primarily to universities,
with a very small amount directed to industry
and non-profit institutions. As Appendix Figure
6 illustrates, the amount of federal basic research
performed directly by federal agencies (in labs
like the National Institutes of Health or the
Department of Energy’s “national labs”) is small
relative to the total federal R&D budget.
Most federally-sponsored basic research sup-
ports agency missions. In this sense, basic
research does not generally conform to its stereo-
type, which is that it is untargeted and devoid
of any defineable goal beyond the advance-
ment of knowledge. In fact, basic research sup-
ported by the Departments of Defense and
Energy, and through the National Institutes of
Health, has very strong goals in specific mission
areas. Only 15 percent is funded through the
National Science Foundation, which provides sup-
port for basic research outside of the agency
missions and is based primarily on scientific
and engineering disciplines. 
Federal support for basic research is by no
means uniform across scientific disciplines. As
Appendix Figure 7, page 53  illustrates, feder-
al basic research outlays in the life sciences far
surpass those in other disciplines. In fact, fund-
ing for the life sciences is on a par with all other
disciplines combined. This disparity in funding
levels appears to reflect a strong public priori-
ty placed on health-related research, particu-
larly in high profile areas like cancer and AIDS
research. However, as many prominent scientists
within and outside of health research have
noted, breakthroughs in medical science often
rely on research conducted in disciplines far
afield from the life sciences, including mathema-
tics, physics, computer science, and the social 
sciences. 
The importance of multi-disciplinary research
is illustrated by the experience of the private sec-
tor. Several of the case studies presented in the next
section demonstrate that successful basic research
often does not mean narrow basic research. Merck’s
efforts in AIDS research have been multi-dimen-
sional by necessity, given the uncertainties of the
basic research endeavor. The Procter & Gamble case
study also illustrates the necessarily wide, cross-
disciplinary net that must be cast to achieve
progress in particular areas of innovation: for
Procter & Gamble, this meant supporting bio-
logical research, far afield from the company’s core
basic research activities in chemistry.
Overview of Resources for University
Research
Public and private funding for university
research has increased dramatically over the
past four decades, from just under $3 billion in
1959 to over $22 billion in 1996 (expressed in con-
Appendix Figure 2
Basic, Applied, and Development
Research Spending by Government and
Industry for 1997
NOTE: Data are preliminary for this year.
SOURCE: NSF, Science Resources Studies Division (data avail-
able at www.nsf.gov).
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stant 1996 dollars; see Appendix Figure 8, page
54). As Appendix Figure 8 indicates, this growth
has been driven largely by increasing federal 
support, although industry and institutional
support have also increased significantly in
recent years. Industry’s share of support has
grown from 3 percent in 1965 to 7 percent in 1996
(see Appendix Figure 9, page 54).
Reflecting the priorities of the federal gov-
ernment, and society at large, university health
research (“life sciences”) has been by far the
largest recipient of federal and non-federal
resources (see Appendix Figure 10, page 55).
All fields have seen some increase in funding
between 1989 and 1996. At the low end, math-
ematical sciences received average annual increas-
es of 1.5 percent (after inflation) during this
period. At the high end, the social sciences
received annual increases averaging 7 percent.
The growth rate for life sciences research was 
3 percent; this increase in resources greatly
exceeds that for other disciplines because it
began from a much higher base level.
Although National Institutes of Health fund-
ing dominates university research (see “HHS”
category in Appendix Figure 11, page 56), other
agencies are more important to disciplines out-
side of the life sciences (see Appendix Figure 12,
page 56). For example, research in the comput-
er sciences relies on Department of Defense
dollars for 58 percent of its federal funding.
The National Science Foundation is the largest
funding agency for the physical, mathemati-
cal, and environmental sciences.
Another important, though indirect, source
of federal funding for university research comes
from medical services revenues.3 University
hospitals have become important providers of
medical care, particularly to Medicare and
Medicaid recipients. As a result, these two pro-
grams have indirectly funded both health research
in the university hospital and research else-
where in the university through cross-subsi-
dization. With the likelihood of more stringent
cost controls in Medicare and Medicaid, this
indirect source of funding for university research
is expected to decline.
Appendix Figure 3
Academic Employment and Total
Employment of Scientists and Engineers
Engaged in R&D in the United States
NOTE: Data for academic employment represent doctoral sci-
entists and engineers. Other data represent all scientists and
engineers.
SOURCE: National Science Board, Science & Engineering
Indicators—1996 (Washington, DC: U.S. Government Printing
Office, 1996), Appendix Tables 3-19 and 5-19.
1981
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
N
u
m
b
er
 o
f 
S
ci
en
ti
st
s 
an
d
 E
n
gi
n
ee
rs
Academic Total
1993
52
Appendix Figure 4
Federal Basic Research Spending as a Percent of Total Federal Outlays
SOURCE: Science Resource Studies Division, NSF (data available at www.nsf.gov); Budget of the United States Government, FY 1998.
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Appendix Figure 5
Entitlements and Net Interest on the Debt as a Percentage of Total Federal Outlays
SOURCE: Budget of the U.S. Government, FY 1999, historical tables, (Washington, D.C.: U.S. Government Printing Office).
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Appendix Figure 6
Federal R&D by Character of Work and Performer 
1995
SOURCE: National Science Board, Science & Engineering Indicators—1996, (Washington, DC: U.S. Government Printing Office, 1996),
Appendix Table 4-18.
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Appendix Figure 7
Federal Obligations for Basic Research by Field
SOURCES: Science Resources Division, National Science Foundation, Federal Funds for Research and Development, Detailed Historical
Tables: Fiscal Years 1956-95, NSF 95-319 (Bethesda, Md.: Quantum Research Corp., 1995), and SRS, Federal Funds for Research and
Development: Fiscal Years 1993, 1994, and 1995 (Arlington, Va.: NSF, forthcoming).
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Appendix Figure 8
Research Expenditures at Universities and Colleges, by Souces of Funds
SOURCE: National Science Foundation, Science Resources Studies Division, Survey of Research and Development Expenditures at
Universities and Colleges, Fiscal Year 1996.
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Appendix Figure 9
Sources of Funding for University Research
SOURCE: National Science Foundation, Science Resources Studies Division, Survey of Research and Development Expenditures at
Universities and Colleges, Fiscal Year 1996.
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Appendix Figure 10
Federal and Non-Federal Funding by Research Field at Universities & Colleges
SOURCE: National Science Foundation, Science Resources Studies Division, Survey of Research and Development Expenditures at
Universities and Colleges, Fiscal Year 1996.
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Appendix Figure 11
Agency Support for Conduct of Research at Universities and Colleges, FY 1996
SOURCE: AAAS Report XXII: Research and Development FY 1998, Intersociety Working Group, (AAAS: Washington, DC), Table I-9.
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Appendix Figure 12
Federal Academic Research Obligations, by Major Federal Agencies, for Various
Sciences. 1993-95 Average
SOURCE: National Science Board, Science & Engineering Indicators—1996, (Washington, DC: U.S. Government Printing Office, 1996),
Table 5-11.
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In this appendix, we present two examples of
university patent policies, from the University
of California system and Cornell University.
Both affirm the primary intent of research at
their universities — the pursuit of knowledge —
while recognizing the potential for by-products
that have commercial potential and are suit-
able for patenting.
These two policies differ, as do others, on the
distribution formulas for licensing revenues.
Although the specific percentages for distribu-
tion vary, formulas are generally structured to
reward the researcher and the researcher’s depart-
ment or laboratory with some percentage of
these revenues. In this way, some of the rev-
enues resulting from research are directed back
to research activities.
A common feature of these policies is the
stated requirement of researchers to disclose
potentially-patentable inventions to the uni-
versity. The university then decides whether or
not to pursue a patent on the invention. Some
policies state the perogative of the researcher to
place research findings directly in the public
domain, effectively forfeiting the university’s abil-
ity to assert intellectual property rights. However,
there is tremendous pressure as well as a finan-
cial incentive for researchers to first disclose
their findings to the university. Universities
emphasize that this disclosure and the patent appli-
cation process need not interfere with the pub-
lication of research findings, but filing for the patent
must occur before publication or other forms of
public disclosure.
APPENDIX 2
UNIVERSITY PATENTING GUIDELINES
UNIVERSITY OF CALIFORNIA PATENT POLICY
(Reprinted with the permission of the University of California)
I. PREAMBLE 
It is the intent of the President of the University
of California, in administering intellectual prop-
erty rights for the public benefit, to encourage
and assist members of the faculty, staff, and
others associated with the University in the use
of the patent system with respect to their dis-
coveries and inventions in a manner that is
equitable to all parties involved. 
The University recognizes the need for and de-
sirability of encouraging the broad utilization 
of the results of University research, not only
by scholars but also in practical application for
the general public benefit, and acknowledges
the importance of the patent system in bringing
innovative research findings to practical application. 
Within the University, innovative research
findings often give rise to patentable inven-
tions as fortuitous by-products, even though
the research was conducted for the primary
purpose of gaining new knowledge. 
The following University of California Patent
Policy is adopted to encourage the practical
application of University research for the broad
public benefit; to appraise and determine rela-
tive rights and equities of all parties concerned;
to facilitate patent applications, licensing, and
the equitable distribution of royalties, if any;
to assist in obtaining funds for research; to pro-
vide for the use of invention-related income for
the further support of research and education;
and to provide a uniform procedure in patent mat-
ters when the University has a right or equity. 
II. STATEMENT OF POLICY
A. An agreement to assign inventions and
patents to the University, except those resulting
from permissible consulting activities without
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use of University facilities, shall be mandatory
for all employees, for persons not employed by
the University but who use University research
facilities, and for those who receive gift, grant,
or contract funds through the University. Such
an agreement may be in the form of an acknowl-
edgment of obligation to assign. Exemptions
from such agreements to assign may be autho-
rized in those circumstances when the mission
of the University is better served by such action,
provided that overriding obligations to other par-
ties are met and such exemptions are not incon-
sistent with other University policies. 
B. Those individuals who have so agreed to
assign inventions and patents shall promptly
report and fully disclose the conception and/or
reduction to practice of potentially patentable
inventions to the Office of Technology Transfer
or authorized licensing office. They shall execute
such declarations, assignments, or other docu-
ments as may be necessary in the course of
invention evaluation, patent prosecution, or
protection of patent or analogous property
rights, to assure that title in such inventions
shall be held by the University or by such other
parties designated by the University as may be
appropriate under the circumstances. Such cir-
cumstances would include, but not be limited to,
those situations when there are overriding patent
obligations of the University arising from gifts,
grants, contracts, or other agreements with out-
side organizations. In the absence of overriding
obligations to outside sponsors of research, the
University may release patent rights to the
inventor in those circumstances when: 
(1) the University elects not to file a patent
application and the inventor is prepared
to do so, or 
(2) the equity of the situation clearly indicates
such release should be given, provided in
either case that no further research or
development to develop that invention will
be conducted involving University sup-
port or facilities, and provided further that
a shop right is granted to the University. 
C. Subject to restrictions arising from over-
riding obligations of the University pursuant to
gifts, grants, contracts, or other agreements with
outside organizations, the University agrees,
following said assignment of inventions and
patent rights, to pay annually to the named
inventor(s), or to the inventor(s)' heirs, succes-
sors, or assigns, 35% of the net royalties and
fees per invention received by the University. An
additional 15% of net royalties and fees per
invention shall be allocated for research-related
purposes on the inventor's campus or Laboratory.
Net royalties are defined as gross royalties and
fees, less the costs of patenting, protecting, and
preserving patent and related property rights,
maintaining patents, the licensing of patent and
related property rights, and such other costs, taxes,
or reimbursements as may be necessary or
required by law. Inventor shares paid to University
employees pursuant to this paragraph represent
an employee benefit. 
When there are two or more inventors, each
inventor shall share equally in the inventor's
share of royalties, unless all inventors previ-
ously have agreed in writing to a different dis-
tribution of such share. 
Distribution of the inventor's share of royal-
ties shall be made annually in November from
the amount received during the previous fiscal
year ending June 30th, except as provided for in
Section II.D. below. In the event of any litigation,
actual or imminent, or any other action to pro-
tect patent rights, the University may withhold
distribution and impound royalties until reso-
lution of the matter. 
D. The DOE Laboratories may establish sep-
arate royalty distribution formulas, subject to
approval by the President. Distribution of the
inventor's share of DOE Laboratory royalties
shall be made annually in February from the
amount received during the previous fiscal year
ending September 30th. All other elements of this
policy shall continue to apply. 
E. Equity received by the University in licens-
ing transactions, whether in the form of stock or
any other instrument conveying ownership
interest in a corporation, shall be distributed in
accordance with the Policy on Accepting Equity
When Licensing University Technology. 
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1. Evaluating inventions and discoveries
for patentability, as well as scientific
merit and practical application, and
requesting the filing and prosecution of
patent applications. 
2. Evaluating the patent or analogous
property rights or equities held by the
University in an invention, and nego-
tiating agreements with cooperating
organizations, if any, with respect to
such rights or equities. 
3. Negotiating licenses and license option
agreements with other parties con-
cerning patent and or analogous prop-
erty rights held by the University. 
4. Directing and arranging for the collec-
tion and appropriate distribution of
royalties and fees. 
5. Assisting University officers in negoti-
ating agreements with cooperating orga-
nizations concerning prospective rights
to patentable inventions or discover-
ies made as a result of research carried
out under gifts, grants, contracts, or
other agreements to be funded in whole
or in part by such cooperating organi-
zations, and negotiating with Federal
agencies regarding the disposition of
patent rights. 
6. Approving exemptions from the agree-
ment to assign inventions and patents
to the University as required by Section
II.A. above. 
7. Approving exceptions to University
policy on intellectual property matters
including patents, copyrights, trade-
marks, and tangible research products.
F. In the disposition of any net income accru-
ing to the University from patents, first consid-
eration shall be given to the support of research. 
III. PATENT RESPONSIBILITIES AND
ADMINISTRATION 
A. Pursuant to Regents’ Standing Order
100.4(mm), the President has responsibility for all
matters relating to patents in which the University
of California is in any way concerned. This pol-
icy is an exercise of that responsibility, and the
President may make changes to any part of this
policy from time to time, including the percent-
age of net royalties paid to inventors. 
B. The President is advised on such matters
by the Technology Transfer Advisory Committee
(TTAC), which is chaired by the Senior Vice
President—Business and Finance. The mem-
bership of TTAC includes the Provost and Senior
Vice President—Academic Affairs, the Director
of the Office of Technology Transfer, and rep-
resentatives from the campuses, DOE Laboratories,
Academic Senate, the Division of Agriculture and
Natural Resources and the Office of the General
Counsel. TTAC is responsible for: 
1. reviewing and proposing University
policy on intellectual property matters
including patents, copyrights, trade-
marks, and tangible research products; 
2. reviewing the administration of intel-
lectual property operations to ensure con-
sistent application of policy and effective
progress toward program objectives;
and 
3. advising the President on related mat-
ters as requested. 
C. The Senior Vice President—Business and
Finance is responsible for implementation of
this Policy, including the following: 
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The following policy was approved by the
Executive Committee of the Cornell University
Board of Trustees on May 26, 1995 to be effec-
tive July 1, 1995. 
A. General Statement
The Board of Trustees of Cornell University,
recognizing that inventions and discoveries of
commercial importance may be the natural out-
growth of research conducted by faculty, staff and
students, and desiring to secure both public
benefit from the applications of such research and
enhancement of the University's capacity for
such research, has established the following
Patent Policy. 
1. Cornell University’s primary obliga-
tion in conducting research is the pur-
suit of knowledge for the benefit and use
of society. 
2. The University depends upon finan-
cial support from governmental agen-
cies, private foundations, corporations,
operated for profit and others for the basic
and applied research endeavors of the
faculty and staff. As University Research
enjoys substantial public support it is
incumbent upon the Univer-sity to seek
assurance that any resultant patent right
be administered consistent with the
public interest. 
3. Inasmuch as new ideas and discoveries
of commercial interest are often a con-
sequence of University Research, and
inasmuch as patent protection can often
enhance the reduction to a public use-
fulness of inventions which result from
University Research, Cornell, as a gen-
eral policy, will seek patent protection
for those ideas and discoveries which
arise out of the research activities of its
faculty and staff where it appears nec-
essary or desirable to do so. 
4. It is the judgment of the University that
the reduction to a public usefulness of
inventions and discoveries resulting
from University Research, the publi-
cation and availability for educational
purposes of the fruits of such research,
and the achievement of a fair and 
equitable distribution of royalties 
which acknowledges both the con-
tribution of the inventor, and the
University can best be assured by oper-
ation of a uniform Patent Policy which
provides for University ownership of
inventions. 
B. University Research
University Research shall be defined, for the
purpose of this Patent Policy, to include all
research conducted in the course of an inventor's
employment with the University (including but
not limited to the performance of a grant con-
tract or award made to the University by an
extramural agency) or with the use of University
Resources.
C. Disclosure of Inventions
Inventions conceived or first reduced to prac-
tice in furtherance of the University Research of
faculty or staff shall be promptly disclosed in writ-
ing to the Cornell Research Foundation. 
D. Ownership of Inventions
1. All patentable inventions conceived or
first reduced to practice by faculty and
staff of Cornell University in the conduct
of University Research shall belong to
the University. The inventor shall coop-
erate and assist the University in all
phases of the patent application process
and shall assign such applications or any
patents resulting therefrom to Cornell
Research Foundation, Inc. 
2. Patentable inventions made by indi-
viduals on their own time and with-
CORNELL UNIVERSITY PATENT POLICY
(Reprinted with the permission of Cornell University)
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out the use of University resources shall
belong to the individual inventor. 
3. In cases in which the University has an
ownership interest in an invention pur-
suant to paragraph D(1) and either does
not file a patent application within one
year, or fails to make a positive deter-
mination regarding pursuit of a patent
within a period of six months from the
date of disclosure, all of the University's
rights shall be reassigned to the inven-
tor upon request, subject only to such
external sponsor restrictions as may
apply. 
E. Royalty Distribution
1. In the case of a patent owned by the
University pursuant to paragraph D(1)
above, and in recognition of the efforts
and contributions of the inventor, total
net royalty income shall be distributed
as follows: 
50% of the first $100,000.00
25% of net royalty income in excess of
$100,000.00 
Joint inventors shall share the percentage of
net royalty income allocated to the Inventor.
Any person hired or retained for the purpose of
producing an invention shall not be entitled to
a distribution of net royalty income with respect
to that invention. 
2. Cornell Research Foundation shall
receive 35% of the net royalty income to
provide operating funds to cover the cost
of service provided to the University with
regard to intellectual property matters
and particularly to cover the costs asso-
ciated with patenting and marketing
inventions where royalty income or
other cost recovery has not been achieved.
Cornell Research Foundation's prior
deficits shall be retired using this por-
tion. The percentage of net royalty
income to Cornell Research Foundation
shall be evaluated annually by the Board
of Directors of the Foundation and
reduced when deficits have been elim-
inated. The Cornell Research Foundation
Board of Directors shall be responsible
to adjust the percentage received by
Cornell Research Foundation with a
two year lead time following the elim-
ination of the Foundation’s deficits. 
3. Net royalty income shall mean gross
royalties received by the University less
directly assignable expenses resulting
from patenting and licensing the par-
ticular invention . 
4. The remainder of the net royalty income
shall be divided (a) 60% to the inventor's
research budget, subunit and University
unit in a manner to be mutually agreed
upon and (b) 40% to the University for
general research support. 
5. For any year in which the net royalty
income distributed to a unit of the
University for a particular invention
emanating from that unit shall exceed
20% of the annual sponsored research
as determined by the Office of Sponsored
Programs for that unit in that year, the
excess received from Cornell Research
Foundation shall be retained as endow-
ment for the unit. The Dean or Director
of the unit may similarly require that cor-
responding royalty income to a sub-
unit exceeding 20% of the total sponsored
research of the inventor's appropriate sub-
unit be retained as endowment for the
benefit of the subunit. In the event that
a lump sum royalty payment contributes
to the generation of excess royalty
income in a given year as defined above,
Cornell Research Foundation may dis-
tribute such lump sum payment to the
unit or subunit over a three year peri-
od together with accumulated interest.
In such case, the provisions of this para-
graph shall apply to the resulting annu-
al distributions. 
6. In the case of an invention unresolvable
dispute over distributions in 4 (a), net
royalty income distributed under 4 (a)
shall be allocated and made on an equi-
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table basis as determined by the Vice
President for Research. 
F. Licensing Policy
It is the general policy of the University to
encourage the development and marketing of
inventions resulting from University research so
as to reach a public usefulness and benefit. It is
recognized that furtherance of such a policy
may require various forms of agreements includ-
ing the granting of exclusive licenses. 
Cornell Research Foundation may, in appro-
priate circumstances with due consideration to
the prospective licensee and when consistent with
law applicable to federally supported research,
license an existing patent or invention on an
exclusive basis for a reasonable period up to
the full term of the patent, provided that such
an exclusive license shall contain provisions to
promote the likelihood that the invention pro-
vides a public benefit, including but not limit-
ed to a requirement of diligence and march-in
rights where the licensee does not adequately per-
form. 
G. Waiver Requests
Waiver of any provisions of the Patent Policy
shall be granted only in extraordinary and com-
pelling circumstances and pursuant to the pro-
cedure described below. 
A request for waiver of any of the provisions
of this Patent Policy shall be submitted to the
President of Cornell Research Foundation &
the Vice President for Research for transmittal
to the Patent Advisory Committee. Such request
shall include an identification of the provision
or provisions of the Policy requested to be
waived, and a full explanation of the reasons for
the waiver including, but not limited to, the
manner in which the waiver is consistent with
the educational purposes of the University and
the public interest. 
The University recognized that certain spon-
sors may wish to impose as a condition of the
award of contract or grant funds special provi-
sions which are at variance with this Patent
Policy. Under such circumstances, the University
may entertain such proposals as requests for
waiver under this paragraph subject to the addi-
tional condition that all faculty or staff members
engaged in research to be supported by the pro-
posed grant or contact containing such provisions
shall acknowledge and accept those specific
provisions. 
The Patent Advisory Committee shall review
each request for waiver and submit a report of
its findings and recommendation to the Vice
President for Research whose decision shall be
final. Each action under this section shall con-
sidered on its own merits in light of all of the facts
surrounding the particular request and shall
have no implication for consideration of sub-
sequent requests. Waiver of provisions relating
to distribution of net royalty income shall, in addi-
tion, require the approval of the Dean or Director
of the unit from which the invention emanated. 
H. Deferral
This statement of Patent Policy shall not pre-
vent participation under research agreements with,
or the conduct of research for, governmental
agencies (local, state or federal) subject to laws
or regulations which require a different dispo-
sition of patent rights than herein provided, or
impose other provisions which are in addition
to, or inconsistent with, its provisions. Such
provisions of this Patent Policy as are inconsis-
tent therewith shall be deem superseded and the
provisions of such laws and regulation shall
apply. 
I. Patent Management Agencies
Cornell Research Foundation may make suit-
able arrangements not inconsistent with the
provisions of this Patent Policy with patent
management agencies or firms for the purpose
of obtaining services and advice with respect to
the patentability of inventions, the obtaining
of patents thereon and the management and
licensing of any such patents. 
J. Patent Agreements
In order to facilitate a distribution of patent 
rights and benefits consistent with the provision
of this Patent Policy, each participant in University
Research shall execute a Patent Agreement.
Pursuant to such Agreement each participant 
shall acknowledge that all such research is sub-
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The Vice President for Research shall report
to the Board of Directors of Cornell Research
Foundation and the President of Cornell University
upon matters of significance relating to the
administration of this Policy. 
Notes:
1. Use of University office space or library
facilities shall not constitute a use of
University resources for this purpose. 
2. For the limited purpose of this policy, staff
members shall also include all research
assistants, graduate research assistants,
teaching assistants, fellows, students
who provide services under sponsor
agreements which require University
ownership, and others who utilize
University resources in the furtherance
of their research. 
3. The distribution provisions contained
herein shall apply to all existing and
future inventions. The distribution table
contained at paragraph E(1) shall be
applied on a cumulative basis to all net
royalty income earned during the life of
an invention, and not annually. 
4. Direct expenses include the costs of
obtaining patent protection for the par-
ticular invention and all marketing,
promotion and licensing costs related to
the particular invention. 
5. Typically the inventor's Department,
School, Section or Center. 
6. Typically the inventor's College. 
ject to the terms of this Patent Policy, and shall
agree to cooperate with the University or its
designee in the assignment to the University of
patent rights in inventions or discoveries con-
ceived or first reduced to practice during such
research and the preparation and prosecution
of patent applications, as may be required in order
to implement its provision. 
This requirement may be waived by the Vice
President for Research only in those limited
cases where University Research occurs within
a discipline in which the prospect of a patentable
invention is, in his or her judgment, extremely
remote. 
K. Patent Advisory Committee
The Vice President for Research shall, after con-
sultation with the Research Policy Committee of
the Faculty Council of Representatives, establish
and appoint, subject to the approval of the Board
of Directors of the Cornell Research Foundation,
a Patent Advisory Committee which shall serve
at his or her pleasure. It shall be the function of
the Committee to advise and recommend to
the Vice President for Research with respect to: 
1. guidelines and procedures for imple-
mentation of this Patent Policy, 
2. proposed amendments to the Patent
Policy, 
3. the granting of individual exceptions to
this Policy, 
4. the University's ownership of particu-
lar inventions, 
5. such other matters as the Vice President
for Research may deem appropriate. 
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In order to deepen our own understanding
of the role of basic research in the innovation
process and the ways in which companies and
institutions employ and conduct basic research,
CED asked its Trustee companies and universities
to offer representative examples of basic research
in their organizations. This section of the report
contains a collection of these responses, assem-
bled as a series of case studies. We believe they
are enormously illuminating in their own right,
and can be read with great interest indepen-
dent of the report. But they also reinforce the find-
ings contained in the Policy Statement.
CASE STUDIES
AIDS RESEARCH AT MERCK & CO., INC.
(Prepared for CED by Merck & Co., Inc.)
America’s pharmaceutical industry has 
achieved global leadership by discovering more
life-saving medicines by far than any pharma-
ceutical industry of any other country. In the
past 20 years, of all important drugs discovered
and introduced globally, nearly half have come
from U.S. companies. In the American wing of
this important industry, Merck has long been at
the forefront of innovation.
With this record of accomplishment in mind,
it would be helpful to look at one of Merck’s suc-
cessful research programs for guidelines as to how
the United States might sustain and strengthen
its science-technology base. Particularly useful
in this regard should be the recent experiences
of the Merck Research Laboratories in discovering
and developing Crixivan (indinavir sulfate), the
company’s new protease inhibitor for the treat-
ment of HIV infection and AIDS.
Merck started this work in 1986, only three years
after the virus that causes the disease had been
positively identified. Scientists at NIH and else-
where were making important progress, but
much research remained to be done on a virus
and disease that were still poorly understood.
During the next ten years, Merck scientists helped
improve the knowledge of both. They conduct-
ed studies that any university scientist would 
identify as basic or fundamental. These studies
were tightly intertwined with research that was
clearly developmental. All of Merck’s research,
basic or otherwise, was “applied” because it
was directed toward the development of useful
therapies for this deadly disease.
By way of contrast, when Merck launched
its research in the mid-1970s aimed at develop-
ing inhibitors that would lower blood cholesterol,
the laboratories were building on over 30 years
of basic research into lipid biosynthesis. Most of
that research had been conducted at the NIH or
in research universities in the United States and
abroad and very little of it would be classified as
“applied.” Its immediate goal was to develop a
better understanding of fundamental biochem-
ical processes, not to develop practical, effec-
tive therapies (such as Mevacor and Zocor, for
persons suffering from hypercholesterolemia). 
That particular program and its outcome provides
an excellent example of the kind of cooperative
interaction among public, nonprofit, and prof-
it-making institutions that has made the United
States a leader in pharmaceutical innovation.
But in the case of AIDS, the pandemic was so
serious, the public and public health authorities
so correctly and deeply concerned, that Merck
started a major, multi-pronged research pro-
gram long before a solid foundation of basic
research existed. Merck attacked the problem
on several fronts because neither the Merck lab-
oratories nor the scientists at NIH and the uni-
versities could predict with any degree of certainty
which approach would be successful.
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Merck tried for several years to develop a
vaccine against HIV infection. The company was
encouraged by the fact that its Virus and Cell
Biology Research had successfully produced the
world’s first recombinant DNA vaccine against
hepatitis B (Recombivax HB), as well as by the
fact that Merck would be able to partner with
biotechnology firms which could bring to bear their
special expertise.4 One of these firms, Repligen,
discovered the V3 loop on the surface of the
virus, and Merck’s scientists tried to use that
portion of the virus to make a vaccine. The com-
pany also probed the use of monoclonal antibodies
(working with MedImmune) as a means of com-
bating HIV infection. Both of these approaches
failed. As Merck’s vaccine researchers observed
in 1990, “the mechanism by which initial virus
infection occurs is not well understood....”5 In lay
terms, they were groping in the dark.
Today Merck is building upon fundamental
research in the HIV vaccine field conducted by
the Merck Research Laboratories and by others
in the last five to six years. Merck’s scientists have
several new directions and technologies to
explore. As their knowledge of the virus and
the process of infection improved, they could see
much more clearly what was likely to work and
what was likely to fail. Virus and Cell Biology
Research at Merck was able to refocus its vaccine
program as a result. But due to the inadequate
base of fundamental research on the immunol-
ogy of HIV infection and HIV vaccinology, sev-
eral years had been lost in the effort to develop
a safe and effective vaccine.
Fortunately, during these same years, Merck
and other companies were exploring several
different paths to a successful HIV therapy. The
major targets were the enzymes involved in the
process by which the virus transcribes its RNA
into proviral DNA, which is then integrated
into the host cell’s genetic material. One of these
was reverse transcriptase, which controls the
first step in viral replication. AZT (zidovudine)
is one of the compounds that interrupts the HIV
life cycle by inhibiting the natural nucleosides.
But AZT’s adverse side effects, relatively low 
antiviral potency, and the ability of the virus to
develop mutations that conferred resistance to
the drug prompted Merck’s scientists to look
for more effective, non-nucleoside analogue
inhibitors of reverse transcriptase.
After screening about 23,000 compounds over
a two-year period, Merck discovered several
non-nucleoside inhibitors (RTIs). But as the early
clinical trials indicated, the virus successfully
mutated around these drugs, as it had around
AZT.6
That put all of the pressure on the third branch
of HIV research, which was focused on the pro-
tease enzyme. Some years earlier, federally sup-
ported cancer research had resulted in the
publication of a paper analyzing the role a pro-
tease enzyme played in the spread of a virus
associated with tumors in chickens. Merck scientists
familiar with that research suspected a protease
enzyme also played an important role in HIV
replication. But they were not absolutely certain
the protease was a good target until Dr. Nancy Kohl
and her colleagues at the Merck Research
Laboratories completed an elegant experiment that
proved the protease was crucial to the replication
of HIV. In the tradition of basic science, they pub-
lished their findings in the Proceedings of the
National Academy of Science.7 Researchers at Merck
and NIH then established the crystal structure of
the protease. This research could have been con-
sidered proprietary information of value to com-
petitors, but the firm’s scientists also quickly
made these findings available to others.8
As this work progressed, MRL researchers
made other vital contributions to the under-
standing of the disease and its treatment. They
conducted analyses of HIV turn-over and pre-
dicted on the basis of their study of one of
Merck’s non-nucleoside RTIs that HIV infection
is a highly active, continuous process. As the sub-
sequent work of David Ho at the Aaron Diamond
AIDS Research Center, Tony Fauci at NIH, and
Xiping Wei at the University of Alabama-
Birmingham demonstrated, the virus replicates
at a high rate and over years erodes the capaci-
ty of the immune system to keep it in check.
Eventually, patients progress toward AIDS.
Prior to Crixivan, all anti-retroviral therapies
had limited effectiveness insofar as they medi-
ated only transient declines of plasma viral lev-
els. We now know—due to the work of scientists
at Merck, other pharmaceutical companies, NIH,
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and academic institutions—that these therapies
failed because of the eventual selection of resis-
tant viral variants. The research of Merck’s Jon
Condra and his colleagues pointed other scien-
tists toward a new concept of the progression of
the infection and the development of resistance
in the presence of suboptimal antiviral therapy.
Merck studies of viral resistance to Crixivan
established that resistance requires the continued
accumulation over time of multiple mutations:
there is a high “genetic barrier” to resistance.
Suppression of the ongoing replication made it
less likely that the virus would develop the
mutations it needed to produce resistance.
Successful antiviral therapy, they established,
had to reduce circulating viral RNA levels below
the limit of detection in the available assays.9 This
perspective is now generally accepted and the
desired decline has been achieved by patients using
Crixivan in triple combination therapy (with
AZT and 3TC).10
Were there other potential targets for HIV/AIDS
research? Yes, scientists might have developed
a fourth line of attack by targeting the integrase
enzyme, which performs the function of incor-
porating the HIV genome in the host cells. This
would have been another means of preventing
HIV from infecting new cells. Until recently,
however, little was know about the integrase
enzyme. Additional resources funneled into
basic research early on could have accelerated this
aspect of the search for effective HIV therapies.
So too in basic vaccine research. Companies
like Merck could have avoided some blind alleys
and focused their resources more tightly on
other targets if the basic research foundation
had been broadened and deepened in the 1980s.
Given the initial lack of fundamental knowl-
edge about the virus or disease, however, Merck
can take considerable satisfaction in what has been
learned and accomplished in the past decade.
Throughout Merck there is great pride in hav-
ing developed Crixivan. Without some elegant
chemistry, a good measure of brilliant process
research and engineering, and an unusually
determined effort in the manufacturing divi-
sion, Merck could never have produced enough
of this complex molecule to complete clinical tri-
als and then to treat the many patients who
were desperately in need of therapy.11 Nor could
Merck have organized a compassionate use pro-
gram for patients who had exhausted all other
HIV therapies. This was done a full year before
the FDA and other regulatory agencies world-
wide cleared Crixivan for marketing.
For the present, it would suffice to say that
throughout the years that it took Merck to devel-
op this new drug, there was no visible seams and
certainly no quality distinctions between research
that others might categorize as basic or applied,
fundamental or developmental. From the
Company’s point-of-view, it was all good med-
ical science serving society, which has been
Merck’s central mission for over a century.
COLUMBIA UNIVERSITY AND VIMRx PHARMACEUTICALS
(Prepared for CED by Columbia University)
In 1996, Columbia University’s research expen-
ditures amounted to $232 million, the vast major-
ity of which ($194 million) derived from federal
grants and contracts. In recent years, however,
a small, but growing, portion of the research
effort at Columbia has involved collaboration with
industry that has taken various forms (such as
direct funding of research by industry, joint
research projects, and partnerships in existing
research centers).
Through the active efforts of the Columbia
Innovation Enterprise (CIE)—a unit of the
Provost’s Office devoted to identifying, evaluating,
protecting, and licensing intellectual property;
encouraging technology transfer; and increasing
private sector funding for research and devel-
opment—Columbia has been exploring new
forms of collaboration with industry. In the
spring of 1997, Columbia and VIMRx
Pharmaceuticals, Inc. reached agreement on an
ambitious collaboration that could, if successful,
form a model for similar partnerships at Columbia
and elsewhere.
Under the terms of the agreement, a sub-
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sidiary of VIMRx (in which Columbia holds a 10
percent ownership stake) will have an option for
exclusive licensing of technology developed at
the Columbia Genome Center. In return, the
VIMRx subsidiary will provide $30 million for
research at the Genome Center over a five-year
period. The Columbia Genome Center is a
research unit devoted to mapping, sequencing,
gene discovery, and technology development
on the genomes of human and selected model
organisms. The explosion of new technology
and information on the structure of genes has per-
mitted the localization and identification of
novel human genes associated with many genet-
ically based diseases; at the Columbia Genome
Center, investigators have been at the forefront
of the race to identify specific genes associated
with such diseases as cancer, late-onset Alzhei-
mer’s Disease, epilepsy, manic-depressive disorder,
and glaucoma. VIMRx is a development-stage
company involved in the development of tech-
nology to treat and prevent disease by control-
ling disease-triggering flaws in the genetic
chemistry of individuals.
Both parties to the agreement see potential ben-
efits of the new arrangement which will permit
the translation of forefront research results into
useful, commercially viable medical products.
VIMRx will have access to world-class research
that it could not expect to carry out on its own;
for its part Columbia will receive a significant infu-
sion of research funding.
The collaboration will extend for a period of
five years, after which Columbia and VIMRx
will have an option to continue the arrangement
indefinitely upon mutual consent.
As a case study in progress, the collaboration
raises a number of questions and issues about uni-
versity-industry interactions:
• Does participation in the broad research pro-
gram of a university research center lead to more
or different commercial benefits for a company
than would more targeted funding of partic-
ular, individual research projects?
• Is the nature of the research undertaken by a
university research center changed signifi-
cantly by the need, real or perceived, to gen-
erate commercially viable research results?
Is there a tendency to focus on more applied
research? Is very basic research threatened?
• Are there effects on the traditional openness
of university research that result from the
proprietary demands of the commercialization
process?
• Do arrangements such as this encourage other
industries to participate in similar ways, or does
an exclusive arrangement between a univer-
sity and a particular company make it more
difficult or less desirable for other compa-
nies to become involved?
PFIZER INNOVATION
(Prepared for CED by Pfizer Inc.)
Pfizer is a health care company committed to
innovation as the key to improving the health and
lives of people. Pfizer’s products, such as Norvasc
(for hypertension), Zoloft (for depression),
Zithromax (for bacterial infections), and Diflucan
(for fungal infections) have helped millions of
patients worldwide. These products play a cen-
tral role in treating their corresponding diseases
by delivering quality outcomes which are much
improved over those offered by earlier therapies.
Unfortunately, many other conditions await
safer, more efficacious, and more convenient
treatments. Lack of such treatments results in dis-
abilities, early deaths, decreased quality of life,
and enormous economic costs. Aging of the
population and rising cost pressures will create
further demand of new, cost-effective health
care solutions. These demands will be met by excit-
ing new technologies for diagnosing, treating,
and preventing illness which are now emerging
from rapid advances in the basic biomedical
sciences.
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The Challenge of Basic Biomedical Research
These recent and ongoing advances have
grown out of a long-term commitment to basic
biomedical research conducted in universities,
medical centers, research institutes, and gov-
ernment laboratories. Academic research in the
biomedical sciences has focused on improving
understanding of the human body, other organ-
isms, and disease processes. In the course of
addressing essential questions about how and why
things occur, such research provides funda-
mental scientific insights into biological function.
An example is the concept of apoptosis, or pre-
programmed cell death, an apparently important
component of many disease processes. Basic
research also results in essential tools and tech-
niques for conducting further research. Core
technologies such as recombinant DNA/genet-
ic engineering, nucleic acid amplification and
probes, gene transfer, transgenic animals, cell cul-
ture, immunoassays, and monoclonal antibod-
ies have both come out of and supported further
basic research infields including molecular and
cellular biology, microbiology/virology, immunol-
ogy, neuroscience, physiology, pharmacology,
and genomics. These technologies have subse-
quently been combined and applied in ways
unforeseen by original researchers, opening up
entirely new avenues of scientific inquiry and tech-
nical development.
A case in point is the Human Genome Project.
Begun by the National Institutes of Health in
1990 with the goal of mapping and sequencing
the entire human genome, this effort has been
made possible by earlier, basic advances in
fields as disparate as molecular biology, genet-
ics, microbiology, computer science, and robot-
ics. Harnessing the efforts of multiple academic
centers, this effort will ultimately provide a
basis for better understanding of underlying body
function and disease processes by delineating
the structure, function, and interaction of the
genes which control the production of pro-
teins, the key actors of biology. It has already
provided intriguing insights into disease occur-
rence and process, such as breast and colon
cancers and obesity, while spawning new tech-
nologies such as bioinformatics. Genomics is rep-
resentative of how biomedical research continues
to provide new methods and topics for inves-
tigation, while it also highlights the growing
underlying complexity of health and disease
knowledge.
Apart from providing basic laboratory tools,
how does such academic research help lead to new
disease therapies? From the perspective of drug
discovery, understanding disease processes and
structure in detail permits identifying points of
intervention (mechanisms and targets). Similarly,
work in pharmacology and organic chemistry may
suggest particular or better approaches to accom-
plishing this goal (lead concepts). Finally, meth-
ods of assessing the validity and correspondence
of particular targets and leads (assays) may uti-
lize some of the core technologies mentioned. In
addition to improving conventional small mol-
ecule drug development, genomic information will
be crucial to developing new diagnostic and
therapeutic modalities, including gene testing, pep-
tide molecules, antisense (DNA blocker drugs),
vaccines, and gene therapy. Academic medical
research centers also provide the sites and patients
for testing new therapies in clinical trials, which
produce the ultimate assessment of their utility
in patient care.
Pfizer’s Response
Pfizer has responded to advances in basic
science by seeking to harness and integrate these
new technologies, while at the same time fostering
interaction with academic researchers. In contrast
to the explanatory focus of basic academic
research, Pfizer’s role centers on how to meet spe-
cific clinical needs through the applied and
directed development of science and technolo-
gy. By spending approximately $2 billion in 1997
on discovery and development of new drugs, a
figure which has risen dramatically over the
past decade, Pfizer seeks to integrate basic sci-
entific findings and new technologies to dis-
cover and develop novel therapeutic agents
meeting important patient needs. This repre-
sents an intrinsically prolonged, risky, and very
expensive innovation process which must be
actively managed. And this process is becoming
even more expensive and risky with the rising
complexity of underlying science and new dis-
ease states targeted.
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How does basic biomedical research factor
into Pfizer’s discovery and development efforts?
First and foremost is the central role that published
scientific literature and meetings play in stimu-
lating thought and generating ideas which pro-
mote the drug discovery and development
process. Whether it is the structure of a receptor
target or pharmacologically active compound, or
some basic insight into pathophysiology, such work
provides valuable input into Pfizer’s directed
efforts. Also, all of the new laboratory tools and
technologies derived from earlier basic research
have been incorporated by Pfizer into its drug dis-
covery efforts. Finally, Pfizer scientists, who rep-
resent the most critical resource in this process,
trained at universities by conducting basic research.
And in a way which parallels the integration of
core technologies in drug discovery and devel-
opment, these scientists are now working in
multi-disciplinary, cross-functional project teams
which are able to leverage and pursue new devel-
opments more rapidly and efficiently. 
Pfizer supports academic research through a
variety of means, including research collabora-
tions with financial support, fellowships, and unre-
stricted grants for basic research in synthetic
organic chemistry. Pfizer also conducts large-
scale clinical trials of drugs in development in col-
laboration with academic health centers.
Pfizer’s methods and strategy for innovation
have integrated basic research findings and tech-
nological tools to create a fundamentally new drug
discovery and development process. Methods have
focused on increasing productivity by increasing
the overall volume of compounds assessed, while
at the same time optimizing target selection.
Pfizer has been a pioneer in incorporating genom-
ic information into drug discovery. By providing
insight into disease processes and targets, this infor-
mation has been combined with high speed com-
binational chemistry (which creates vast numbers
of potential drug-like compounds) and high
throughput screening techniques (which tests
them for possible drug properties by checking fit
and correlation with targets), technologies derived
in part from basic science research. Technology
access strategy in this increasingly rich, com-
plex, and fast-moving environment has focused
on early stage collaborations with a variety of small-
er, entrepreneurial firms and academic researchers.
The total number of collaborations has reached
270, placing Pfizer in a position to understand and
foster basic research. This approach gives Pfizer
the flexibility to follow the directions and oppor-
tunities opened up by science, taking advantage
of unforeseen spill-overs into new areas rather than
being limited to specific, pre-set fields of devel-
opment.
Pfizer has referred to these collaborative
efforts as a “Web of R&D Innovation” which
has produced tangible results. For each ongoing
project, 1000 compounds a week can now be
synthesized (versus 6 five years ago), while
thousands of compounds can be screened each
week. In 1996, 20 million such tests were performed
on 100,000 compounds, yielding 18 new drug can-
didates. This represents 70 staff-years to gener-
ate a new drug candidate, compared to 100-250
staff-years for other firms. Use of these new
technologies has effectively reduced time from
initial idea generation (project start) to candidate
nomination (preclinical development) from just
over 4 to 2.3. staff-years, with an additional 12
months of study required prior to first human tri-
als. Pfizer now has over 100 research projects
underway - more than at any time in its histo-
ry. Many of these gains have resulted in part from
basic biomedical research. The final result will
be more, innovative new drugs available to
patients sooner.
Key Final Points
Some key lessons have emerged from this
review of basic biomedical science research and
Pfizer’s corresponding role in medical technol-
ogy development:
• Innovation is central to improving health and
quality of life, resulting in important products
which meet significant patient needs.
• Basic biomedical research plays a crucial role
in providing a healthy environment for inno-
vation by providing fundamental insights
into normal body function and disease, devel-
oping new technological tool and techniques,
and expanding human knowledge capital
and skill base.
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• Results of basic biomedical research are often
creatively applied and combined in unforeseen
and unpredictable ways, making short-term
and directed planning approaches risky and
likely detrimental to long-term innovation.
• Industry and academia each play vital yet
different roles in this process, with industry
focusing on integrating basic science find-
ings in a directed, applied process of managed
drug development, which has been trans-
formed by new technologies and multi-dis-
ciplinary team approaches.
• This development enterprise is considerably
different from the inquisitive, open-ended
nature of basic academic research.
• Basic biomedical research needs continued
support from all sources in order both realize
its exciting current potential and chart new paths
which will ultimately form the basis for future
innovation.
PROCTER & GAMBLE BIO-ENGINEERED ENZYMES
(Prepared for CED by Procter & Gamble)
The use of enzymes in synthetic detergents goes
back over 30 years to their first application in both
Europe and the United States as a cleaning
enhancement. Many difficult-to-remove stains,
such as grass, blood, and fats consist of very
large molecules that are more easily removed when
their size is reduced. Enzymes such as proteas-
es and lipases are extremely effective in selectively
solublizing these stains and removing them.
Enzymes are well-established biological prod-
ucts derived from fermentation reactions. Their
discovery, production and usage dates back to
the original work of Louis Pasteur over 100
years ago. But enzymes are also difficult mate-
rials to make effective given their sensitivity to
the reaction conditions created in a typical wash-
ing machine cycle. They are only active in a fair-
ly narrow temperature range, are highly sensitive
to the solution pH, and their catalytic performance
is affected by trace contaminants.
Despite these limitations, enzymes were suc-
cessfully introduced into detergents in 1960.
While their performance enhanced the overall
cleaning of the washing products, there were
important concerns about allergic reactions due
to inhalation. Inadequate industrial hygiene in
some manufacturing facilities resulted in a low
level of employee sensitization, and a concern about
larger scale problems in the general population.
These concerns resulted in a highly cautious
approach to greater usage, higher performance
levels or a broader range of enzyme materials.
In 1974, the detergent industry voluntarily with-
drew all enzymes from the market until the
industry could assure their safety. They were
not reintroduced until enzyme-containing par-
ticles were developed that essentially avoided the
inhalation issue.
In the late 1970’s the emergence of new science
in biotechnology created the possibilities for
bio-engineered materials tailored for specific
applications, as well as the dream of much lower
usage levels. The fermentation products suc-
cessfully used up until this time were not well
characterized. But advances in analytical chem-
istry—a P&G core competency—were now allow-
ing a better understanding of the protein structure
and composition of the most desirable materials.
Nevertheless, the field of biotechnology was
new to Procter & Gamble and it had to make a
strategic decision on how to enter this new and
exciting technical field.
A few highly committed technology man-
agers and research scientists became convinced
that Procter & Gamble could develop the exper-
tise and exploit biotechnology effectively and safe-
ly in our consumer products. They set up a small
biotechnology group by recruiting talent pri-
marily from key departments in leading uni-
versities to augment experienced chemists on our
staff. This became the catalyst for technical dis-
coveries.
Early on, Procter & Gamble recognized that
commercialization of basic scientific discoveries
would require experienced industrial partners.
Procter & Gamble approached the two leading
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companies, Novo in Denmark and Genencor in
the United States, to propose joint development
relationships. Genencor was at the leading edge
in molecular modeling and gene transplanting.
Novo was the most advanced in fermentation
scale-up. Genencor, a small start up biotechnol-
ogy company, was enthusiastic and Procter &
Gamble worked initially with them. Novo became
interested after initial product successes began
to have an impact on their enzyme business.
While Procter & Gamble was not known for its
biological science expertise, its track record of com-
mercializing new technology in products having
a well established market success, and in large
quantities, was appealing.
For nearly a decade Procter & Gamble jointly
worked to develop a basic understanding of the
biological sciences required to utilize recombinant
DNA technology to tailor the genetic make up of
the most promising enzymes. This allowed us to
develop more effective, genetically engineered
enzymes and gain some useful industrial expe-
rience with these materials. Akey organization inter-
vention was the linkage of the basic research
organization with the scientists within the laun-
dry technology group who would have respon-
sibility to determine the efficacy of the new
enzymes as soil removers in the laundry cycle. Then
there was the final linkage to the product devel-
opment groups worldwide. They had the ultimate
responsibility to assess the final product perfor-
mance and process conditions required to suc-
cessfully manufacture bio-engineered detergents.
The culmination of this work was the identi-
fication of a unique, highly specific cellulase
enzyme which was recently and exclusively
introduced into P&G detergents worldwide.
This new cellulase has the capability to selectively
remove the fuzz and pills from frequently laun-
dered color cotton garments that otherwise
would look aged and worn. In doing so, this
enzyme allows the original fabric color to show
through. It, therefore, provides the “new fabric”
color even after extensive washings.
To dimensionalize the technical challenge,
we identified a single, highly effective cellulase
from an enzyme cocktail. This unique material
was successfully isolated, cloned and the entire
process scaled up to a commercial level. Methods
were developed to stabilize it in the detergent man-
ufacturing process and tailor its usage for different
fabrics in our key worldwide geographies. All this
was done while solving the key technical and
potential public relations problem of determin-
ing the correct level of enzyme so that the
defuzzing and depilling process was no more detri-
mental to fabrics than other detergents.
In the process Procter & Gamble also learned
that fuzz and pills became damaged after mul-
tiple launderings, and in addition to losing their
dyes faster than the rest of the yarn, they inhib-
ited the basic detergent cleaning process. That is,
if clothes don’t have damaged fuzz and pills
they are less likely to pick up and retain dirt. So,
what started out as a color-retention technology
turned out to have an even larger benefit as a clean-
ing enhancement ingredient.
As Procter & Gamble has restructured its
approach to basic research over many years, it
has developed some effective guidelines. 
First, constantly reach out for new scientific
advances. While many discoveries occur entire-
ly within Procter & Gamble’s own lab walls, his-
tory says that no research organization has the full
capability to make all of its own scientific discoveries. 
Second, when an important emerging relevant
technology appears, consciously create internal
expertise and build a strong core technological
base. To deal with the breadth of capable outside
research organizations, core internal expertise is
critical to maximize the value, choose relation-
ships and transfer expertise.
Third, utilize the company’s technology leads
to attack the most important business problems.
This is the linkage of technology and business
strategies, or, marrying what’s needed with
what is possible. 
Finally, commercialize technologies. It is
important to drive new technology advances
into superior performing products, packages
and processes. This may entail the use of an
external partner who can supplement our capa-
bility to accelerate speed to market. The innovation
game is played in the marketplace. There are no
wins in the labs! Great science is only effective
if it results in new commercial opportunities.
And the entire organization must realize this is
the only true measure of its effectiveness.
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Knowledge that Makes a Difference
Mind/Brain/Behavior (MBB) is a university-
wide initiative at Harvard University that inves-
tigates the complex interaction of biology and
culture that gives rise to human thought, feel-
ing and behavior. If our brains are so similar, why
are human beings so different? When and why
do human beings act irrationally? How does
the brain change over time? How do cultures and
brains interact to influence health?
Acollaborative effort among some of Harvard’s
leading faculty, MBB was created in 1992 by
Harvard’s President Neil Rudenstine along with
four other Interfaculty Initiatives. He envisioned
a Universitiy that could unite its nine distinct fac-
ulties and bring its vast but decentralized
resources to bear on problems of importance
to society. MBB helps realize this vision by focus-
ing on questions and problems of human poten-
tial and vulnerability that require a creative
uniting of forces because they fall between the
cracks of traditional disciplinary inquiry.
MBB engages experts from diverse disci-
plines in explorations of themes relevant to our
society. Imagine a discussion about drugs and
addictions aimed at limiting the abuse of drugs
and reducing the undesirable side-effects of
prohibition, that avoids rhetoric and partisan-
ship, and incorporates the latest research in
neuroscience, psychology, criminology, and
public policy.
Mind/Brain/Behavior represents an innova-
tive approach to the study of human nature.
MBB is committed to thinking about the impli-
cations and applications of knowledge as it is to
the adventure of discovery. Where other institu-
tions have brought neurobiologists together with
pyschologists to advance knowledge about human
beings, Harvard has cast its net far wider. MBB
enables public policy experts, lawyers, theologians,
physicians, anthropologists, historians, philoso-
phers, and organizational researchers to join
forces with laboratory scientists in neuroscience
and psychology to develop projects that are inno-
vative and designed to make a difference to insti-
tutional communities—from hospitals to schools
to work organizations—outside the academy.
Faculty Fellowships and Working Groups
MBB’s interdisciplinary work takes root in a
Faculty Fellowship comprised of 35 scholars
from across the University. The Fellowship gath-
ers six times a year for a series of seminars and
discussions centered on the complex interac-
tion of biology and culture. The faculty have
discovered that the single greatest barrier to
effective collaboration is misunderstanding.
Each scholar brings to the table assumptions, ter-
minologies and ways of approaching problems
that are unique to his or her discipline. These dis-
cussions enable faculty to exchange perspec-
tives and methodological approaches in the
service of generating new ideas.
Through their interactions in the Fellowship,
faculty identify specific topics ripe for interdis-
ciplinary investigation that no single discipline
or department has managed to address effectively
alone. Smaller collaborative groups—called
working groups—are formed to enable more
focused study of these topics. Each group is
chaired by a faculty fellow and includes a broad
cross-section of faculty from both within and
outside the Harvard community. The working
group topics fall into one of three broad categories:
reason and emotion, learning and development,
and health and illness.
MBB has already seen concrete results from its
working groups. For example, the working group
The Brain in the Sociocultural World produced a
landmark conference and related book on the
placebo-effect in healing. The Drugs and Addictions
group recently briefed top federal officials on
current issues in U.S. drug policy, and the work-
ing group Early Brain Development is planning a
national conference on the brain bases for read-
ing difficulties.
Research and Education
A committee comprised of members of MBB’s
Faculty Fellowship awards funds for innova-
HARVARD UNIVERSITY’S MIND/BRAIN/BEHAVIOR
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tive, cross-disciplinary research projects. Faculty
members, students, and post-doctoral scholars
working in the mind, brain and behavioral sci-
ences are encouraged to submit proposals to
the Research Committee. Recently funded pro-
jects include: the relationship between visual
perceptions and mental processing and the neu-
robiological origins of anxiety and fear.
Faculty fellowship members have also creat-
ed an undergraduate certificate program. The pro-
gram is hosted in four departments in the College:
biology, computer science, history of science,
and psychology. The program integrates MBB
coursework common in all departments, inter-
disciplinary seminar work, electives, and hon-
ors thesis. Innovative new courses designed by
MBB faculty include: “Human Behavior and the
Developing Brain;” “The Philosophy of
Neuroscience;” “The Biology of Morality;” and
“Remembering and Imagining.”
Structure and Leadership
MBB is led by co-directors—a psychologist and
an historian of science—and by a steering com-
mittee consisting of faculty from different schools.
The directors set MBB’s research and teaching
priorities and oversee the Initiative’s activities
in consultation with the steering committee and
with the Provost of the University.
Mind/Brain/Behavior is an ambitious exper-
iment. In keeping with President Rudenstine’s
vision, MBB seeks to reconnect with life outside
the university by uniting fractured faculties in the
service of complex problems that matter to us all.
XEROGRAPHIC PROCESS RESEARCH
(Prepared for CED by Xerox)
This case study demonstrates the unpre-
dictable, non-linear nature of the entire R&D
process, as well as the way in which firms employ
a “fill-in-the-gap” approach to conducting basic
research. In this case, the need for fundamental
scientific insights came after a product had
already been brought to market. Yet, improve-
ments in product performance were not simply
a matter of fine-tuning; there were significant gaps
in the knowledge of how certain processes
worked that could only be addressed through basic
research. The story unfolds over six decades,
from Chester Carlson’s invention in 1938 to the
awarding of the 1997 American Institute of
Physics Prize for Industrial Applications of
Physics to a Xerox researcher.
The invention of xerography by Chester
Carlson in 1938 represents one of the signifi-
cant technology achievements of the 20th Century.
Xerographic copying and printing has exerted a
major impact on the democratization of infor-
mation on a global scale. Although the basic
requirements for xerography were identified by
Carlson in his early work, the successful com-
mercialization of the technology through the
introductions of the Xerox 914 copier in 1959
required a number of subsystem and material engi-
neering advances. In a six-year period following
the invention, Carlson was unsuccessful in per-
suading 20 business equipment companies to con-
sider the commercial development of the process.
Finally, in 1944, Carlson established a working
relationship with Battelle Memorial Institute, a
private research foundation in Columbus, Ohio.
Many advances were made at Battelle in xero-
graphic materials and processes. Some notable
inventions included two component developer
(in which the toning powder was triboelectrically
charged by mixing with larger carrier beads), amor-
phous selenium photoreceptors with 1000 times
more sensitivity to light than the sulphur used
by Carlson, and electrostatic transfer of the
developed powder image to paper. The Haloid
Corporation, a small photographic paper com-
pany in Rochester, New York, acquired a license
to the process in 1947. Further technology
advances enabled the marketing of several
copiers in the ‘50s. The company’s name was
changed to Haloid-Xerox Corporation in 1955 and
Xerox Corporation in 1961 following the wide mar-
ket acceptance of the legendary Xerox 914 which
automatically produced plain paper copies from
an original page placed on the platen of the
machine.
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Although the first Xerox products introduced
in the late ‘50s and early ‘60s were commercial
successes, the scientific foundations of many of
the xerographic process steps and materials
were poorly understood. Up to this point xerog-
raphy had been the province of inventors, tech-
nologists, and business people: it was now the
turn of the scientists to analyze and extend the
process to enable high copy speeds and improved
copy quality. For example, the Xerox 9000 fam-
ily of products, introduced in 1974, generated 120
copies per minute. A research center in Webster,
NY was established in the mid-’60s for the pur-
pose of studying the xerographic process to
enable improvements in subsystems and mate-
rials. The intent was to spawn new products
that embodied improved image quality, higher
reliability, lower manufacturing cost and high-
er copying speeds. Major efforts were mounted
to study charge carrier generation and trans-
port in amorphous semiconductors, the electri-
cal and rheological properties of toner (powder)
materials processes for developing electrostatic
images, gaseous ion charging physics, mechanisms
of triboelectrification and particle adhesion,
processes for fusing toner to paper, and cleaning
methods for removing residual toner from the pho-
toreceptor. Due to the multi-disciplinary nature
of this effort, teams consisting of physicists,
chemists, materials scientists, electrical engi-
neers and mechanical engineers were assem-
bled. The research efforts by Xerox and its
competitors over the subsequent years have
advanced the performance of xerographic tech-
nology to a level that approaches offset printing
quality and productivity.
The xerographic research effort was orga-
nized around the individual steps in the xero-
graphic process. These are: 1) photoreceptor
charging, 2) light exposure to form an electrostatic
image, 3) development of the electrostatic image
with charged, pigmented poser (called toner), 4)
electrostatic transfer of the developed toner to
paper, 5) fixing of the toner to the paper with heat
and/or pressers, and 6) cleaning of any residual
toner from the photoreceptor before the next
cycle. Research programs at Xerox have enabled
significant advances in all of these process steps,
as well as in photoreceptors themselves. This fact
can be illustrated by exploring the chronology
of advances in the performance of xerographic
development systems.
The designs for xerographic development
systems have gone through a number of gener-
ations since the cascade development system
used in the Xerox 914 with two component
developer. The two component mixture was
cascaded over the photoreceptor to develop the
electrostatic image. Only line copy and the edges
of broad image areas were developed with this
technique. To improve the development of broad
image areas, the next generation of magnetic
brush development systems was introduced in
the early 1970s. The developer material con-
sisted of polymer-coated, magnetic carrier beads
which enabled the developer to be transported
on a rotating roll containing stationary perma-
nent magnets. The proximity of the roll to the elec-
trostatic image on the photoreceptor and the
brushing action of the non-conducting devel-
oper enabled improvement in the development
of board image areas, a technique called two-com-
ponent insulative magnetic brush development.
Nevertheless, using this technique, the achieve-
ment of adequate image density development at
high speeds (120 copies per minute) required a
large development system with five development
roles. To provide improved high-speed broad area
development with a compact design, another gen-
eration of magnetic brush designs was intro-
duced for which the carrier beads were made
conducting for the purpose of bringing the 
effective development electrode closer to the
electrostatic image on the photoreceptor. In this
system, however, the effectiveness in develop-
ing fine features in the image was comprised com-
pared to images developed with insulative
magnetic brush development. In addition to the
cascade and magnetic brush systems, other
development system designs have been utilized
for special applications. For low speed copiers
and printers, single component development
systems are widely used. In this case, the toner
is triboelectrically charged by a metering blade in
self-spaced contact with a rotating sleeve. For
the development of colored images, most color
development systems use a gentle magnetic brush
of insulative two component developer in com-
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bination with an AC electric field to generate a toner
cloud in the development zone. For each gener-
ation of these designs, extensive research has
ultimately resulted in Xerox products.
Magnetic brush development system designs
are favored for high-speed copiers and printers.
The insulative magnetic brush systems provide
excellent development of image details but are
not efficient in developing broad image areas. On
the other hand, conductive magnetic brush
development systems are efficient in developing
the broad areas, but compromise image detail.
To understand the shortfall in the broad area
performance of insulative magnetic brush devel-
opment, the physics of two component developer
materials and magnetic brush development sys-
tems was intensely studied at Xerox during the
‘70s and ‘80s. From this work, it was determined
that the limitation on broad area development with
a magnetic brush was due to a net carrier bead
charge caused by toner deposition onto the pho-
toreceptor. The identification of this limitation
mechanism and a corresponding broad area
development model provided important new
insights into critical material and process para-
meters. In understanding the cause of the per-
formance shortfall, a new system design called
Highly Agitated Zone (HAZE) development
was invented which provided both excellent
broad area and image detail development with
hardware that was smaller (fewer rolls) and
lower cost. This design was first incorporated in
a 62-copies-per-minute Xerox product, the Xerox
1065 Marathon copier, introduced in 1987. The
product received “Product of the Year” awards
for two years in a row. 
Over the past 10 years, this product family has
produced more than 100 thousand machines in
the U.S. Furthermore, the HAZE design has sub-
sequently been incorporated in several addi-
tional major Xerox product platforms for copiers
and printers. Particularly noteworthy is the
inclusion of the design in a highly successful
family of high-speed (135 prints per minute)
duplicators/printers introduced in 1988. The
development system technology continues to
play a key role in a number of new product
offerings. The combined revenue from all of the
products embodying this development system
was nearly half of Xerox’ total revenue in 1996.
In recognition of the contribution of the HAZE
development process to the success of three gen-
erations of Xerox’ current products, and of the
invention of further development systems like-
ly to be used in Xerox’ future products, the
inventor of the process was awarded the 1997
American Institute of Physics Prize for Industrial
Applications of Physics.
In summary, xerography evolved from the key
invention of Chester Carlson and subsequent
material and process inventions at Battelle which
provided the foundation for copier products at
the Haloid Company and ultimately led to the
first automate electrophotographic copy machine,
the commercially successful Xerox 914. The suc-
cess of this product and the need to generate sub-
sequent generations of improved versions
motivated the establishment of a research lab-
oratory organized around the xerographic
process steps and devoted to generating an
evergreen stream of improved xerographic
marking engines for both copiers and printers.
Improvements in each process step generated by
research were incorporated into new subsys-
tem designs which in turn were offered to the
public in successive generations of Xerox copiers
and printers during the past four decades. By way
of an example, the generations of development
system designs were reviewed to illustrate 
the sequence of advances driven by research
programs. 
A more detailed description of the HAZE
process serves to illustrate how fundamental
insights gained through basic research can result
in superior product performance over multiple
generations of products. Although this case
study has emphasized the role of the develop-
ment system design in contributing to the
advanced performance of copiers and printers,
comparable pay offs have been achieved with other
xerographic materials and subsystems. The net
result is that investments in basic research have
provided a highly leveraged source of profits for
generation after generation of Xerox products from
the Xerox 914 to the recently announced Xerox
6180 digital press which incorporates the HAZE
development system process to produce 180
prints per minute.
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The Research function in IBM is located in three
U.S. laboratories and four international labora-
tories in Beijing, Haifa, Tokyo, and Zurich. The
technical population consists of nearly 2000
engineers and scientists, most of whom have
PhDs. The scope of activities is broad as would
be expected of a company covering nearly every
area of information technology. In addition to work
that address the product needs of the IBM busi-
nesses, there are activities in new and alternative
technologies and areas of basic research that
contribute to the scientific understanding under-
lying the technologies in our business. The largest
part of the Research funding comes from corporate
headquarters, followed by funding from the
various IBM product and sales organizations. A
very small amount of funding comes directly from
the outside in the form of government contracts
and occasional external revenue sources.
Research remains organizationally independent
from IBM’s development functions, creating both
opportunity and responsibility with respect to its
role in the IBM Corporation. Such independence
permits the division to explore new technologies
and applications, carry out basic research, and pro-
vide independent technical advice to IBM regard-
ing current and future product directions being
undertaken by the product groups. With such inde-
pendence goes the responsibility of contributing
recognized value to the IBM corporation through
such means as creating intellectual property, cre-
ating and developing leadership technologies
for rapid infusion into the IBM product line,
enhancing IBM’s technical image through pub-
lic awareness of its world class science and tech-
nology, and creating a technical view of the future
that can provoke and guide the product and
sales groups in the creation of their business
strategies. To carry out our mission in IBM,
Research works with more than 30 organiza-
tions within the corporation.
To be a successful research organization
requires that the right programs be defined and
that these programs be effective, both in carry-
ing out the research but also in translating the
results into values that can be leveraged by the
rest of the company.
The Research planning process begins with an
annual exercise to identify the future trends of
the information technology business. Although
focused on the basic technology trends, e.g. the
reduction of size and increased speed of circuits
or capacity of storage, societal and business
trends are also examined in order to define the
external environment within which IBM will
exist in the near future. Although IBM science and
exploratory programs often create the game
changers for its industry, Research is keenly
aware that many of the major changes come
from laboratories and companies outside IBM and
therefore we expect our professionals to be tuned
to the external science and technology commu-
nities. The need for a clearer view of the future,
particularly in areas other than basic technolo-
gy, has motivated Research to establish a small
group of specialists in long term market planning.
Using this view of the future, IBM’s technical strate-
gists prepare plans for the year that take into
account not only the anticipated trends but also
the nearer term requirements of the IBM units with
which it collaborates to provide technical lead-
ership in IBM’s product lines.
Having created an annual plan of activities it
remains for the management to monitor and
track the success of the research in delivering value
to IBM. At the end of each year, the top division
management gathers to review the work of the
year. The review includes evaluations by other
IBM divisions regarding delivery of results, the
degree to which collaborative relationships have
been successful in delivering needed technolo-
gy and direction to other parts of IBM (alignment
of strategy, people relationships, etc.), the num-
ber of U.S. patents filed for the year, the number
of external awards and other recognition received
by IBM researchers (Nobel prizes, National
Medals, Fellows, etc.), and self assessments of key
results for the year, both in the field of science as
well as those affecting IBM. These measures are
taken quite seriously by both the management
IBM RESEARCH
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and non-management research personnel, as
the final result gets translated into compensation
for Research employees. Most importantly, this
thorough review of Research’s activities is an excel-
lent source of feedback about how well IBM
research is contributing to the company.
BBN AND THE DEFENSE ADVANCED 
RESEARCH PROJECTS AGENCY 
(Prepared for CED by BBN/GTE Internetworking)
Maintaining the nation’s economic well-being
and preserving its security are two of the federal
government’s most important responsibilities.
It has long been recognized—and often established
as public policy—that innovation and technological
preeminence contribute to both goals by creat-
ing new capabilities, and giving rise to new
industries and jobs. Nowhere is this more evi-
dent than in the development of computer tech-
nology; and no office of government has been
more effective in this arena than the Defense
Advanced Research Projects Agency (DARPA).
Originally created as the Advanced Research
Projects Agency (ARPA) by President Dwight
Eisenhower shortly after the Soviet Union
launched its first Sputnik satellite in 1957, it
was designed to be a fast-response, R&D mech-
anism that would ensure American leadership
in future technologies. Over the years, howev-
er, ARPA shifted its focus to “high-risk, high-pay-
off,” long-term basic research, and research
sponsorship of new ideas. By drawing talent from
the nation’s finest universities, public, and pri-
vate research laboratories—and by allowing
scientists to apply their ideas through experi-
mentation—ARPAbuilt a community that includ-
ed some of the best technical and scientific
minds in American research. 
For more than thirty years, BBN Technologies
has been a vital member of that community,
and its long and productive relationship with the
agency has led to a host of innovations; most
notably the ARPANET, the forerunner to the
Internet. At the time of the network’s develop-
ment in the late 1960s, agency scientists were using
different computers, running different operat-
ing systems, in different parts of the country. ARPA
reasoned that, by electronically linking these
machines, researchers at various institutions
could more easily share resources and results.
But that would require building an experimen-
tal network based on packet switching—a new
method of transmitting data by dividing electronic
messages into small, uniform segments.
When ARPA sent out its request for propos-
als to develop the packet switches—which were
first called Interface Message Processors (IMPs)—
BBN responded with an extensive and detailed
description of the entire network, incorporating
test programs and performance checks, expla-
nations of how to handle congestion and recov-
er from computer and line failures, and
computations, equations, and tables dealing
with queuing of packets and transmission delays.
Once it was chosen for the job, the Company’s
engineers designed the software to form a fully
integrated network. They studied interactions
among programs to ensure the actions taken
by one program did not conflict with actions taken
by others. And they created a system where the
components worked together smoothly, so most
users did not sense its underlying complexity.
By the early 1970‘s, BBN had successfully devel-
oped and quickly expanded the first network of
packet switches.12 But it took more than IMPs
to make the emerging network truly useful.
The initial goal of designing, implementing,
and fielding the ARPANET generated new inter-
est in the kinds of protocols and distributed
computing technology that could further enhance
the utility of the experimental network. By 1975,
protocol investigation within DARPA led to the
concept of a network of networks—which ulti-
mately became the Internet—and to TCP/IP as
a means for universal interconnection. At the same
time, BBN, as part of both DARPA’s research com-
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munity and the university computer science
research community at large, began investigat-
ing the impact of computer-to-computer com-
munication capabilities on new applications
such as distributed air traffic control and unified
medical records across hospitals; and on the
operating systems software needed to deliver com-
munication services to those applications.13, 14
Early work in these areas proved conclu-
sively that such applications were complex and
difficult to build. This led to two parallel tracks
of development. One concentrated on the direct
implementation of a very limited set of imme-
diately useable applications, including e-mail, tel-
net, and ftp; while the other focused on additional
infrastructure to enable more general-purpose
applications to be developed using wide area com-
munications capabilities. The latter activity
spawned what has come to be known as “mid-
dleware,” because it was strategically placed
between the network and the application to pro-
vide a richer, simpler network environment for
a wide variety of uses.
With continuing DARPAsupport, and employ-
ing the experimental method championed by the
agency to test and refine new ideas, BBN devel-
oped, tested and evaluated two generations of mid-
dleware systems throughout the later part of the
1970’s. The first generation provided solutions for
distributed computing in a homogeneous sys-
tems environment, based on a message-passing
paradigm. The second perfected this work and
developed additional solutions for a more general,
heterogeneous system environment. But one that
was based on a remote procedure-call form of ori-
entation. Though these technical investigations were
very successful, the impact of applying them eco-
nomically on the prevailing computer technical
infrastructure was less so.
Indeed, the computing landscape at the time was
shifting from one of a few large computer systems
to many smaller, cheaper systems enabled by
innovations in chip fabrication; and from a few large
networks to many smaller, locally managed net-
works enabled by technologies such as Ethernet.
Moreover, the transformation from a program-
ming environment dominated by custom assem-
bly language to a variety of high level languages
(e.g. “C,” Lisp), enhanced the conception and exe-
cution of more complex applications. It was becom-
ing clear that the proliferation of new technologies
would depose many of the older computing hier-
archies. It was clear, too, that middleware would
have to change to keep pace with the size, scope
and variety of the computer technology base. 
Consequently, BBN’s third generation mid-
dleware system, Cronus, which began in 1981,
was based on the development of distributed object
computing.15 This approach also enabled The
Company to address the challenge of creating com-
plex, distributed applications in an extensively
heterogeneous and rapidly changing environment.
The sort of environment required by the military
to effectively operate the variety of new computer
and communication technologies which were
fast being developed and adopted.
As BBN’s knowledge of the middleware tech-
nology matured, financial support for develop-
ing a new distributed, object-based, middleware
infrastructure moved to the Air Force Rome
Laboratory. By the mid-1980’s, BBN engineers had
a working Cronus system suitable for evaluation
and use by government projects. The first trials
involved developers working with early adopters
on prototype concept demonstrations. Each led
to further refinements in the technology, and to
better understanding of how it could be used by
application developers. In the late 1980’s, the
Navy’s San Diego R&D Lab joined its Air Force
counterpart in testing the technology on opera-
tional problems that were being addressed by BBN
application developers for a number of Navy and
DARPA programs. 
These trials were extremely successful and
fielded new network-based capabilities quickly
and cost-effectively, particularly when compared
with non-middleware-based development pro-
jects. Distributed application engineers at BBN
worked with Department of Defense (DoD) con-
tractors and operational personnel to deploy
systems such as CASES, TARGET, and DART, and
were able to tackle significant operational issues
for distributed command-and-control applica-
tions.16, 17 Along with conducting various tests and
evaluations, they trained DoD contractors and uni-
versity engineers, programmers, and system
management personnel to use the new technol-
ogy. Subsequently, the systems were incorpo-
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rated into advanced concept demonstrations by
other DoD and DARPA contractors. Universities
and industrial research labs also synthesized the
results with their own technical investigations, fur-
ther extending middleware’s use and refine-
ment.18 Over time, successes such as these, in
distributed object computing, led to several large-
scale, distributed integration programs making
world wide military command-and-control oper-
ations more responsive and cohesive.
By the start of this decade, capabilities like those
of Cronus began to appear in commercial prod-
ucts from major companies such as Digital, IBM,
SUN Microsystems, and Microsoft, as well as from
small startup firms. But because no two sys-
tems were alike, operating between them was
extremely difficult. To remedy the situation,
commercial vendors and users of distributed
object technology joined forces to set acceptable
industry standards. They formed the Object
Management Group, and established the Common
Object Request Broker Architecture, or CORBA.
Their grassroots efforts attracted a great deal of
interest, first, from vendors, and then from users
who saw it as a way to voice their requirements
for the newly emerging commercial offerings. In
time, Cronus was adapted to the CORBA stan-
dard and given the new name Corbus.
Since its development, middleware technol-
ogy has played a major role in the growth of dis-
tributed networks, including the Internet. In
fact, the World Wide Web is, itself, a special-
ized form of middleware. Prior to its emergence,
many people only saw utility for middleware and
distributed applications in the context of local area
computing. Now, with the increasing popular-
ity of the Internet, middleware becomes even more
important as a means to simplify, and more
effectively manage, an extremely complex envi-
ronment. In addition to the Web, there is also Java,
with its own brand of middleware, to compete
with DCOM and CORBA, and scores of nar-
rowly specialized technologies employing mid-
dleware solutions.
Today, middleware represents just one of
sundry successes that have resulted from the
long relationship between BBN and DARPA
that have continually raised the technology bar.
Just as important, it is a notable example of how
the transition from basic to applied R&D is not
always well-delineated. This occurs in many
fields, but it is especially true in computer science,
where systems are man made and abstract in
nature, and differ considerably from the more
familiar patterns associated with the phy-
sical sciences. Innovations such as middleware
actually combine basic and applied activities
simultaneously. While the earliest investigations
represent fundamental research, in that they
seek functional organization of ideas and abstrac-
tions, the later tests, evaluations and refine-
ments are clearly applied, because they identify
particular uses and users, and establish practi-
cal applications. This is often the case for many
DARPA-sponsored programs, which are intend-
ed, not only to develop potential capabilities, but
to demonstrate—early on—the feasibility of new
concepts prior to their actual widespread accep-
tance and availability.
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Page 5, James Q. Riordan
I would add another paragraph to this list stat-
ing that while federal support for basic research
is necessary, we also need to have basic research
conducted in the United States by the private sec-
tor. In the past, CED has supported tax incentives
for private research. This report does not call for
such incentives. We should, however, call for
the elimination of all tax disincentives for U.S.
research. Every dollar spent on research in the
United States should be treated as a U.S. source
deductible expense in computing taxable income
and available foreign tax credits.
MEMORANDUM OF COMMENT, RESERVATION, OR DISSENT
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CHAPTER 2
1. The Procter & Gamble case study (see Case Studies section) illus-
trates the necessity for diverse basic research activities to meet inno-
vation goals. P&G saw promise in biological research, a scientific
field in which the company previously had no expertise. Recognizing
the potential, they developed a basic research capacity in this
area, primarily through cross-industry alliances, with a considerable
payoff in the form of a better detergent product. 
2. As explained in Box 2 on page 12, these characteristics of basic
research, including the economic benefits that flow to those not
involved in the discovery, provide justification for government fund-
ing.
3. The theoretical framework for these growth studies was devel-
oped in the 1950’s by Robert Solow of the Massachusetts Institute
of Technology, who was awarded a Nobel Prize for his work. The
pioneering empirical work in this area was undertaken by Edward
Denison while he worked for the Committee for Economic
Development. See Edward F. Denison, The Sources of Economic
Growth in the United States and the Alternatives Before Us, (Washington,
D.C.: Committee for Economic Development, 1962).
4. Dale W. Jorgenson “Investing in Productivity Growth," in
Technology and Economics, (Washington, D.C.: National Academy
Press, 1991), p.59.
5. The new theory is associated with the work of Paul Romer of
Stanford University. For a brief summary of these issues, see J. Bradford
DeLong, “What Causes Economic Growth?” (paper prepared for
a symposium on tax policy sponsored by the American Council
for Capital Formation, Washington, D.C., December 5, 1996).
6. “The internal rate of return provides a concise method for com-
paring different investments. Suppose, for example, the R&D
investor could alternatively invest in a savings account with a con-
stant interest rate. The internal rate of return on the R&D invest-
ment answers the question: what would the interest rate on the savings
account have to be in order to make the investor indifferent
between putting the investment in the savings account and mak-
ing the R&D investment?”
7. Most rate-of-return studies use an R&D measure rather than a
more narrowly defined basic research measure.
8. M.I. Nadiri, Innovations and Technological Spillovers, Working
Paper no. 4423, (Cambridge, Mass.: National Bureau of Economic
Research, 1993). Nadiri’s consensus estimate was derived from a
survey of 63 rate of return studies.
9. MIT: The Impact of Innovation, ABankBoston Economics Department
Special Report, (March 1997). “MIT-related companies” are firms
founded by MIT graduates.
10. E. Mansfield, “Academic Research Underlying Industrial
Innovations: Sources, Characteristics, and Financing,” The Review
of Economics and Statistics 77 no. 1, (1995), pp. 55-65.
11. Francis Narin, Kimberly S. Hamilton, and Dominic Olivastro,
“The Increasing Linkage Between U.S. Technology and Public
Science,” Research Policy, 26(3) (1997) 317-330.
12. For examples of this “new thinking,” see Terence Kealey, The
Economic Laws of Scientific Research, (New York: St. Martin’s Press,
1996), and “What Price Science?” Business Week, 26 May 1997.
13. Microsoft’s Bill Gates has suggested that the scientists who are
currently sequencing DNA might provide the “algorithms” in
carbon that can be transferred to silicone for purposes of creating
a “computer that learns.” Remarks made at the American Association
for the Advancement of Science Annual Meeting, February 1997,
Seattle, Wash.
14. Total basic research spending from all sectors was $31.2 billion
for 1997 and GDP in that year was $8,083 billion. 
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15. According to the National Science Board, federal government
support for basic research was $17.1 billion in 1995 (59 percent of
total support), industry support was $7.5 billion (25 percent of total
support), and other support. including universities’ own funds, non-
profits, and state/local governments, was $5 billion (17 percent of
total support). National Science Board, Science & Engineering
Indicators—1996 (Washington, D.C.: U.S. Government Printing
Office, 1996), NSB 96-21.
16. Bush was the wartime director of the Office of Scientific
Research and Development. His influential 1945 report, “Science,
the Endless Frontier,” was an important point of reference for
post-war R&D policy.
17. Harvey Brooks and Lucien Randazzese, “University-Industry
Relations: The Next Four Years and Beyond,” in Investing in
Innovation: Creating a Research and Innovation Policy That Works, ed.
Lewis Branscomb and James Keller, (Cambridge, Mass.: MIT
Press, 1998).
18. Brooks and Randazzese, “University-Industry Relations: The
Next Four Years and Beyond.”
19. The industry case studies section illuminates the way in which
industry views basic research.
20. Before passage of the Bayh-Dole Act, there was no government-
wide policy concerning ownership of inventions made under fed-
eral funding. Agencies were generally reluctant to grant ownership
rights to an invention to the inventing institution. Bayh-Dole and
subsequent amendments to it, all of which were finalized in 1987,
made it government-wide policy to grant such rights. Bayh-Dole
and its related amendments today constitute the “operating man-
ual” for technology transfer offices at universities and other insti-
tutions receiving federal research funds.
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21. Universities’ licensing of their intellectual property has result-
ed in a rapidly expanding source of revenue, though still very small
relative to total research dollars. According to the Association of
University Technology Managers, royalties on licenses were $274
million in 1995 for surveyed universities, an increase of 108 per-
cent from 1991 (see also Figure 3, page 23). The survey sample includes
87 of the top 100 research universities in the United States, ranked
according to research dollar volume.
22. In “Research Universities and the Marketplace,” (page 22), we
discuss the problems that can arise as a result of university-indus-
try partnerships and the patenting of university research. In
Chapter 4, we offer principles which we believe provide the
appropriate safeguards to facilitate technology transfer without imped-
ing basic research.
23. Wesley Cohen, Richard Florida, Lucien Randazzese, and John
Walsh, “Industry and the Academy: Uneasy Partners in the Cause
of Technological Advance,” in Challenges to Research Universities,
ed. Roger Noll, (Washington, D.C.: Brookings Press, 1998).
24. Medical school professors are a notably large exception; many
are clinical professors with minimal or no teaching responsibili-
ties. See Linda Cohen, “Biomedical Research Support and the
Decline of Medical Services Research Subsidies at Medical Schools,”
in AAAS Science and Technology Policy Yearbook, (Washington,
D.C.: AAAS, 1998).
25. One-quarter of scientists and engineers who have received gov-
ernment support have obtained funding from more than one fed-
eral agency. See National Science Board, Science & Engineering
Indicators—1996 (Washington, D.C.: U.S. Government Printing Office,
1996), NSB 96-21. 
26. National Science Board, Science & Engineering Indicators—1996
(Washington, D.C.: U.S. Government Printing Office, 1996), NSB
96-21.
27. National Science Board, Science & Engineering Indicators—1996
(Washington, D.C.: U.S. Government Printing Office, 1996), NSB
96-21.
28. This competition for researchers is not limited to universities.
Prominent researchers can be the focus of intense competition
between universities and other nonprofit research institutes. As we
describe in “Nonprofit Institutions,” (page 26), these nonprofits can
be attractive alternatives for researchers because of lower fund-rais-
ing and administrative burdens. In this way, competition between
universities and the nonprofits puts pressure on universities to keep
these burdens to a minimum.
29. National Science Board, Science & Engineering Indicators—1996
(Washington, D.C.: U.S. Government Printing Office, 1996), NSB
96-21.
30. Over the life of the patents, which expired on December 2, 1997,
the universities expect revenues to total over $220 million from 369
licensees.
31. Wesley Cohen and Lucien P. Randazzese, “Eminence and
Enterprise: The Impact of Industry Support on the Conduct of
Academic Research in Science and Engineering,” (working paper,
Belfer Center for Science and International Affairs, John F. Kennedy
School of Government, Harvard University, 1997); David Blumenthal,
Nancyanne Causino, et al., “Relationships Between Academic
Institutions and Industry in the Life Sciences — An Industry
Survey,” The New England Journal of Medicine, (February 8, 1996);
Walter Powell and Jason Owen-Smith, “Universities and the
Market for Intellectual Property in the Life Sciences,” Journal of Policy
Analysis and Management, Vol (17) No (2), pp. 253-277. For a sum-
mary of studies in this area, see Harvey Brooks and Lucien
Randazzese, “University-Industry Relations: The Next Four Years
and Beyond,” in Investing in Innovation: Creating a Research and
Innovation Policy that Works, ed. Lewis Branscomb and James
Keller (Cambridge, Mass.: MIT Press, 1998).
32. Basic research conducted by the federal government accounts
for 9 percent of total basic research in the United States (NSF,
Science and Engineering Indicators 1996, Appendix Table 4-5).
33. The Washington Post, 11 September 1997, p. A23.
34. In this case, the federal subsidy does not come directly from
an allocation of federal dollars for the project. Industry will pro-
vide the cash resources to cover salaries and other expenses.
Nonetheless, there is a substantial indirect federal subsidy involved
in making the three national labs available for the project. 
35. See Kenneth M. Brown, Downsizing Science: Will the United
States Pay a Price?, (Washington, D.C.: The AEI Press, 1998). Brown
provides a thoughtful discussion of the “twin” problems that
plague the labs: disappearing missions and bad management.
36. Secretary of Energy Advisory Board, Task Force on Alternative
Futures for the Department of Energy National Laboratories,
Alternative Futures for the Department of Energy National Laboratories
(February 1995), p. 41.
37. The most prominent are the 1983 Federal Laboratory Review
Panel, chaired by David Packard, and the task force chaired by William
Galvin, which produced the 1995 report Alternative Futures for the
Department of Energy Laboratories.
38. The IBM case study (see Case Studies) indicates that IBM sci-
entists must be tuned in to research occurring outside of the com-
pany, even though IBM performs a great deal of basic research in-house.
39. See the CED policy statement, Connecting Students to a Changing
World: A Technology Strategy for Improving Mathematics and Science
Education (1995).
40. National Assessment Governing Board, What Do Students
Know? 1996 NAEP Science Results for 4th, 8th, & 12th Graders
(Washington, D.C.: NAGB, 1997).
41. Results reported for high school seniors. Ina V.S. Mullis et al.,
Mathematics and Science Achievement in the Final Year of Secondary
School: Third International Mathematics and Science Study (Chestnut
Hill, Mass.: Boston College, 1998).
42. National Science Board, Science and Engineering Indicators,
1996.
43. Committee on Science, Engineering, and Public Policy, Reshaping
the Graduate Education of Scientists and Engineers, (Washington,
D.C.: National Academy Press, 1995).
44. Between 1973 and 1993, the number of full-time faculty appoint-
ments for doctoral scientists and engineers grew by 67 percent. During
the same period, postdoctoral appointments rose by 223 percent
and part-time faculty appointments increased 95 percent.
45. National Science Board, Science & Engineering Indicators—1996
(Washington, D.C.: U.S. Government Printing Office, 1996), NSB
96-21.
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46. National Science Board, Science & Engineering Indicators—1993,
(Washington, DC: U.S. Government Printing Office), 1993, p. 139.
47. Walter Powell and Jason Owen-Smith, “Universities and the
Market for Intellectual Property in the Life Sciences,” Journal of Policy
Analysis and Management, Vol 17 No (2), p. 268.
48. As we argue later in this chapter, some projects prove to be too
expensive to support at the national level and should be pursued
in conjunction with other countries.
49. The President’s 1999 budget proposal would increase the fund-
ing disparity. Of the proposed $1.2 billion increase in basic research
funding between 1998 and 1999, $616 million (just over half)
would go to the NIH basic research budget. This would raise
NIH’s share of the federal basic research budget slightly, from 46
percent to 47 percent. See AAAS Analysis of R&D in the FY 1999 Budget,
available at www.aaas.org on the Internet.
50. As described in Appendix 1, Medicare and Medicaid have
been important sources of funding for research at university med-
ical centers and, indirectly, a significant source of funding for
university research in general. Structural reforms in these programs
may result in less research funding from these sources.
51. See Roger Noll and William Rogerson, “The Economics of
University Indirect Cost Reimbursement in Federal Research
Grants,” in Challenges to Research Universities, ed. Roger Noll,
(Washington, D.C.: Brookings Press, 1998). Noll and Rogerson
provide an analysis of the cost reimbursement problem and jus-
tification for a “benchmarking” alternative to the current system.
52. National Academy of Sciences, Allocating Federal Funds for
Science and Technology, Committee on Criteria for Federal Support
of Research and Development, (Washington, D.C.: National
Academy Press, 1995), pp. 25-26.
53. National Science Board, Science & Engineering Indicators—1996
(Washington, D.C.: U.S. Government Printing Office, 1996), NSB
96-21, pp.4-28.
54. CED has recently proposed remedies for the Social Security com-
ponent of entitlements. See Fixing Social Security (March 1997).
55. See Kenneth M. Brown, Downsizing Science: Will the United
States Pay the Price?, (Washington, D.C.: The AEI Press, 1998).
56. Data are for 1995. NSF, NSF Data Brief, 1997 no. 3 (March 13,
1997); U.S. Department of Labor, Monthly Labor Review (January 1998),
Table 43.
57. See the CED policy statements Putting Learning First: Governing
and Managing the Schools for High Achievement (1994), Connecting
Students to a Changing World: A Technology Strategy for Improving
Mathematics and Science Education (1995), and The Employer’s Role
in Linking School and Work (1998).
58. Some have suggested that agencies that sponsor research (such
as the NSF, NIH, and the Department of Defense) could provide
a significant boost to mentoring, internship, and other educa-
tional outreach initiatives by providing additional resources to 
research institutions for these purposes.
59. For a recent discussion of this issue, see Committee on Science,
Engineering, and Public Policy, Reshaping the Graduate Education
of Scientists and Engineers (Washington, D.C.: National Academy
Press, 1995). 
60. Committee on Science, Engineering and Public Policy, Reshaping
the Graduate Education of Scientists and Engineers. See also Committee
on Science, Engineering and Public Policy, Advisor, Teacher, Role Model,
Friend: On Being a Mentor to Students in Science and Engineering,
(Washington, D.C.: National Academy Press, l997).
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For more than 50 years, the Committee for
Economic Development has been a respected
influence on the formation of business and pub-
lic policy. CED is devoted to these two objectives:
To develop, through objective research and informed
discussion, findings and recommendations for private
and public policy that will contribute to preserving
and strengthening our free society, achieving steady
economic growth at high employment and reasonably
stable prices, increasing productivity and living stan-
dards, providing greater and more equal opportuni-
ty for every citizen, and improving the quality of
life for all.
To bring about increasing understanding by pre-
sent and future leaders in business, government,
and education, and among concerned citizens, of the
importance of these objectives and the ways in which
they can be achieved.
CED’s work is supported by private voluntary
contributions from business and industry, foun-
dations, and individuals. It is independent, non-
profit, nonpartisan, and nonpolitical.
Through this business-academic partnership,
CED endeavors to develop policy statements
and other research materials that commend
themselves as guides to public and business
policy; that can be used as texts in college eco-
nomics and political science courses and in man-
agement training courses; that will be considered
and discussed by newspaper and magazine edi-
tors, columnists, and commentators; and that
are distributed abroad to promote better under-
standing of the American economic system.
CED believes that by enabling business lead-
ers to demonstrate constructively their concern
for the general welfare, it is helping business to
earn and maintain the national and community
respect essential to the successful functioning of
the free enterprise capitalist system.
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STATEMENTS ON NATIONAL POLICY ISSUED BY THE COMMITTEE
FOR ECONOMIC DEVELOPMENT
SELECTED PUBLICATIONS:
Modernizing Government Regulation (1998)
U.S. Economic Policy Toward The Asia-Pacific Region (1997)
Connecting Inner-City Youth To The World of Work (1997)
Fixing Social Security (1997)
Growth With Opportunity (1997)
American Workers and Economic Change (1996)
Connecting Students to a Changing World:  A Technology Strategy for Improving Mathematics and Science
Education (1995)
Cut Spending First:  Tax Cuts Should Be Deferred to Ensure a Balanced Budget (1995)
Rebuilding Inner-City Communities:  A New Approach to the Nation’s Urban Crisis (1995)
Who Will Pay For Your Retirement?  The Looming Crisis (1995)
Putting Learning First:  Governing and Managing the Schools for High Achievement (1994)
Prescription for Progress:  The Uruguay Round in the New Global Economy (1994)
*From Promise to Progress: Towards a New Stage in U.S.-Japan Economic Relations (1994)
U.S. Trade Policy Beyond The Uruguay Round (1994)
In Our Best Interest:  NAFTA and the New American Economy (1993)
What Price Clean Air?  A Market Approach to Energy and Environmental Policy (1993).
Why Child Care Matters:  Preparing Young Children For A More Productive America (1993)
Restoring Prosperity:  Budget Choices for Economic Growth (1992)
The United States in the New Global Economy:  A Rallier of Nations (1992)
The Economy and National Defense:  Adjusting to Cutbacks in the Post-Cold War Era (1991)
Politics, Tax Cuts and the Peace Dividend (1991)
The Unfinished Agenda: A New Vision for Child Development and Education (1991)
Foreign Investment in the United States:  What Does It Signal? (1990)
An America That Works:  The Life-Cycle Approach to a Competitive Work Force (1990)
Breaking New Ground in U.S. Trade Policy (1990)
Battling America’s Budget Deficits (1989)
*Strengthening U.S.-Japan Economic Relations (1989)
Who Should Be Liable?  A Guide to Policy for Dealing with Risk (1989)
Investing in America’s Future:  Challenges and Opportunities for Public Sector Economic Policies (1988)
Children in Need:  Investment Strategies for the Educationally Disadvantaged (1987)
Finance and Third World Economic Growth (1987)
Reforming Health Care:  Market Prescription (1987)
Work and Change:  Labor Market Adjustment Policies in a Competitive World (1987)
Leadership for Dynamic State Economies (1986)
Investing in Our Children:  Business and the Public Schools (1985)
Fighting Federal Deficits:   The Time for Hard Choices (1985)
Strategy for U.S. Industrial Competitiveness (1984)
Productivity Policy:  Key to the Nation’s Economic Future (1983)
Energy Prices and Public Policy (1982)
Public-Private Partnership:  An Opportunity for Urban Communities (1982)
Reforming Retirement Policies (1981)
Transnational Corporations and Developing Countries:  New Policies for a Changing World Economy
(1981)
Stimulating Technological Progress (1980)
*Statements issued in association with CED counterpart organizations in foreign countries.
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CED COUNTERPART ORGANIZATIONS
Close relations exist between the Committee for Economic Development and independent, nonpo-
litical research organizations in other countries. Such counterpart groups are composed of business
executives and scholars and have objectives similar to those of CED, which they pursue by similar-
ly objective methods. CED cooperates with these organizations on research and study projects of com-
mon interest to the various countries concerned. This program has resulted in a number of joint policy
statements involving such international matters as energy, East-West trade, assistance to develop-
ing countries, and the reduction of nontariff barriers to trade.
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